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Abstract
An enzyme-linked immunosorbent assay was developed for the detection 
of antibodies to Pasteurella antipestifer in duck sera. The assay was shown to be 
sensitive, specific and reproducible. Its superiority over rapid slide agglutination 
and agar gel precipitin tests for detecting early antibody responses to the organism 
was demonstrated. Serum antibody titres were shown to correlate with protection 
against virulent intramuscular challenge. Moreover, the formation of the 
antigen/antibody complex in vivo was shown to effect an immunological memory to 
the organism. The protection afforded by different pre-formed preparations of 
antigen/antibody complex to intramuscular challenge was investigated and their 
efficacy discussed. \
Epidemiological studies indicated that ducklings were most susceptible 
to infection given intramuscularly; those infected orally neither died nor showed 
clinical signs of the disease. Intranasal instillation caused no deaths, but signs of 
infection were occasionally observed in the treated birds. In the orally challenged 
group, specific antibodies were detected in the tracheal washings of five of nine 
birds examined, but circulating antibodies to the organism were found in only one 
individual. Specific antibodies were also shown to be present in the tracheal 
washings of nine of twelve birds infected intranasally, whilst serum antibodies were 
detected in four of these individuals. It was further shown that antibodies present 
on the tracheal surface could also be derived from those administered 
intraperitoneally.
Experiments were conducted to evaluate the efficacy of an experimental 
combined P. anatipestifer - E. coli vaccine in the field. A single injection of 
vaccine given at 10 or 14 days of age effected significant reductions in mortalities 
caused by these diseases. Immunological data indicated that the vaccine effected a 
priming of the neonatal humoral immune function, thus increasing the efficacy of 
the antibody response following exposure to the organism.
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Chapter 1
General Introduction 
1.1' THE ORGANISM 7
Pasteurella anatipestifer, species incertae sedis, is responsible for a 
commercially important septicaemic disease of ducklings, particularly in intensive 
husbandry systems. The disease has also been reported in a variety of other avian 
species including pheasants, (Bruner e t  al. 1970) swans (Munday et al. 1970) and 
turkeys (Heifer and Helmbolt, 1977).
The disease and isolation of the causative organism was first described 
by Hendrickson and Hilbert (1932) in the USA. It has since been reported in England 
(Asplin, 1933), Canada (Taylor, 1953), the Netherlands (Donker-Voet, 1962), 
Germany (Hinz et al. 1976) and France (Bisgaard, 1982). The organism is of variable 
morphology, having a tendency to form long filamentous Gram-negative rods, 
although coccobacillary forms may be also observed. Isolates of P. anatipestifer are 
generally found to be proteolytic, non-fermentative, urease-positive, 
non-haemolytic and Voges-Proskauer Methyl Red-negative. Litmus milk is not 
reduced and no growth is found on MacConkey agar or c itra te  agar (Heddleston, 
1975). However, the taxonomic status of P. anatipestifer is uncertain. Bangun e t  
al. (1986) reported that strains of P. anatipestifer have lower base compositions than 
those found with Moraxella and other Pasteurella species. Furthermore, DNA 
hybridisation investigations undertaken by these workers showed tha t strains of 
P. anatipestifer shared low DNA homology with Moraxellas and other Pasteurella 
species. On the basis of these findings, Bangun et al. suggested that the strains of 
P. anatipestifer are unrelated to either Pasteurellas or Moraxellas, and thus should 
be excluded from the genera. However, it would seem from the published avian 
literature tha t since the findings of Bangun et al. there have been no formal 
a ttem pts  to re-classify the organism.
1.1.1. Serotypes of P. anatipestifer
In 1981, Houghton Poultry Research Station held fifteen strains of 
P. anatipestifer designated by the letters  A to O. Bisgaard (1982) found that two of 
these serotypes were identical and to avoid further confusion suggested the adoption 
of the American system of nomenclature using Arabic numbers. It would appear 
that the National Animal Disease Centre (Ames, Iowa) nomenclature is now
regarded as standard in the published American Literature. According to Harry and 
Deb (1979), serotype 1 is the most virulent and the strain responsible for most of the 
outbreaks of P. anatipestifer septicaemia in the U.K. Bisgaard (1982) reported the 
identification of six different serotypes isolated from ducks in Denmark during the 
years 1976-1980, but indicated that the majority of the outbreaks were caused by 
serotypes 1 and 3. Sandhu and Harry (1981) investigated the relative incidence of 
the strains responsible for outbreaks of the disease in the U.S.A. and found that 
more than 93% of isolations made from 1975 to 1979 belonged to serotypes 1, 2 and 
5. However, it was noted that the incidence of serotype 1 isolates almost doubled in 
1977-1978. It was suggested that this may have resulted from the widespread use of 
sulphadimethoxine-ormetoprim since some serotype 1 isolates were found to be 
resistant to this antibiotic.
1.1.2. Transmission of the disease
Hendrickson and Hilbert (1932) reported that the i.v. injection of
P. anatipestifer infected tissue into ducklings, usually, but not always produced the 
disease. Further, it was found that the same preparation, when given orally, failed 
to produce signs of infection. Similarly, Dougherty et al. (1954) demonstrated the 
successful infection of ducklings when given suspensions of ground liver and spleens 
containing the organism via the i.p. and intranasal routes. Harry (unpublished data) 
demonstrated high mortality in ducks following i.m., intratracheal or oral 
administration of the organism. In contrast, Asplin (1956) reported no signs of 
disease in ducks infected orally or intranasally, and demonstrated that wounds,
particularly of the feet, were important routes of entry in disease transmission. In 
agreement with these findings, Leovobitz (1972) suggested that foot and leg lesions 
were important in transmission. Smith £ t  al. (1987) described high losses in turkeys 
caused by P. anatipestifer. These workers speculated that mosquito vectors were 
responsible for transmission of the disease, originating from a commercial duck 
farm of close proximity to the turkey premises. Further preliminary investigations 
by Smith et al. indicated that the disease was most readily transmitted following the 
i.v. and i.m. injection of turkeys with the organism, thus further supporting the role
V c 'of biting insects as vectors in these instances. (
1.1.3. Clinical Signs
The disease is usually associated with ducklings aged between two and 
five weeks, although occasionally losses due to P. anatipestifer septicaemia may be 
found in the older birds (Hatfield, unpublished observations). The first signs of 
infection consist of ocular discharge, depression and ruffling of the feathers. This is 
usually accompanied with a greenish-white diarrhoea and resultant staining of the 
feathers around the vent. Later, the bird may develop head tremors followed by 
complete prostration. Individual birds may die within 1 to 5 days after symptoms 
appear and the course of the disease within infected flocks may be from one to five 
weeks (Hatfield, unpublished observations). Morbidity, indicated by ocular discharge 
and diarrhoea may be as high as 100%. The extent of the mortality is dependant on 
several factors, including the virulence of the infecting strain, level of infection, 
rearing conditions and age of bird. Levels approaching 10% are not uncommon and 
may be as high as 65% (Dougherty £ t  al. 1954).
1.1.4. Lesions
Fibrinous pericarditis is one of the more usual and striking features of 
the disease (Dougherty e t al. 1954). During the chronic phase of disease, a fibrinous 
exudate is conspicuous on the airsacs and on the serous membranes covering the
surface of the liver (Pickrell, 1965). Hilbert and Hendrickson (1932) reported a 
white mottling of the spleen, but no appreciable enlargement. In contrast, 
Dougherty e t  al. (1954) found that in 89 of 100 birds examined with the disease, the 
spleen was enlarged to three to five times its normal volume. Pickrell (1965) 
suggested that splenomegaly occurs only in field infections and results from 
concurrent infection. In female ducklings, the oviduct may be distended throughout 
its length by a caseous exudate, aj/ feature which may occasionally be found in the
t
absence of other gross lesions (Hatfield, personal observations). In birds exhibiting 
nervous symptoms, cerebral lesions may be found in the acute phase, but are usually 
not present in the chronic phase of disease (Pickrell, 1965).
Post mortem findings can be confused with other diseases of ducks 
including Group D Streptococci, Esherichia coli and Pasteurella multocida 
infections. Diagnosis should therefore be confirmed by the isolation and 
identification of the causative organism.
1.1.5. Immune responses
A review of the published literature (English language only) indicates 
that there have been no reports describing the role of humoral or T-lymphocyte 
mediated immunity in protective resistance against P. anatipestifer infection in the 
avian species. In view of the economic importance of this pathogen and the fact 
that vaccines are reportedly effective in the control of the disease (see section
1.4.2.9.1.) these areas of investigation are clearly neglected.
1.2 THE AVIAN IMMUNE SYSTEM
The immune system performs a vital role in the defence of the host 
against infectious disease. In vertebrates, the immune response is characterised by 
three features. Firstly, it is specific so that exposure to an infectious organism 
results in the stimulation of the immune mechanisms and consequently, protection
against that organism. Secondly, the system possesses memory, thus a repeat 
exposure to antigen results in a quicker and greater response than that of the first 
exposure. Thirdly, the system is capable of discriminating between self and non-self 
antigens; however, failure of this example of immunological tolerance may result in 
reaction to body components causing auto-immune disease.
Although many of the features associated with immunity in mammals are 
also found in avians, there are differences. Notable of these is the avian bursa of 
Fabricius, an organ which is important as a site of B-cell differentiation and 
immunoglobulin synthesis. The equivalent of the avian bursa has not been 
demonstrated in mammals. The other major organ performing a crucial role in the 
normal functioning of both avian and mammalian immunity is the thymus which is 
responsible for the T-cell mediated immune reponse. These two organs form the 
primary or central component of the lymphatic system, whereas other areas of the 
lymphatic tissue including, the spleen, bone marrow, gut, caecal tonsils and the 
glands of Harder comprise the secondary or peripheral component.
1.2.1. The bursa of Fabricius
The bursa is a round to oval hindgut lymphoid organ peculiar to birds. An 
immunological function was first attributed to this organ following the important 
findings by Glick (1956), who showed that early bursectomy reduced the ability of 
chickens to produce antibodies against Salmonella typhimurium. The realisation 
that the bursa was necessary for the compartmentalisation and subsequent 
differentiation of B-cells into antibody producing cells enabled the systems of 
immunity to be differentiated; thus avians, in particular the fowl, have become 
important as immunological models in developmental immunology.
1.2.1.1. Immunoglobulins
Three major classes of immunoglobulin isotopes have been identified in
the chicken of sufficient similarity to mammalian immunoglobulins to be termed 
IgM, IgG and IgA. Skin fixing antibodies have been described in the chicken, but 
insufficient physico-chemical criteria exist to classify these as IgE or IgE subclass 
antibodies (see Chi. et al. 1981). IgM is usually produced early in the immune 
response to most antigens. In the fowl the molecule of IgM has a molecular weight 
of 890,000 and exists as a pentamer with each unit consisting of two heavy and two 
light chains joined together by disulphide bonds (see Higgins, 1975). However, serum 
IgM of molecular weight 800,000 has been described in the duck (Ng and Higgins, 
1986) although why this should differ from the molecular weight of fowl IgM was not 
indicated. Furthermore, Ng and Higgins (1986) demonstrated the presence of an IgM 
related molecule (mol wt. 890,000) in duck bile but carrying additional determinants. 
These workers proposed that bile Ig, secreted independently of serum Ig’s, performs 
a role in mucosal protection. In both mammals and avians, however, IgG 
immunoglobulins are the major Ig isotopes. The molecule of mammalian IgG has a 
molecular weight of 160,000 (see Smith, e t al. 1964), whilst fowl IgG due to a higher 
carbohydrate content has a molecular weight variously estimated between 165,000 
and 206,000 (see Higgins, 1975).
Higgins (1988) has recently reported that ducks produce anti-HIgG 
precipitins in response to repeated immunisation with DNP-H Ig G. The resultant 
antibody populations were electrophorectically homogeneous 5.7S Ig G, but differed 
with respect to the mass of the heavy chains. Non-precipitating antibodies had 
heavy chains with a mol, wt. of 37k Da whilst that of the precipitating antibodies 
were predominantly 41k Da. Higgins suggested that the steric configuration of the 
Ig antibodies containing the 37k Da polypeptide is not condusive to cross-linking 
different molecules of antigen. However, the reasons for the unique structural 
differences between the two populations of 5.7S IgG antibodies remains unclear.
IgA immunoglobulins (mol. wt. 180,000) are important in immunity at the 
mucosal surface, although a secretory form of IgA, important in the protection of 
the gut lamina propria, of molecular weight 360,000 has been described (Watanabe, 
e t al. 1975). Both secretory and non-secretory forms of IgA exist as dimers 
consisting of two joined subunits each of two heavy and light chains.
1.2.1.2. Ontogeny of B-cells and Immunoglobulin synthesis
Thorbecke e t al. (1968), using enzyme-immunohistocytochemical 
techniques, demonstrated the synthesis of IgM in the bursa on day 18 of embryonic 
development, whilst low IgG biosynthesis was not detected until one-day after 
hatching. The same workers also described the eventual detection of IgM and IgG 
class antibodies in the spleen at 3 days after hatching, whilst not until 15 days of 
age were IgG secreting cells first detected in the thymus. Thorbecke et al. 
suggested, on the basis of findings using germ free chickens, that IgM synthesis was 
independant of antigenic stimulation in the developing embryo, but the possible 
activating effects of virus present in the egg cannot be excluded. In comparison 
with the findings of Thorbecke et al., Kincade and Cooper (1971) demonstrated the 
earlier presence of IgM secreting cells in bursa removed from 14-day-old embryos 
and IgG immunoglobulins were detectable on day 21 of incubation. Furthermore, 
Kincade and Cooper investigated the sequential seeding of the immunoglobulin 
synthesizing B-cells originating from the bursa to the secondary lymphoid 
components. They showed that colonisation occurred first in the spleen, followed by 
the caecal tonsils and finally the thymus. Kincade and Cooper (1971) noted the lack 
of different immunoglobulin class-bearing cells associated with the sites of B-cell 
expression, an observation confirming the earlier reports of Cebra et al. (1966) and 
Takahashi jst al. (1968), and suggested the occurance of a switch from IgM to IgG 
synthesis in the bursa. The suggestion of an IgM - IgG switch occurring in the bursa 
was challenged by Blythman and White (1977). They bursectomised chicks jn ovo on 
day 18 of incubation which were subsequently challenged at 4 weeks of age with
SRBC. These procedures failed to reduce the IgM response to challenge, however, a 
severe lack of germinal centres were found in the spleen and the IgG response was 
ablated.
Young et al. (1975) injected bursectomised chickens with allogeneic 
anti-SRBC antiserum and compared the suppression of the antibody response against 
that of bursectomised birds following challenge with SRBC. The lowest 
concentrations of circulating antibodies were found in the passively 
immunised/bursectomised group of birds, however, both groups showed similar 
anamnestic responses to a second challenge of SRBC. On the basis of these 
observations, Young j5t al. suggested that the anti-SRBC antiserum effected a 
blocking of immunoglobulin synthesis a t the B-cell level. Ivanyi (1981) suggested 
that the normal secondary response to antigen found in bursectomised birds was 
probably due to the presence of B-memory cells remaining in the bursal remnants.
Bienenstock et al. (1972) showed that the seeding of lymphocytes 
expressing the synthesis of IgA immunoglobulins was bursa dependant. Lawrence et 
al. (1979) investigated the preponderance of IgA secreting cells in the various 
lymphatic tissues of the fowl and found the highest ratios of IgA to IgG synthesis in 
the lamina propria (0.9), intestinal epithelium (0.31) and the lungs (0.19). A 
secretory component, similar to that found in mammals, has been described 
associated with the gut secretory IgA response in the fowl (Watanabe et al. 1975), 
whilst IgA secreting cells found in the tracheobronchial mucus, bile, seminal plasma 
and tears appeared to function independently of the secretory component.
1.2.1.3. The role of the bursa in disease resistance
Several investigators have used bursectomy and thymectomy techniques 
in order to eluicidate the relative importance of the cells of the lymphoid series in 
immunity to certain diseases of the fowl.
Bursectomy was found to increase the mortality following infection with 
Salmonella typhimurium (Glick 1956; Chang et  al. 1959), Leptospira 
icterohaemorrhaqae (Kemmes and Pathes, 1963) and E. coli (Sadler and Edgar, 1969). 
However, removal of the bursa has been shown to have no significant effect on the 
development of immunity to fowl pox virus, NDV (Sadler and Edgar, 1968), MD 
(Payne and Rennie, 1976) and LTV (Fahey et al. 1983). However, dissection of the 
mechanisms of immunity dependant on the thymus and the bursa fail to take into 
account the interplay which exists between these two organs, and consequently 
necessary for the optimal performance of the immune system in the protection 
against disease.
1.2.2. THE THYMUS
The thymus is a paired organ, consisting usually of fourteen lobes, 7 on 
each side of the neck adjacent to the jugular vein. Stem cells originating from the 
yolk sac, committed for T-cell function, enter the thymic rudiment about day 6 of 
incubation. This event is followed by a second wave of stem cell migration shortly 
before hatching which continues for some two weeks thereafter (Le Douarin et al. 
1977). The stem cells gradually mature within the thymus to become functional 
T-cells, which eventually migrate to colonise the peripheral lymphatic tissue and 
organs (see section 1.2.).
Thymic lymphocytes are important in several important immunological 
phenomenon, including graft versus host rejection, delayed hypersensitivity 
reactions and furthermore, perform, a regulatory function by acting upon B-cells to 
suppress or enhance immunoglobulin biosynthesis. Zucker et al. (1973) used cell 
volume, electrophoretic mobility and bouyant density techniques to reveal the 
presence of three major subpopulations of T-cells in the thymus of 16 weeks old 
chickens. The function of each of the three distinct subpopulations of
T-lymphocytes will now be discussed.
1.2.2.1. Helper role of T-cell in bursal function
The role of T-cell helper function in avians was first demonstrated by 
Weinbaum j3t al. (1973). A source of B-cells was obtained following the injection of 
chickens with the hapten 2,4,6 TNP conjugated to KLH, whilst bursectomised birds 
were injected with BSA to induce the proliferation of T-cells. These workers 
demonstrated that a mixture of B and T-cells obtained from each of the TNP-KLH 
and BSA primed birds respectively, stimulated a greater antibody response following 
the challenge of bursectomised recipients with TNP-BSA than that of bursectomised 
birds given either B or T-cells only prior to challenge. It is now established that the 
optimal immune response is usually dependant on the co-operation of principally 
B-cells, T-cells and macrophages. T-cells are usually activated by presentation of 
the specific antigen by mononuclear phagocytes. The antigen is subsequently 
presented by the T-cell to the antigen specific B-cell. This process usually results in 
the synthesis and secretion of soluble lymphokines by the activated T-cells. 
Lymphokines perform a function in the activation and recruitment of macrophages 
to the site of immunological reaction, whilst others inhibit macrophage migration. 
Further activities of lymphokines have been described, for example, lymphotoxins 
against tumors and interferon in controlling viral proliferation (Bulow, V.v. and 
Klasen, 1983).
1.2.2.2. Suppressor T-cells
Kermani-Arab and Leslie (1977) transplanted spleen, bone marrow and 
thymus lymphocytes from agammaglobulinaemic chicks into normal 
non-bursectomised recipients with the resultant suppression of IgM, IgG and IgA 
biosynthesis. Moreover, they found that the injection of normal birds with 
lymphocytes and anti-T-cell antiserum plus complement prevented the suppressive 
effect of immunoglobulin synthesis, thus indicating that the suppression of antibody 
was T-cell mediated. Droege (1976) found that the injection of thymus cells into 
irradiated recipients significantly increased (P<0.001) the number of long lasting
h i on '
allografts when given to histo-noncompatable recipients. In contrast, irradiated 
chickens given no lymphocytes usually completely rejected the skin allografts within 
8 to 15 days.
1.2.2.3. Cytotoxic T-cells
Subpopulations of T-cells are capable of exerting a cytotoxic effect upon 
the target antigen. Treatment of cellular suspensions of T-cytotoxic cells with 
anti-T-cell antiserum results in some inhibition of the cytotoxic effect (Sharma and 
Tizard, 1984), although not all cytotoxic cells are T-cells (Chi e t al. 1981). 
Cytotoxic lymphocyte assays, using neutral red as the indicator for lysis, have been 
used to demonstrate T-cell cytoxicity activity against certain viral disease of avians 
including Rous sarcoma virus (Weinberg et al. 1973), IBV and fowl pox virus (Chubb 
e t  al. 1987) and MD (Ross et al. 1977).
1.3 METHODS FOR THE DETECTION AND QUANTITATION OF THE
ANTIBODY RESPONSE IN AVIAN SPECIES.
This section will provide a brief mention of some of the methods used 
routinely in poultry diagnostic laboratories for the detection of antibodies to 
specific diseases. However, the majority of the procedures described detect only 
precipitating or agglutinating antibodies, and therefore fail to reflect the total 
magnitude and duration of the humoral immune responses. However, it is clear from 
the published avian literature that many of these methods of antibody detection are 
rapidly being replaced by the more sensitive and practicable immunoassay 
procedures which are described in greater detail in section 1.3.4.
1.3.1. Agglutination tests
Rapid slide agglutination tests are used principally in the serotyping of 
various disease agents including E. coli (Sojka, 1965) and P. anatipestifier (Sandhu, 
1981). These tests have also been used to detect the agglutinating antibody response
in ducklings following experimental infection with S. typhimurium (Sari and Thai, 
1983), but have found little application in field studies^
Micro-agglutation tests have been used to detect antibodies in avians 
against diseases including Alkaliqenes faecalis (Jackwood and Saif, 1980). 
Pasteurella multocida (Marshall et  al. 1981), and S. typhimurium (Sari and Thain, 
1983).
1.3.2. Agar gel precipitin tests
These procedures have been described as the standard technique for the 
detection of antibodies to haemorrhagic enteritis virus in the fowl (Domermuth and 
Gross, 1980). AGP tests have also found application in the detection of antibodies 
to avian IBV (MacDonald et al. 1982), goose parvovirus (Gough, 1984) and EDS virus 
(Piela and Yates, 1983). These methods have also been used for serotyping strains of 
P. anatipestifer isolated from commercially raised ducklings (Harry, 1969).
1.3.3. Haemaqqlutination/haemaqqlutination inhibition tests
Indirect haemagglutinating procedures have been described for the 
detection of antibodies to P. anatipestifer (Harry, unpublished data) and P.multocida 
(Solano et al. 1983). Similar methods, using erythocytes sensitised with antigenic 
extracts have been used in the detection of Mycobacterium avium antibodies in both 
the duck and the fowl (Kwatra et al. 1972).
McCraken et al. (1978) demonstrated that the virus responsible for egg 
drop syndrome in the fowl was capable of haemagglutinating CRBC's. Subsequently, 
Calnek et al. (1978) described the development of a haemagglutination inhibition 
test for the detection of antibodies against the virus. This method still remains the 
standard procedure for the detection of antibodies to the EDS virus. 
Haemagglutination inhibition tests have also been described for the detection of
antibodies to NDV following the vaccination of fowl with the live H120 vaccine 
strain (Monreal et al. 1985).
1.3.4. Immunoassay
This term is used to describe those immunological assay methods not 
requiring the use of precipitating antibodies in the primary reaction, and are 
characterised by the employment of labelled forms of antibody, antigen or hapten 
for quantification of the analyte.
1.3.4.1. Principle of immunoassay
The original immunoassay was conceived by Yarlow and Berson (1960),
who described a method for measuring plasma insulin using '^Iodine-labelled
hormone and a specific antibody to that analyte. The principle of the classical 
immunoassay used by these investigators is shown in the equation below:-
*J ■'>
Ag + Ag*Ab ----- > Ag* Ab + Ag Ab / (J 1
It is characterised by the fact that it is a limited reagent system and
obeys the Law of Mass Action: a concentration of antibody (Ab) is chosen on the 
basis that it will bind only 50% of the labelled antigen (Ag*) introduced into the 
system. Subsequently, the greater the concentration of unlabelled antigen (Ag) 
present in the sample (or standard), the greater the competition with labelled 
antigen for the limited number of antibody binding sites present. Following a period 
of incubation to allow the formation of the antigen-antibody complexes, the bound 
and free fractions of the antigen are separated and the activity of the labelled 
antigen in one of the fractions determined. The concentration of analyte present in 
the sample can then be determined by reference to a standard curve.
1.3.4.2. Alternatives to RIA
The development of RIA provided the basis for a method of vastly
superior sensitivity and specificity for the detection of very small quantities of
analyte, providing that antisera could be raised (to these) and the appropriate
antigens, labelled. However, the employment of radioactive isotopes as labels has
considerably restricted theif application, particularly in smaller laboratories and
also in food laboratories. Equipment used to measure radioactivity is expensive;
furthermore, the shelf life of labelled reagents is limited and departments
employing these methods are subject to strict legislation. Moreover, the most
125commonly employed radioisotope, Iodine, has a half life of 60 days, consequently
125regular preparation of I-labelled antigens are necessary and may pose real and 
cumulative risks to health. It is for these reasons that much effort has been focused 
on finding alternative labels for use in immunoassay. The numerous labels used as 
substitutes for radioisotopes in immunoassays have been reviewed by Schall and 
Tenoso (1981). These include bacteriophages, chemiluminescence precursors, 
enzymes and co-enzymes, fluorochromes, fluorogens, inhibitors, various 
particulates, metal atoms and stable free radicals. Although many of the problems 
associated with the use of radioisotopes were overcome, Schall and Tenoso indicated 
that none of the alternative labels reviewed were found to be ideal, but that each 
presented a positive potential for application in its own niche.
The first use of enzymes as labels was reported almost simultaneously by 
Engvall and Perlmann (1971) and Van Weeman and Schuurs (1971). Engvall and 
Perlmann elected to describe the new method as an enzyme-linked immunosorbent 
assay, this term subsequently gained popular usage and is presently used to describe 
all immunoassays employing enzyme-labelled reagents and involving the adsorption 
of one of the immunoreactants onto a solid phase. Enzymes have since become the 
label of choice in many immunoassay procedures and their application in these 
systems has been extensively reviewed (Wisdom, 1976; Schuurs and Van Weeman,
Table 1,1. 
Enzymes used in E.I.A.
Heterogeneous
assays
Horseradish peroxidase 
Alkaline phosphatase
6-D-galactosidase 
Glucose oxidase
Urease
Homogeneous
assays
3-galactosidase
Lysozyme
Malate dehydrogenase
Glucose-6-phosphate
dehydrogenase
Ribonuclease
Immunohistochemistry
Horseradish peroxidase 
Alkaline phosphatase 
Glucose oxidase
Acetylcholinesterase
1977; O’Sullivan et al. 1979, Blake and Gould, 1984). The enzymes which have been 
used in EIA are shown in Table 1.1 and selection should be based on satisfying most 
of the following criteria in the assay procedure used:
1) high substrate conversion
2) ease of detection of its product
3) high specific activity
4) conjugated preparations should have a long shelf life
5) absence of interfering substances in samples ie. enzymes,
co-enzymes substrates, proteases
6) available in pure form at reasonable cost ^
In heterogeneous EIA (assays requiring a separation phase) (see section
1.3.4.3.2.) alkaline phosphatase, $-D-galactosidase and horseradish peroxidase are 
commonly employed as enzyme labels (Wisdom, 1976; O'Sullivan et al. 1977). Of 
these, however, horseradish peroxidase is the most widely used, on account of its 
cheaper cost, greater ease of detection of its products and ease of conjugation 
(Tijssen, 1983). Furthermore, a wide range of substrates are available for use with 
this enzyme, including 3AS, ABTS, OT and OPD. Of these, Voller (1979) has shown 
that OPD is by far the most sensitive indicator of peroxidase activity. However, 
some of the peroxidase substrates oxidised by H2 O2 , including OPD are reportedly 
mutagenic in test systems (Voogd et al. 1980).
The product of enzyme activity is usually detected using purpose 
designed spectrophotometers which are now obtainable at reasonable cost from a 
variety of commercial sources. In the absence of suitable photometers, the products 
of urease or horseradish peroxidase activity are easily discernable visually and thus 
can be used to indicate a positive result. The various assay designs employing 
enzymes or labels will now be discussed.
I ID 
UlLl.
Hydrochlorothiazide 
and Amiloride Hydrochloride, MSD
1.3.4.3. Enzyme-immunoassay
EIA procedures involving the use of antigen, antibody or hapten labelled 
with an enzyme may be categorised into either homogeneous or heterogeneous 
procedures depending on the salient features of the assay design.
1.3.4.3.1. Homogeneous immunoassay
The most commonly employed assay of this type is known by the trade 
name EMIT (enzyme mediated immunoassay technique), the principle of which is 
shown in Fig. 1.1. This procedure was first used by Rubenstein e t al. (1972), who 
noted that when antibodies to morphine were bound to an enzyme conjugated 
morphine derivative, the peptidoglycan substrate was not utilised. Furthermore, it 
was found that by introducing free unlabelled morphine into the system some of the 
inhibitory effect was removed. It is thought, in this instance, that the binding of 
antibody to the enzyme-hapten conjugate produces a steric hindrance of the 
substrate: the inhibitory effect is subsequently removed proportionately to the 
concentration of analyte added to the system. With these systems, however, 
inhibition of enzyme activity is so slight (Voller et al. 1979), only small differences 
(0.1 to 0.2 absorbance units) between the inhibited and non-inhibited reaction can be 
measured. Moreover, since no phase separation is required, these assays are very 
sensitive to interference from substances present in some biological fluids, which 
may further decrease the sensitivity of these procedures. It is for these reasons 
that the more versatile heterogeneous procedures are preferred for the quantitation 
of analytes, and in particular the detection of antibodies to infectious diseases.
1.3.4.3.2. Heterogeneous immunoassay
These methods are characterised by the fact that phase separation 
systems are employed to separate the antibody bound and free reactants. The use of 
second antibodies for phase separation has been described (Utiger e t al. 1962), but 
solid phases, for example, polystyrene tubes (Catt and Tregear, 1967) cellulose
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(Engvall and Perlmann, 1971), and agarose (Holmgren and Svennerholm, 1973) were 
usually preferred for immobilisation of the appropriate immunoreactant. However, 
the practicability of these systems was greatly improved following a report by 
Voller et al. (1974) describing the usage of plastic micro-titration plates for the 
immobilisation of malarial antigens and subsequent detection of their specific 
antibodies. This method of immobilising a selected immunoreactant was rapidly 
adopted by many investigators for the detection of antigens eg. HBs Ag (Wolters et 
al. 1976) and in particular for the detection of antibodies to infectious agents eg. 
Neisseria qonorrheae (Glynn and Ison, 1978) and IBV (Mockett and Darbyshire, 1981).
The use of microtitration plates as solid phase supports is worth 
particular attention. These are available in either polystyrene or polyvinyl and 
consist of 96 wells arranged in a 8 x 12 format: each well may contain up to 400pl. 
They are obtainable from a variety of commercial sources at reasonable cost; 
however, they must be assessed carefully prior to usage in routine procedures. 
Denmark and Chessum, (1978) reported unacceptable variations in absorbance values 
existing between the outermost and central wells (the edge effect) with some types 
of plates. The effect was critically investigated by Oliver e t  al. (1981), who 
demonstrated that a temperature gradient can exist between the peripheral and 
inner wells during incubation, thus causing the rim or edge effect. They found that 
the problem could be overcome by the use of specially designed forced air flow 
microtitration plate incubators, but warming up the plates and reagents to required 
incubation temperature is a simple alternative (Tijssen, 1985). Furthermore, 
considerable variations in antigen binding has been described in batches of plates 
obtained from the same manufacturer (Denmark and Chessum, 1978). The extent of 
the variation can be assessed simply from the absorbance measurements obtained 
following the assay of a positive sample, added to each of the antigen coated wells. 
The various assay designs employing a solid phase for the immobilisation of antigen 
or antibody in heterogeneous procedures will now be discussed.
1.3.4.3.3. Competitive method of ELISA
The first EIA reported were of this type (Engvall and Perlmann, 1971; 
Van Weeman and Schuurs, 1971). In these systems, a limited quantity of the specific 
antibody is immobilised on to the solid phase surface. The sample is then added to 
the system, together with a labelled form of the antigen. The labelled and 
non-labelled analyte compete for the limited number of antibody binding sites and, 
after  a suitable period of incubation, the free and bound phases are separated. It 
follows, therefore, that increasing the concentration of unlabelled analyte produces 
a proportionate decrease in the amount of labelled antigen binding and the fainter 
will be the colour in the system. The incubation of known concentrations of 
unlabelled analyte in the presence of fixed amounts of labelled antigen enables a 
standard curve to be derived from which concentrations of analyte in test samples 
can be determined by interpolation.
1.3.4.3.4. Non-competitive methods of ELISA
These are probably the most commonly employed EIA procedures. In
these methods, the immunoreactant to be immobilised on to the solid phase is
usually added in excess to ensure complete binding of all the analyte present in the
&
sample. Following a period of incubation to allow immobilisation, the solid phase m
washed at least three times to remove any non-bound or weakly bound material.
Optimum concentrations of reagents are determined by chequerboard titration using
positive and negative control reference sera: concentrations of immunoreactants
giving the greatest positive to negative discrimination and low NSB are selected for
/$
use in the test procedure. The simplest of these procedures ipf the direct method,
whereby the immobilised antigen (Ag) reacts directly with the conjugate (Ab.E) as
A
shown.
Ag + Ab.E ------------> Ag - Ab.E
Direct procedures are little used for quantitative 
determinations, but find extensive application in enzyme-immunohistochemistry 
methods for the identification and localisation of antigen in tissues, for example, 
papillovirus, hepatitis B surface and core antigens, herpes simplex virus (Bourne, 
1983).
The indirect non-competitive methods of EIA have become 
extremely popular for the quantitation of antibodies and antigens. Following 
immobilisation of the appropriate immunoreactant, the test sample is added and any 
bound analyte reacted with the corresponding enzyme-labelled antiserum. 
Subsequently, the extent to which the enzyme labelled reagent is bound in the 
system can be used to measure indirectly the concentration of analyte present in the 
sample.
For reasons of convenience, many laboratories prefer to work 
with commercial preparations of enzyme-labelled conjugate; however, if 
enzyme-labelled antibodies specific for the primary reaction antibodies are 
unobtainable, bridging antibodies can be employed between the immobilised primary 
reaction antibodies and the enzyme-labelled antibodies. The principle of this 
procedure is shown below:-
Ag + Ab(test) + Ab(bridge) + Ab.E > -Ag - Ab(test) -Ab (bridge) -Ab.E.
A useful variant of these non-competitive ELISAs in disease diagnosis is the 
antibody class capture method. These methods are based on the observation that 
lgM class antibodies predominate during the early stage of infection and are 
gradually replaced by IgG class antibodies as the disease progresses. In these 
procedures antigen is immobilised on the solid phase and after incubating with 
sample, the anti-class immunoglobulin antiserum is used to detect any bound IgM or 
IgG present in the sample. These methods have been used to diagnose early
infections for example, of rubella (Enders, 1983), leptospirosis (Terpstra et al, 1986) 
and avian IBV (Mockett and Cook, 1986). Similar methods have also been employed 
successfully in the detection of IgA class immunoglobulins in the fowl tracheal 
mucosa (Hawkes e t al. 1983).
1.3.4.4. Non-specific effects and assay performance
Non-specific adsorption of sample, second antibodies or enzyme label to the
plastic wells of the micro-titration plate can reduce assay performance. These
non-specific effects can normally be identified during reagent optimisation in
heterogeneous procedures; however, if too high a dilution is selected on the basis of
low N5B the detection limit of the assay will be impaired. These effects can
normally be avoided by the use of various buffer additives^jtp block the excess
adsorption sites unoccupied by the immunoadsorbent. The inclusion of detergents in
the wash and incubation buffers can be used to inhibit NSB (Engvall and Perlmann,
1971); however, Kenna et al. (1985), working with human sera, found the
replacement of Tween 20 with casein to be a more effective blocking agent. Avian
immunoglobulins were shown by Slaught e t al. (1979) to have a particularly high
affinity for plastics, and they suggested a pre-treatment of the assay wells with
foetal calf serum to overcome this problem. However, the procedure suggested by
Slaught et al. was found to increase the absorbances obtained for 'negative* sera in
an assay for the detection of antibodies to Mycoplasma iowae (JordQn et al. 1987).
Case et al. (1982) reduced the NSB of avian serum proteins by the inclusion of high
salt concentration in the wash and incubation buffers; however, they found that it
fcho
was necessary to wash the reaction wells t h y ghly with distilled water prior to
As.
addition of substrate to avoid possible enzyme inhibition.
Many biological substances possess endogenous enzymes, co-enzymes, 
proteases or other interfering substances which may inhibit or enhance the enzyme 
reaction. In heterogeneous procedures such interference is normally removed during
the various washing steps employed following incubation of the immunoreactants.
1.3.4.5. Precision and sensitivity of EIA
The term precision is used to denote the degree of replicability of a result 
determined either in the same assay or in a series of assays under prescribed 
conditions. The extent of this variation is usually expressed as the % CV. The 
within-assay variation can be assessed by assaying one sample many times in the 
same assay and the between-assay variation determined by assaying a sample in a 
number of different assays.
The precision of a number of EIA employed for the detection of antigens and 
haptens has been tabulated (Schuurs and Van Weeman, 1977). They concluded, from 
their own findings and those of other workers, that the precision of EIA can be of 
the same order of magnitude as that of other immunoassays, notably RIA.
The precision and reproducibility of EIA can be monitored simply by the 
incorporation of QC samples into the assay system, selected on the basis of potency 
over the working range of the assay. The mean and standard deviation of the 
absorbance measurements obtained for each of the QC pools can then be plotted on 
a simple QC chart. If two or more pools give measurements outside the statistical 
confines determined for each pool, the assay should be rejected.
A precision-dose profile (Rodbard, 1974) can be derived by plotting the % 
CV of the estimates of a sample against its mean potency value. The data is then 
binned and the resultant curve indicates ^change in assay precision over the 
analytical range therefore providing an estimate of the reliance which can be placed 
on the assay result a t a particular dose level.
Many factors influence the sensitivity of EIA including the affinity of 
antigen-antibody binding, choice of assay procedure, time and temperature used for 
the various incubations, interference effects, detectability of the system, purity of
reagents and reagent concentrations. For these reasons, comparisons between the 
various immunoassay procedures employed for the quantification of a particular 
analyte are difficult to establish.
The use of affinity-purified immunoglobulins has been shown to be an 
important factor governing the sensitivities of sandwich type ELISAs. Ishikawa e t 
al. (1982), using affinity-purified Fab fragments labelled with 8-D-galactosidase, 
increased the sensitivity of the method 10-50 fold for assays of ferritin, 
immunoglobulin E and TSH. The use of affinity-purified immunoglobulins reduces 
the amount of label required for conjugation, decreases background colour and 
allows larger concentrations of specific antibodies to be immobilised on the solid 
phase (Tijssen, 1985).
Most authors compare the sensitivities of ELISAs for the detection of 
antibodies with those of existing methods such as agglutination (Marshall e t al. 
1981), micro-immunofluorescence (Evans et al. 1983), immunodiffusion (Piela and 
Yates, 1983) and find them to be of greater sensitivity and practicability. Garret e t 
al. (1983) and Smart and Grix (1985) found that VN tests and ELISAs for the 
detection of antibodies to infectious AEV were of comparable sensitivity. The 
ELISAs used by these workers, however, detected only anti-AEV IgG class 
immunoglobulins, whereas the VN test would detect antibodies other than the IgG 
class. However, both of these groups of workers concluded that the ELISA was by 
far the most practicable method for the assay of large numbers of avian sera, and 
suggested that the VN test will be gradually replaced by solid phase EIA for the 
detection of antibodies to this virus.
In ELISAs for the detection of antibodies, a variety of methods have 
been used to establish the detection limit for the assay based on the upper limit of 
absorbance for the negative sera; these include, twice the mean value (Garrett et al.
1983), mean plus three standard deviations (Snyder et aL 1983), four times the 
standard deviation (Adair et al. 1985) and the mean plus two standard deviations 
(Mockett e t al. 1986). Jordan et al. (1987) investigated the application of these 
various formulae in an attempt to reduce the number of false positives in an ELISA 
for the detection of antibodies to Mycoplasma iowae. They found that the heating 
of 'negative' sera at 56°C for 30 minutes and using a detection limit set a t the mean 
absorbance value plus three standard deviations resulted in the least number of false 
positives. They considered, however, that the application of this formula might 
reduce the sensitivity of the assay procedure.
1.4 VACCINES
Nearly 200 years ago, Jenner showed that material obtained from cow 
pox lesions was capable of inducing immunity in humans against the virulent small 
pox virus. Since these beginnings, vaccines have been employed extensively in the 
control of human and animal associated infectious diseases. The poultry industry 
represents a special case, since the intensive systems of husbandry presently 
employed as a commercial necessity for the continuance of success are dependant 
on vaccination programmes for its existance. The environmental and rearing factors 
provide ideal opportunity for the rapid spread of a host of infectious diseases, some 
of which would unequivocally result in unacceptable high levels of mortality, 
reduced flock performance and high rejections in the absence of the appropriate 
vaccination procedures. However, the cost of the individual bird is relatively low, 
consequently, there would appear to be little justification for the diversion of huge 
funds into the development of novel vaccines which are presently stimulating much 
interest in the field of human medicine. Nevertheless, these novel vaccines offer 
potentially greater benefits over the conventional vaccines presently employed in 
the poultry industry. This discussion will therefore be predominately concerned with 
those types of vaccine which are presently employed in the control of poultry 
pathogens; however, this review would be incomplete without some mention of the
recent progress towards the development of the novel type vaccines.
1.4.1. Vaccines: definition and function
Vaccines are preparations which employ usually a killed or attenuated 
form of the virulent agent to stimulate the mechanisms of immunity active against 
the specific disease, and consequently prevent its spread to the target tissues and 
organs where the pathological damage is done.
Primary vaccination usually effects an immunological memory, whilst a 
booster injection results in a greater stimulation of immunity and thus increases the 
duration of immunity against the specific infectious agent.
1.4.2. Types of vaccines
The greatest successes in the control of human diseases have been 
achieved by the use of live vaccines, for example, measles, mumps, rubella and 
smallpox. Live vaccines are usually preferred to killed vaccines for the 
immunisation of poultry because they allow the application of mass administration 
methods ie. in drinking water or by aerosol spray. Furthermore, live attenuated 
vaccines behave in much the same way as their wild virulent counterparts on 
effecting the appropriate immune response. Nevertheless, disadvantages do exist 
with the attenuated vaccines, including possible reversion to virulence, insufficient 
attenuation may be cause clinical signs of disease and reduced bird performance; 
whilst contamination of viral substrates with adventitious agents can occur. 
Although killed vaccines are safe to use, their application tends to result in a 
shorter duration of immunity than live vaccines, consequently regular booster 
injections are sometimes necessary which are labour intensive and therefore 
expensive.
The immunogenicity of inactivated vaccines given parentally is enhanced 
by the incorporation of adjuvant into the antigen mix. There are many and various 
substances which have adjuvant activity including alum, aluminium hydroxide,
endotoxins, peanut oil, saponin, tapioca, turpentine and water in oil emulsions. 
However, with the exception of aluminum hydroxide and water in oil emulsions, few 
of the other listed substances have positive application. Mineral oil adjuvants 
cannot be used in humans because of the tissue reactions they induce (see Churchill, 
1981). Reid and Blackhall (1986) compared the efficacies of vaccines containing 
five different adjuvants for the control of infectious coryza, (Haemophilus 
paraqillinarum) in chickens. Vaccines containing aluminium hydroxide as adjuvant, 
or a combination of aluminium hydroxide plus mineral oil were found to provide the 
best protection against homologous challenge. Mineral oil-adjuvant vaccines were 
shown to produce granulomatous swellings at the site of injection, whereas saponin 
(Quil A) vaccine gave no significant increase in protection as compared with the 
non-vaccinated/challenged controls. However, the employment of aluminium 
hydroxide as adjuvant, if included in the primary vaccinations, may not be necessary 
in subsequent booster injections (Chang £ t  al. 1986). These investigators further 
showed that the antibody titres in rabbits were greatly enhanced following a booster 
injection of a potential anti-pregnancy vaccine containing OK432 (from 
Streptococcus spp) as supplementary adjuvant.
The usage of vaccines in the control of some of the major diseases of 
poultry will now be discussed.
1.4.2.1. Newcastle disease vaccines
Bennejean et al. (1978) recommended the simultaneous application of 
live (Hitchner Bl) vaccine strains and inactivated oil-emulsion vaccines for use in 1 
day-old chicks with maternal antibodies. These procedures were found to induce 
immunity for 11 weeks thereafter; a degree of protection was found following the 
usage of live vaccine alone, whilst the inactivated oil-emulsion vaccine, when given 
in the presence of maternal antibodies, resulted in a poor initial protection against
virulent challenge. Thornton et al. (1980) compared the efficacy of various live 
lentogenic ND vaccines. La Sota strains (now illegal in the U.K.) were found to 
produce a greater protection against challenge than the conventional B1 and Ulster 
2C strains. In agreement with these findings, Borland and Allan (1980) reported La 
Sota vaccine to be more immunogenic than the B1 strain; however, the AG68L strain 
was shown to be even more immunogenic than either B1 or La Sota strains.
1.4.2.2. Infectious bursal disease vaccines
Cursiefen et al. (1979) demonstrated the efficacy of a mutant strain 
CU-IM of the IBD virus to protect against bursal degeneration following exposure to 
the virulent strain in the field. However, some reduction in antibody titre  levels 
was noted following the vaccination of chicks at a time when maternal antibodies 
were present. As a consequence, they recommended a further application of the 
live vaccine strain given via the drinking water. Giambrione and Clay (1986) 
investigated the efficacy of various vaccination protocols employing the usage of 
live and killed vaccines for the simultaneous immunisation of chickens against ND 
and IBD infections. In areas of high risk, they recommended the vaccination of 
chicks at one-day of age with the live ND/IBD vaccine strains, followed 2 hours 
later by a s.c. injection of combined inactivated ND/IBD vaccine. However, a 
second exposure to the live vaccine via the drinking water was recommended at 18 
days of age to ensure immunity over the period of 7 to 8 weeks prior to slaughter.
1.4.2.3. Marek's disease vaccines
Protection against MD may be achieved by vaccines employing 
attenuated, naturally avirulent forms of the virus or the related HTV. However, 
breakdowns in vaccine efficacy are frequently reported (Thornton, 1980). Biggs et 
al. (1980) investigated the lack of efficacy associated with a particular flock and 
noted the variability in antibody titres following the vaccination of chicks at 1-day 
of age. They suggested that the high levels of maternally derived antibodies found
in a proportion of the chicks prior to vaccination were responsible for the variability 
in response to HT\A Witter (1982) compared the efficacy of monovalent and 
polyvalent attenuated viral vaccines to protect against virulent stains of MDV. Poor 
protection using homologous vaccines in the face of heterologous challenge was 
found, thus suggesting that the immunity conferred to chickens by vaccination was 
partially strain specific.
1.4.2.4. Infectious bronchitis virus
Winterfield and Fadley (1972) assessed the clinical effects in chickens 
following eye drop application of each of six different commercial live IBV vaccines. 
They found that three of the vaccine strains induced moderate to severe signs of 
respiratory distress in the recipients. Further vaccination/challenge studies by the 
same investigators showed that none of the commercial vaccines investigated were 
totally effective in chickens challenged with a heterologous virulent strain of IB. 
Gough et al. (1977) increased the duration to immunity of IB in layers following the 
employment of inactivated oil-emulsion vaccines as secondary boosters. Box e t al. 
(1980) spray vaccinated chicks at 4 weeks of age with live attentuated IB (H120) 
virus followed by an i.m. injection of inactivated vaccine given at point of lay. 
Subsequent challenge of these birds with virulent IB of the Massachussets type 
resulted in no loss of egg production. In contrast, birds given live vaccine only prior 
to challenge showed a sharp decline in egg production.
1.4.2.5. Vaccines employed against other viral diseases of poultry.
Avian influenza oil-emulsion vaccines have been shown to protect 
broilers and layers against mortality and morbidity following homologous challenge 
(Stone 1987). There have been no published reports describing the employment of 
live attentuated vaccines in the control of this disease.
C*
Live vaccines have been shown to be efficious in the control of DVH
A
(Woolcock and Crighton, 1979); however, the Rispens 55, Quodling (Q) and 
DVH-C-MLV live vaccine strains used for evaluation by these authors were found to 
revert to virulence following passage in ducklings. Gough and Spackman (1981) 
recommended the employment of inactivated DVH vaccines given to breeders at 8, 
16 and 22 weeks of age in order to provide antibody of sufficient titre  for the
protection of progeny during the first 3 weeks against susceptibility to the disease.
Formalin-inactivated oil adjuvant EDS 76 vaccines have been employed in the 
successful control of the disease caused by the EDS virus (Baxendale e t al. 1980).
1.4.2.6. Bordetella vaccines
Houghten et al. (1986) demonstrated that the efficacy of a live
temperature sensitive mutant vaccine of Bordetella avium was dependant on the 
type of challenge strain used. Spray and eye drop methods of vaccine application 
were found to only moderately reduce the severity of gross lesions in the trachea 
following challenge with a type 105 isolate of B. avium.
1.4.2.7. Escherichia coli vaccines
The efficacy of an oil-adjuvant inactivated E. coli vaccine in the
protection of fowl following virulent homologous challenge has been described (Deb 
and Harry, 1977). Panagraphy (1983) showed that booster injections of oil emulsified 
E. coli vaccines given s.c. to broilers over the intitial grower protected against 
challenge given by the respiratory route. Parry and Porter (1981) indicated that the 
infections caused by E. coli are normally secondary to some other primary infection, 
and as a consequence, control of the primary infection should eliminate the problem.
1.4.2.8. Mycoplasma qallisepticum vaccines
High concentrations of circulating antibodies were detected in chickens 
following a second immunisation with oil emulsified M. qallisepticum vaccine
(Panagraphy £ t  al. 1981). Furthermore, these investigators noted no clinical signs of 
disease in the vaccinated birds when challenged intra-ocularly with a 24 hour broth 
culture of virulent M. qallisepticum (R strain). Lin and Kleven (1983), recognising 
the need for an improved attenuated live vaccine in the control of this disease, 
investigated the potential of the attenuated F, S and A5969 strains of 
M.qallisepticum for the immunisation of broilers. The A5969 strain did not induce 
immunity against aerosol challenge, whilst the S strains were found to revert to 
virulence following back-passage through chickens. High passaged F strains, 
although shown to produce a good level of protection in chickens, were found to be 
virulent for turkey poults.
1.4.2.9. Pasteurella vaccines
A naturally avirulent isolate of P. multocida (Heddleston serotype 3) was 
shown to produce a satisfactory level of immunity in turkeys following challenge 
with virulent X-73 and type 1 strains (Singer and Malkinson, 1971). Ghazikhanian et 
al. (1982) demonstrated a significant level of protection against virulent challenge 
using the attentuated P. multocida (Clemson University) vaccine strain; however, 
following wing web application of this vaccine, local inflammatory responses, 
together with lameness were noted in some of the infected birds. Oil-adjuvant 
formolised inactivated P. multocida vaccines have been shown to protect ducklings 
against homologous challenge although booster injections were usually necessary 
(Layton, 1984).
1.4.2.9.1. P. anatipestifer vaccines
Harry and Deb (unpublished observations) investigated the suitability of 
an attenuated P. anatipestifer isolate (HPRS 2409) for use as vaccine. Parenteral 
administration induced protection in ducklings following homologous i.m. challenge, 
but its employment resulted in a 15% reduction in body weight when compared with 
the unvaccinated controls. There have been no published data in the avian literature
describing the employment of live attenuated or naturally avirulent strains of 
P. anatipestifer as vaccines in the control of the diseased
Harry and Deb (1979) were the first to describe the efficacy of 
inactivated vaccines in the control of the disease on farms in the U.K. However, 
the use of these vaccines has not gained popularity in this country and it would 
appear that the poultry industry has been prepared to accept the huge annual losses 
attributable to the disease. In contrast, killed vaccines are widely employed in the 
U.S.A. and Canada for the control of P. anatipestifer septicaemia in ducklings. 
(Layton and Sandhu, 1984).
In laboratory trials, Harry and Deb (1979) compared a number of 
inactivated P. anatipestifer vaccines and found a formolised antigen to be the most 
suitable for protection: the efficacy of the vaccine was not improved following the 
addition of aluminium hydroxide. In field trials, it was shown that the s.c. 
vaccination of ducklings reduced the level of mortality attributable to 
P. anatipestifer by more than 8 per cent.
Layton and Sandhu (1984) described the production of a broth grown 
bacterin designed for commercial usage prepared from strains 1, 2 and 5. This 
formolised inactivated bacterin, containing no adjuvant, was reportedly highly 
effective in reducing mortality and morbibity in flocks exposed to the disease. It 
was found that two i.m. injections given to ducklings at 10 and 17 days of age 
produced the greatest reduction in mortality, although a significant reduction in 
mortality was demonstrated using the one injection given at 10 days of age.
Sandhu and Layton (1984) suggested that the significance of E. Coli 
septicaemia in ducks was unclear and considered that P. anatipestifer infections 
may predispose ducklings to increased E. coli mortality. However, they found that 
the effective vaccination against P. anatipestifer did not reduce losses due to
E. coli. For these reasons, a combined E. coli/P. anatipestifer vaccine was produced 
which was found to give a significant reduction in mortality in ducklings vaccinated 
against E. coli/P. anatipestifer compared with ducklings given P. anatipestifer 
vaccine only. Apparently, the combined E. coli/P. anatipestifer vaccine has been 
subsequently tested in large scale trials on Long Island duck farms and has 
reportedly become the accepted method for the control of these diseases in the 
U.S.A. (Sandhu and Layton, 1984).
1.4.3. THE NOVEL VACCINES
1.4.3.1. Vaccines from recombinant DNA
The use of vectors for the expression of foreign genes coding for 
immunogenic proteins may provide a useful contribution in the development of the 
next generation of vaccines.
Following the work of Moss et al. (1984), much attention has been 
focused on the potential of the vaccinia virus as vector. Moss e t  al., using genetic 
manipulation techniques, inserted the HBs Ag immunogene into the thymidine kinase 
region of the vaccinia virus genome. The resultant recombinant vaccine was shown 
to induce protective immunity in chimpanzees against subsequent virulent HBV 
challenge. Over the period of challenge, only low levels of anti-HB core Ag 
antibodies were noted in vaccinated individuals, whilst high levels were detected in 
a chimpanzee given wild type vaccinia virus prior to challenge. Furthermore, 
evidence of liver damage, as indicated by the presence of high serum amino 
transferase levels, was found in the control animal. No clinical or pathological 
evidence of infection was found in the chimpanzees immunised with the recombinant 
vaccinia virus vaccine prior to challenge with HBV.
Wick et al. (1984) used the vaccinia virus as the vector for the expression 
of the rabies virus spike glycoprotein. These investigators inserted the immunogene
into the pG 520 plasmid which was subsequently used for transfection of the gene 
into the vaccinia virus genome during growth in BHK cells. Anti-spike glycoprotein 
monoclonal antibodies demonstrated the expression of the transplanted gene product 
in the cytoplasm and on the cell surface of the infected BHK cells. Moreover, mice 
and rabbits immunised with the vaccinia - rabies glycoprotein recombinant vaccine 
were shown to be protected following a severe intracerebral challenge with rabies 
virus. Binns et al. (1986) have been investigating the possibility of using the 
vaccinia virus-related fowl pox virus as a vector for i n s e r t i o n t h e  IBV spike, 
protein immunogene. These investigators have succeeded in characterising the IBV 
genome coding for synthesis of the viral coat spike protein; however, investigations 
are continuing to establish the non-essential regions of the fowl pox virus genome 
necessary for the insertion of the IBV spike immunogene.
There is a requirement for an improved vaccine in the control of 
coccidiosis in broilers. Effective multivalent live vaccines are available; however, 
their usage requires careful management and further, there is the danger of 
introducing new vaccine strains into the rearing system. Genetically-engineered 
vaccines may perform a function in the future control of the disease. Dansforth and 
Augusta (1985) inserted regions of the coccidial genome into the bacteriophage gt 
11 and used Western blot techniques to identify those viral recombinants expressing 
the coccidial proteins. The coccidial genes were then removed from the appropriate 
recombinants and inserted into a plasmid which was subsequently transferred into 
E. coli bacterial vector. Purified preparations of coccidial antigens, expressed 
by the E. coli vectors, were shown to induce a partial immunity in fowl following 
infection with parasite.
I.4.3.2. Synthetic peptides as vaccines
Arnon et al. (1971) and Langbeheim et al. (1976) successfully 
demonstrated that synthetic peptides could be used to induce an antibody response
against the native molecule. However, not until several years later were 
investigations undertaken to establish whether chemically pure synthetic vaccines 
could be employed in the control of specific infectious disease. In one of the first 
investigations of this type, Beachey et al. (1981) established that the immunogenic 
M protein of Streptococcus pyogenes consisted of repeating covalent structures. 
They synthesised a 35 amino acid sequence of the native molecule which was then 
conjugated to a multichain poly-lysine structure and emulsified in complete Freund's 
adjuvant. Mice immunised with the synthetic peptide vaccine were found to be 
protected against subsequent challenge with 5. pyogenes.
Similar experimental systems, using animals as models, have been used 
to assess the efficacy of synthetic peptide vaccines in the control of diphtheria 
(Audibert et al. 1981). These workers synthesised a fragment of the diphtheria toxin 
loop which was then coupled to BSA carrier. Guinea pigs immunised with the 
synthetic peptide were shown to be protected against the dermonecrotic effects of 
the diphtheria toxin.
Foot and mouth disease still remains a problem of worldwide concern. 
Live vaccines are usually used in the control of this disease. However, some viral 
strains cannot be grown to high concentrations and moreover, insufficient 
attenuation of the live vaccine strains has resulted in outbreaks of the disease (King 
et al. 1981). The VPI polypeptide of FMDV has been shown to be immunogenic 
(Moleon et al. 1979). The 213 amino acid sequence of the VPI polypeptide was first 
translated by Kurz et al. (1981). Bittle et al. (1981) used this information to 
synthesize seven different amino acid sequences on the VPI molecule. They found 
that the sequences 141 to 160 and 200 to 213 stimulated high levels of neutralising 
antibody following multiple s.c. immunisation of rabbits. However, further 
investigations by Bittle and colleagues established that a single injection of 
synthetic peptide sequence 141 to 160, using aluminium hydroxide as adjuvant, not
only induced higher concentrations of neutralising antibodies but also provided a 
greater protection against FMDV challenge than the synthetic peptide 200 to 213,
1.4.3.3. Anti-idiotype vaccines
Those determinants on the hypervariable regions of the immunoglobulin 
molecule are referred to as idiotypes, and, as the following discussion will illustrate, 
are themselves capable of inducing an immunological response (Jerne, 1975). Thus 
the injection of a recipient with idiotypic antibodies, induces the production of 
anti-idiotypic antibodies the antigen combining site of some of them being 
analogous to the three dimensional configuration of the epitope on the original 
antigen against which the first antibody was raised. Consequently, if anti-idiotypic 
antibodies are used as vaccines, the immunological response provoked should be 
specific for the orginal antigen.
This concept was applied in the early work of Sege and Peterson (1978),
who raised antibodies against RBP and insulin. The anti-idiotype antibodies raised
against RBP were shown to bind to ra t intestine epithelial cells having receptors for
RBP. The binding of anti-idiotype antibodies to the surface receptors was further
reinforced following the demonstration of a progressive decrease in binding of
anti-RBP antiserum to the epithelial cells in the presence of increasing
concentrations of anti-idiotypic antibodies. Similar competitive experiments
performed by these authors showed that the anti-idiotype antibodies against
125antibodies to insulin had the effect of inhibiting the binding of I labelled insulin 
to epidermal fat cells. Furthermore, the idiotype antibodies were shown to increase 
the uptake of a-aminosobutyric acid in ra t thymocytes, thus suggesting that the 
anti-idiotype antibodies raised against antibodies to insulin exerted as insulin-like 
effect. Sege and Peterson suggested that idiotype antibodies may form the basis of 
immunological methods for eluicidating the functional and structural relationships 
of cell surface receptor mechanisms.
In a survey of idiotypic networks, Roitt et al. (1981) highlighted the 
practical and theoretical considerations for the employment of anti-idiotype 
antibodies as immunogens. Kennedy et al. (1984) described the possible usage of 
anti-idiotype antibody vaccines for the control of Hepatitis B viral infections. 
Presently, the HBs Ag used for vaccination is obtained from patients chronically 
infected with the disease, consequently, not only is the source of antigen limited but 
also frequent collections of plasma is a distressing process for the patient. It is 
clear, therefore, that there is a need for an improved method of obtaining antigen 
for immunising against this disease. Kennedy et al. demonstrated that the idiotype 
associated with antibody to H Bs Ag (subtype a y w) induced the production of anti- 
HBs antibodies when given parentally to mice. Furthermore, the anti-idiotype 
antibodies were shown to recognise the HB group specific 'a' determinant inferring 
that the anti-idiotype vaccine may be useful against the heterologous subtypes of 
HBV for example, a d w and a d r.
Antibodies raised against the PC moiety of the polysaccharide surface 
antigen of Streptoccus pneumoniae are effective in protection against the disease 
(Briles et al. 1982). Using this information, McNamara et al. (1984) showed that the 
injection of groups of mice with monoclonal anti-PC. antibodies and the 4C11 
(internal image) antibodies, when coupled to a KLH carrier, induced the production 
of high titres of circulating antibodies to the original PC antigen. The LD^g dose of 
5. pyogenes for mice immunised with PC-KLH and 4C 11 - KLH was subsequently, 
shown to be nearly 100 times greater than that of the unimmunised control mice.
Clearly, these discussions indicate that the employment of anti-idiotypic 
antibodies may have potential applications in the next generation of vaccines. 
However, none of the novel vaccines described in these discussions have been 
formally submitted for licencing. Many criteria including, for example, comparison 
of efficacy with existing vaccines, safety, occurence of side effects, relative costs
of manufacture, efficacy of multivalent preparations, still remain to be established 
before their employment of the fields of human and veterinary medicine can be 
realised.
1.5 OBJECTIVES
The objectives of the study are to develop and validate an enzyme-linked 
immunoassay procedure for the detection of humoral antibody to Pasteurella 
anatipestifer in the White Pekin duck.
It is proposed to use the ELISA methodology to investigate:
a) the protective capacity of passively transferred 
anti-P.anatipestifer antibodies against systemic infection
b) influence of the route of infection on the clinical and immune 
response
c) immunological response and protection against field infection in 
ducklings given experimental autogenous vaccine.
It is intended that the P. anatipestifer ELISA will find positive 
application in the improvement of poultry health schemes for increased flock 
performance and profitability.
Chapter 2
Chapter 2
Materials and General Methods
2.1 REAGENTS
All chemicals and reagents used in these studies were of analytical
grade.
2.1.1. General reagents
The following chemicals were obtained from BDH Chemicals Ltd., 
(Poole); sodium chloride, sodium bicarbonate, citric acid, sodium di-hydrogen 
orthophosphate, di-sodium hydrogen orthophosphate, sulphuric acid, polyoxyethylene 
sorbitan mono-oleate (Tween 80), hydrogen peroxide, acetic acid, methanol and 
formalin (40% HCHO).
Orthophenylene-diamine dihydrochloride (OPD) was obtained from the 
Sigma Chemical Company (Poole).
2.1.2 Stains
Safranine, carbolfuchsin and Coomassie Brilliant Blue were purchased
from BDH.
2.1.3. Water
Water was glass distilled and de-ionized (Elgastat B102, Elga Group, High 
Wycombe) prior to use. This was used in the preparation of all buffer and aqueous 
solutions.
2.1.4. Commercial kits for the identification of Gram negative bacteria.
The API 20E series profile recognition systems were supplied by API 
Laboratory Products Ltd. (Basingstoke); aqueous solutions of oxidase and Kovac's 
reagents were also obtained from the same source.
2.1.5 Viable count determinations.
Triple vent plastic petri dishes were purchased from Fahrenheit 
Laboratory Supplies, (Sheffield); blood agar base from Oxoid Ltd. (Basingstoke); 
tryptose soya broth, and defibrinated sheep blood were obtained from Difco (East 
Molesey).
2.1.6. BUFFER SOLUTIONS.
2.1.6.1. Antigen coating buffer.
0.05M Carbonate-bicarbonate buffer pH 9.6 was prepared with sodium 
carbonate (0.02M) and sodium hydrogen carbonate (0.03M).
2.1.6.2 Assay wash (and serum dilution) buffer.
Phosphate buffered saline/Tween 80 buffer pH 7.0 was prepared with
di-sodium hydrogen orthophosphate (2.5mM), sodium chloride (1M) to which was
added Tween 80 (0.05% v/v).
2J.6 .3 . Phosphate citrate pH 5.0 buffer.
This buffer consisted of 24.3ml of 0.1M citric acid, 25.7 ml of 0^2M 
di-sodium hydrogen orthophosphate made up to lOOmls with distilled water.
2J .6 .4 . Substrate solution for horseradish peroxidase.
The substrate is light sensitive and therefore is prepared in a dark bottle
covered in aluminium foil. It was prepared immediately before use by dissolving 
40mg of OPD in 100 mis of the phosphate-citrate, pH 5.0 buffer to which was added 
40pl of 30% H2 Oz.
2.1.6.5. Storage.
Carbonate bicarbonate, pH 9.6 and PBS/Tween pH 7.0 buffers were 
stored at + 4°C prior to use and replaced by fresh solutions prepared at weekly 
intervals.
2.1.7. BLOOD SAMPLES
Blood samples were usually collected from the brachial vein; however, 
sampling from the femoral vein in the leg was preferred in ducklings aged fifteen 
days and younger. Samples were incubated at 37°C for 1 hour to encourage clotting 
and then centrifuged a t 2,000 x g for 10 minutes. The resulting sera were harvested 
and stored at 20°c until required for assay by the ELISA.
2.1.8. ANTIBODIES
2.1.8.1. Primary antibodies
Antibodies to P. anatipestifer were obtained from ducklings injected 
with formolised inactivated antigen. Full details of the procedures used are given in 
Chapter 3 (see section 3.2.2.).
2.1.8.2. Bridging antibodies
Rabbit anti-duck Ig antiserum was obtained from Nordic Immunological 
Laboratories (Maidenhead).
2.1,Q.3. Enzyme-labelled second antibodies.
Affinity-purified horseradish peroxidase labelled donkey anti-rabbit IgG 
antibodies were supplied by Guildhay Antisera (University of Surrey, Guildford).
2.2. EQUIPMENT.
2.2.1. Autoclaves.
Where appropriate, materials and aqueous solutions were sterilised at
_ n
115 C (lOlb/in ) for 15 minutes using a portable electric type autoclave obtained 
from Gallenkamp (Loughborough).
2.2.2. Incubators.
Cultures of P. anatipestifer were grown at 37°C (+ 2°C) in a standard 
bacteriological incubator (Laboratory Thermal Equipment, Oldham). 
P. anatipestifer antigen was immobilised onto the solid phase following an 
incubation at 4°C; an incubator (Cat. no. IH 330) obtained from Gallenkamp was 
used for this purpose. A similar incubator obtained from the same source, but 
maintained a t 22°C was employed for the incubation of the enzyme-substrate 
reaction in the ELISA. The other incubation stages of the ELISA were carried out at 
37°C (io.5°C) using a water jacketed incubator (Cat. no. 21214) purchased from 
Baird and Tatlock, (Chadwell Heath).
2.2.3. Microtitration plates.
These were obtained from several different sources i.e. (1) Nunc 
Immunoplate II (Gibco UK Ltd., Paisley. Cat. no. 42404A); (2) Falcon Microtest III 
(Becton and Dickenson UK Ltd., Cowley Oxford. Cat. no. 3912); (3) non-treated 
PVC (Flow Laboratories, Irvine, Cat. no. 77-172-05) and (5) Linbro EIA (Flow 
Laboratories. Cat. no. 76-381-04).
2.2.4. Plate Washer
The wells of the microtitration plates were washed using a Titertek 
Handiwash 110 plate washer (Cat no. 78-441-00) supplied by Flow Laboratories.
2.2.5. Liquid Handling.
Pipetting procedures used in the preparation of the various reagent 
solutions for use in the ELISA were performed using micropipettors (50-200pl) 
obtained from Jencons Scientific (Leighton Buzzard). Micropipettors (200-1000pl) 
obtained from the same source were used for the dispensing of larger volumes of 
aqueous reagents. A Titertek 8-channel dispenser (Flow Laboratories) was used for 
the addition of the various reagents to the wells of the assay plate.
2.2.6. Sample mixing.
Diluted samples of sera were mixed in pairs for approximately 15 
seconds using a vortex mixer (Fisons Scientific Apparatus, Loughborough).
2.2.7. Centrifugation
Where appropriate, centrifugation procedures were performed using a 
MSE Super Minor bench centrifuge (Model no. SK 1316A) obtained from Jennings 
Laboratory Supplies (Nottingham).
2.2.8. Photometry
Absorbances of solutions were determined using a Pye Unicam SP600 
spectrophotometer (Unican Instruments, Cambridge) or a Corning 252 
spectrophotometer (Stone, Staffordshire). A Multiskan ELISA plate reader (Flow 
Laboratories), set a t 450nm, was used to measure the intensity of the colour 
formation in the reaction wells of the microtitration plate.
2.1. GENERAL METHODS
»
2*3.1. Strain of P. anatipestifer!
The P. anatipestifer type 2 strains used in these investigations were 
obtained from commercial flocks infected with the disease. Cultures were 
maintained at 30°C on blood agar and re-passaged every 4 to 5 days. To reduce any 
possible loss of virulence of the infecting strain, fresh isolates were obtained every 
6 or 7 weeks.
2.3.1.1. Isolation of P. anatipestifer.
All experimental ducklings which died during the course of these studies 
were submitted for post mortem examination and samples of brain and heart muscle 
removed, unless stated otherwise, for the attempted isolation of P. anatipestifer by 
culture.
2.3.1.2. Identification of P. anatipestifer.
The presumptive isolates of P. anatipestifer were stained using the Gram
method.
2.3.1.3. Carbohydrate and enzyme activity determinations.
Biochemical activity determinations, using the API 20 E series profile 
recognition systems (see section 2.1.4), were only performed on those isolates of 
P. anatipestifer designated for the experimental infection studies. All isolates 
culturally resembling P. anatipestifer were, however, tested for (a) catalase and (b) 
oxidase activity. These procedures were performed as follows:-
a) Catalase
A loopful of culture was transferred onto a clean glass 
microscope slide to which was added 2 to 3 drops of 30% H202* 
In the presence of the enzyme catalase, 0 2 wgs liberated#
b) Oxidase
Filter paper discs were impregnated with culture and 1 to 2 
drops of tetramethyl-p-phenylenediamine (1% aqueous solution) 
added. The oxidation of the reagents to form a blue complex 
indicated a positive result.
2.3.1.4. Serotypinq.
Slide agglutination tests were performed on glass microscope slides. 
Isolates of P. anatipestifer were emulsified in saline (0.83%) and gently mixed 
following the addition of the strain specific antiserum. Agglutination, as indicated 
by the clumping of cells, was recorded as a positive reaction.
2.3.1.5. Determination of viable count for P. anatipestifer in broth culture.
Colonies of P. anatipestifer were inoculated into 30ml of tryptose soya 
broth and incubated at 37°C on a shaker apparatus. At intervals of 1, 2, 3, 4, 5, 7, 9 
and 20 hours following incubation, samples were removed from the broth culture for 
optical density and viable count determinations. The standard plate count method 
was employed to determine the number of viable cells in each of these samples. In 
brief, 1ml of culture was diluted in iog^g steps, using sterile tryptose soya broth as 
diluent, to give a final dilution of 7 log^gj 0.5ml aliquots of each dilution were then 
transferred to the surface of a blood agar plate and distributed evenly over its 
surface using a glass spreader. These plates were then transferred to a 
bacteriological incubator and incubated at 37°c for 48 hours. Following incubation, 
the number of colonies of P. anatipestifer formed at each dilution was then 
determined. This information was used to construct a growth curve for the 
organism from which the number of viable cells in subsequent broth cultures was 
established.
2.3.2. Protein determinations.
Protein nitrogen was estimated using the standard Kjeldahl method. The 
factor 6.23 was used to covert N to protein.
2.3.3. Statistics and analysis of data.
Where appropriate, statistical analyses were performed using a 
pre-programmed Hewlett Packard HP-41C statistical calculator.
2.4. BIRDS AND MANAGEMENT.
2.4.1. Design of isolation units.
This consisted of two blocks, each of five pens, divided by a central wall. 
Each of these pens was provided with a separate heat, light and ventilation facility.
2.4.2 Experimental ducks.
White Pekin ducklings were used throughout this study and obtained as 
day olds from Cherry Valley Farms Ltd (Lincolnshire). These were reared in the
on
special isolation units described above and kept deep litter. Air temperature was
A
maintained a t  22°C (+2°C) for the first 10 days after hatching, after which time the 
temperature was reduced to 16°C. Illumination was provided with a constant 14 
hour day light and ventilation adjusted to operate on a 5 minute on/off cycle. They 
were fed on commercial rations of duck starter  (Dalgety, Gainsborough) for the first 
two weeks after hatching and duck grower pellets thereafter. Food and water was 
always provided ad libitum.
Chapter 3
Chapter 3
Development of an ELISA for the detection of antibodies to Pasteurella
anatipestifer in duck sera.
3.1 INTRODUCTION
Since the first reported isolation of P. anatipestifer from ducklings 
raised on Long Island farms in the USA, (Hendrickson and Hilbert, 1932) the disease 
has now become of widespread concern to the commercial duck producer (see 
section 1.1). Although vaccines have been described which, it is claimed, are 
effective against the disease (see section 1.4.2.9.) the mechanisms of immunity 
involved in the protection of ducklings against P. anatipestifer infection remain 
unclear. RSA and AGP tests have been used to serotype the various isolates of 
P. anatipestifer recovered from infected ducklings (Harry and Deb, 1979; Sandhu and 
Harry, 1980; Bisgaard, 1981); however, the employment of these procedures in the 
study of the immunological responses to P. anatipestifer in the duck has not been 
described so far. AGP and RSA methods have been described for the detection of 
the antibody response to other diseases in the avian species (see section 1.3). These 
procedures, however, are insensitive and only detect agglutinating or precipitating 
antibodies, and consequently fail to reflect the total protective capacity of the 
humoral antibody response. Clearly, there is a requirement for a simple, sensitive 
and practicable procedure for the detection of all types of antibodies to 
P. anatipestifer in the duck. Since the first development of ELISA methodology by 
Engvall and Perlmann (1971), and subsequent modification by Voller (1974) it is clear 
that these methods are gaining increased acceptance as avian diagnostic procedures 
particularly for the determination of the antibody response to infectious disease (see
F i:ksection I.3.4.3.).
The present studies therefore describe the development and validation of 
an ELISA for the detection of antibodies to P. anatipestifer in the White Pekin duck.
3.2. METHODS
3.2.1. Preparation of P. anatipestifer antigen.
P. anatipestifer type 2 was grown on blood agar base enriched with 3% 
sheeps blood for 18 hours at 37°C. The cells were then harvested into sterile saline 
(0.83%), washed and recovered by centrifugation at 3,000 xg for 30 minutes. This 
process was repeated until a clear supernatant was obtained. Following the final 
centrifugation, the pellet was resuspended in 0.05M carbonate -bicarbonate pH 9.6 
buffer. This preparation was vortexed and then further diluted in the same buffer to 
give an absorbance of 1.0 at 520nm. This preparation was found to contain 50mg of 
protein/100 ml as determined by the Kjeldahl method. The suspension of cells was 
divided into 23ml aliquots and subjected to three slow freeze/thaw treatments from 
room temperature down to -20°C (+1°C) in order to lyse the cells. Following the 
final freeze/thaw treatment, the stock antigen preparations were stored at -20°C 
until required.
3.2.2. Preparation of the reference serum pools
Eight ducklings, 1 day of age, were obtained from a parent flock with no 
previous history of P. anatipestifer infection and raised in isolation on a medicated 
diet containing sulphaquinoxaline 400. ppm. Four of these birds were injected s.c., 
into the back of the neck, with 1ml of an alhydrogel adsorbed, formolised 
P. anatipestifer vaccine given a t 23 and 48 days after hatching. The remaining four 
birds were given no vaccine and were designated the negative control group. Blood 
samples were obtained from both groups of birds via the brachial vein 10 days after  
the second injection. These samples were incubated at 37°C for 1 hour to allow clot 
formation and subsequent retraction. The sera were harvested and shown to contain 
agglutinating antibodies to P. anatipestifer by RSA. These samples were therefore 
pooled to form the positive reference control sample.
At this stage of assay development, the detection limit for the assay had 
yet to be determined. However, a fter  this had been established, it became apparent 
that the designated negative serum pool did in fact contain low levels of antibodies 
to P. anatipestifer; therefore, this pool was replaced by a fresh serum pool obtained 
from birds reared in isolation and having no detectable antibodies as determined by 
the ELISA.
3.2.3. Assessment of microtitration plates
Several types of microtitration plates were obtained from various 
commercial sources (see section 2.2.3) and assessed for their suitability as a solid 
phase in the P. anatipestifer ELISA.
The plates were washed once before use in carbonate-bicarbonate buffer 
pH 9.6. lOOpl of freeze/thawed P. anatipestifer antigen, diluted 1:8 in the same 
buffer, yi&rh then added to all 96 wells of each plate and incubated overnight at 
4°C. The following morning, the plates were washed 6 times with PBS/Tween 80 
buffer, pH 7.0, containing 0.1M NaCI, and lOOpl of the positive serum pool, diluted 
to 1:1000 in the same buffer, added to each of the antigen coated wells. The ELISA 
was then performed as described under ELISA procedure, (see section 3.2.5.) The 
overall % CV of each plate was then calculated from the standard deviation of the 
individual absorbance measurements obtained for the 96 wells. The Students-t-test 
was used to determine the absence of an edge-effect by testing the level of 
significance between the mean absorbance measurements of the outer 36 wells and 
the inner adjacent 28 wells of each plate.
3.2.4. Investigation of the effect of sodium chloride on the level of NSB.
Case e t al. (1982) reported that the inclusion of a high molarity NaCI 
concentration in wash and incubation buffer greatly reduced NSB in an ELISA for 
antibodies to avian IBV. It was therefore decided to investigate the effects of
\X
varying concentrations of NaCI in PBS/Tween 80 wash and incubation buffer upon 
the level of NSB of duck sera to the wells of the assay plate (Nunc Immunoplate IlX
Positive and negative sera were diluted to 1:100 in each of a series of 
PBS/Tween 80 buffers containing various concentrations of NaCI ranging from 0.15 
to 2.0M. Wash buffers of the same saline composition as for the incubation buffer 
were used in each test. lOOpl of each diluted reference serum were added, in 
duplicate, to both antigen coated and non-coated wells of the assay plate and the 
ELISA performed taking care to include a wash with distilled water before addition 
of substrate.
3.2.5. ELISA procedure: optimisation of reagent concentrations.
The principle of the indirect 'double sandwich' ELISA which was used in 
these investigations for the detection of antibodies to P. anatipestifer in duck sera 
is illustrated in Fig 3.1.
Fig. 3.1.
Illustration of the stages involved in the indirect 'double sandwich' ELISA for the 
detection of antibodies to P. anatipestifer; = solid phase, Ag = P. anatipestifer 
antigen, c< - anti.
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3.2.5.1. Antigen and serum sample concentrations.
Optimum concentrations of antigen and duck serum for use in the 
P. anatipestifer ELISA were determined using a chequerboard titration format. The
stock P. anatipestifer antigen was diluted 1:2, 1:4, 1:8, 1:16 and 1:32 with carbonate 
bicarbonate pH 9.6 buffer, and lOOpl aliquots of each dilution dispensed in duplicate 
into the wells of the microtitration plate. The antigen was allowed to 
immunoadsorb onto the wells by incubating overnight a t 4°C, in a humid 
atmosphere, provided by a sandwich box. Unadsorbed antigen was removed by 
washing the wells 6 times with PBS/Tween 80 wash.buffer containing 1.0 M NaCI, 
using a manual 8 channel Titertek plate washer. The positive and negative 
reference control sera were diluted over the range of 1:10 to 1:2,000 using the same 
wash buffer, and lOOyl of each serum dilution incubated in duplicate against each of 
the antigen concentrations. The plate was covered with a lid and transferred to a 
water jacketed incubator for 1 hour at 37°C (+ 0.3C). The plate was then washed as 
before with the PBS/Tween buffer and lOOpl of RADIg, diluted to 1:600 in the same 
buffer, added to each reaction well. Following a further incubation at 37°C for 1 
hour, the plate was washed to remove any unbound RADIg, and lOOpl of horseradish 
peroxidase labelled DAR IgG diluted to 1:4,000 in PBS/Tween buffer added. The 
plate was re-incubated at 37°C for 1 hour. Excess enzyme-labelled conjugate was 
removed by washing in PBS/Tween buffer followed by a further wash six times using 
distilled water to remove any interference from residual traces of NaCI. lOOpl of 
freshly prepared substrate (see section 2.1.6.3) were then added to each of the 
reaction wells. Immediately following the addition of substrate, the plate was 
covered in foil to keep out the light and incubated at 22°C (+0.2°C) for 30 minutes. 
After exactly 30 minutes of incubation, the enzyme-substrate reaction was stopped 
by the addition of lOOpl of 2.5M H^SO^ to each of the assay wells. The absorbance 
was measured using a Multiskan ELISA plate reader set at 450nm and blanked on the 
empty wells of the microtitration plate. The mean absorbance measurement was 
recorded for each of the duplicated assay well incubates in the ELISA less the 
absorbance for NSB.
3.2.5.2. Rabbit anti-duck Ig and conjugate concentrations.
Using the pre-determined optimal concentration of antigen (1:8) and 
duck serum (1:100), the optimal concentrations of RAD Ig and conjugate for use in 
the ELISA were determined using a similar chequerboard titration format. Dilutions 
of RADIg were prepared in PBS/Tween buffer ranging from 1:200 to 1:1,000 and 
evaluated against dilutions of conjugate diluted 1:2,000 to 1:6.000 in the same 
buffer. The NSB of the enzyme-labelled conjugate was evaluated by incubating each 
dilution of conjugate in the presence of antigen only.
3.2.6. Effect of incubation time upon the enzyme-substrate reaction.
lOOpl aliquots of the positive serum pool, diluted to 1:100 in PBS/Tween 
buffer, were added in quadruplicate to the antigen coated wells of the 
microtitration plate and the ELISA performed. The reaction of enzyme upon 
substrate was allowed to proceed for exactly 15, 30, 45 and 60 minutes at 22°C 
(+0.2°C). At the end of each time interval, the foil was lifted away from the 
appropriate target wells and lOOpl of 2.5M h^SO^ added, taking care not to allow 
light to enter the remaining reaction wells. The foil was then replaced. When all 
the reactions had been stopped, the foil covering the plate was removed and the 
absorbance values determined.
3.2.7. Prediction curve
The measured absorbances obtained with the 1:100 dilutions of duck sera 
in the ELISA were converted to antibody titre  values using a prediction curve which 
was derived as follows. Nineteen sera obtained from a variety of sources and shown 
to have varying levels of antibodies when assayed by ELISA, were titrated in 
doubling dilutions a t log2 l  intervals down to log27. Endpoint titres were then 
obtained for each of these samples where the serum dilution curve intercepted the 
base line. The base line for the assay was established as being the mean absorbance 
value for a group of sera when assayed at a 1:100 dilution in the ELISA, plus two
standard deviations! A graph of the absorbance value for each of the nineteen 
samples versus the corresponding end-point titre  value was then constructed! The 
prediction curve was thus derived using the method of least squares linear regression 
analyses to construct the line of best fit through the data.
3.2.8. Reproducibility
Three duck serum QC pools representing high, mid-range and low levels 
of antibodies to P. anatipestifer, as determined by the ELISA, were diluted to 1:100 
in PBS/Tween buffer and added randomly to 10 antigen coated wells of the assay 
plate. The ELISA was then performed. From the standard deviation of the 
individual absorbance measurements, the within-assay CV was derived for each of 
the Q. C. pools. The between-assay CV was determined by assaying the same QC 
pools in the ELISA over six consecutive assays (n=60, where n = total number of 
absorbance measurements obtained for each of the QC pools).
3.2.9. Precision-dose profile
The mean CV was calculated for each of the above three QC pools and 
plotted against the corresponding log2  mean antibody titre. This titre  was derived 
from the mean absorbance measurement (n = 60, replicates in six assays, where n = 
total number of observations obtained for each of the QC pools).
3.2.10. Specificity of the ELISA
Blood samples were obtained from a group of seven ducks at 27 days
after hatching and their sera shown to contain no detectable antibodies to
P. anatipestifer. Each of these birds was then injected with one of the following
\ £  3
bacterial antigens: P. anatipestifer types 1 and 2, Salmonella typhimurium,
4: £ £>
Salmonella anatum, Escherichia coli (078), Acinetobacter calcoaceticus and
Pasteurella multocida. Blood samples were collected from each of these birds 14
days later and, subsequently, their sera were shown to contain agglutinating
antibodies to the homologous antigen by RSA. These sera samples were then 
assayed in the P! anatipestifer ELISA!
3.2.11. AGP test
The same preparation of P. anatipestifer used as coating antigen in the
P. anatipestifer ELISA was also used as antigen in the AGP test described below. 
The method used was similar to that described by Heddleston (1973). The plates 
containing the appropriate immunoreactants were incubated in a humid atmosphere 
in a sandwich box for 72 hours at room temperature. At the end of this period, the 
plates were washed for 20 minutes in 5% (w/v) sodium citrate, and then immersed 
overnight in 0.83% (w/v) sodium chloride. They were then stained using 0.1% (w/v) 
Coomassie Brilliant Blue in 10% methanol/5% acetic acid, and decolourised with 
three washes of the methanol/acetic acid solution.
3.2.12. RSA methodology
This was performed as described in section 2.3.3.3.
3.2.13. Comparison of ELISA, RSA and AGP for the detection of antibodies to
P. anatipestifer.
Nine, one-day old ducklings, obtained from a parent flock having no 
previous history of exposure to P. anatipestifer, were wingbanded and raised in 
isolation on medicated feed (section 2.4.2.). Twenty-seven days after hatching, five 
of the group were injected s.c. into the back of the neck, using 1ml of an alhydrogel
9
adsorbed formolised vaccine containing approximately 10 P. anatipestifer 
organisms per ml. The remaining four birds were given no vaccine and designated 
the negative control group. Blood samples were obtained from both groups of birds 
immediately prior to vaccination and afterwards at intervals over a period of three 
weeks. Sera were stored at -20°C until required for assay by the methods described.
3.3. RESULTS
3.3.1. Preparation of P. anatipestifer antigen
This organism was found to grow very readily when cultured on to 
blood-enriched agar, and following incubation, it was possible to obtain a sufficient 
cellular yield from six heavily seeded plates to produce approximately 1 litre of 
stock antigen for use in the ELISA.
3.3.2. Assessment of microtitration plates
The Flow treated plate was found to have an overall CV of 8.75% with 
CVs of 9.17% and 9.40% respectively for the outer 36 wells and adjacent inner 28 
wells of this plate. The Linbro EIA, Falcon Microtest III and Flow non-treated 
plates showed respective overall CV's of 11.34%, 13.05% and 10.26%. Therefore, 
these plates, having an overall CV in excess of 10% were rejected as being 
unsuitable for use in the assay under the conditions described. Of the plates
examined, only with the Falcon-Microtest III type were significant differences
(P<0.05) demonstrated between the mean absorbance measurements for the outer 
and adjacent inner wells. In contrast, the Nunc Immunoplate II was found to have an 
overall CV of only 5.5% with CVs of 5.4% and 6.9% demonstrated for the outer and 
inner wells. Furthermore, these plates were found to have a variation of only 
+ 0.005 absorbance units for the empty uncoated wells. For these reasons, the Nunc 
Immunoplate II was chosen as being the most suitable of the plates investigated for 
use in the P. anatipestifer ELISA. The findings of these investigations are 
summarised in Table 3.1.
3 .3 .3  The effects of sodium chloride on NSB
p £> £
The results show (Table 3.2) that the assay of 1:100 dilutions of 
reference sera in the ELISA, using PBS/Tween 80 containing 0.15M NaCI as wash 
and incubation buffer, failed to prevent the NSB of duck serum proteins to the wells 
of the assay plate, with the result that unacceptably high blanks occurred.
Table 3.1.
Assessment of micro-titration plates from different manufacturers for their 
suitability as solid phase in the ELISA.
Manufacturer 
Plate type 
Code number
Overall % CV 
for 
96 wells
% CV of 
outside 
36 wells
% CV of 
inner 
28 wells
P
Significance 
outside v inside
Gibco UK Ltd 
Nunc Immunoplate II 
4-42404 A.
5.5 5.4 6.9 NSa
Becton and Dickinson 
Falcon Microtest III 
3912
13.05 15.44 12.1 P<0.05b
Flow Labs
PVC non-treated
77-172-03
10.26 10.64 9.04 NS
Flow Labs 
PVC treated 
76-364-05
8.75 9.17 9.40 NS
Flow Labs 
Linbro EIA 
76-381-04
11.34 15.77 8.35 NS
aNS = Non-significant differences between means. 
Significant differences between two means.
However, it was found that increasing the NaCI concentration in the wash and 
incubation buffer from 0.15M to UOM reduced the NSB to a constant value of only 
0.04 absorbance units. Increasing the molarity of the NaCI to 2.0M did not decrease 
the NSB any further.
Table 3.2 also shows that the reduction in NSB was accompanied by a 
reduction in the absorbance measurements for those samples incubated in the 
antigen coated wells, although this effect was not as marked as that occurring in 
the uncoated wells. A constant absorbance was achieved from 1.0M onwards. 
Furthermore, the data shows that with a concentration of 1.0M NaCI in the wash 
and incubation buffer, there was minimal binding of RAD Ig and enzyme-labelled 
conjugate in the coated wells, and virtually no binding of these reagents in the 
uncoated wells. On the basis of these observations, it was therefore decided to use 
a concentration of 1.0M NaCI in the wash and incubation buffer in all further 
studies.
3 .3 .4 .  Optimisation of duck serum and P. anatipestifer antigen concentrations
The results shown in Table 3.3. indicate that the assay of 1:100 dilutions 
of positive and negative sera by the ELISA gave the greatest difference in 
absorbance a t 450nm after correction for NSB. For this reason a 1:100 dilution of 
serum was chosen as optimal for use in the ELISA procedure.
The same table records a linear response for the difference in 
absorbance using the optimal dilutions of reference sera incubated in the presence 
of antigen diluted 1:4, 1:8, 1:16 and 1:32. Subsequently, to ensure the future 
reproducibility and precision of the assay procedure, a 1:8 dilution of antigen was 
chosen.
Table 3.2
Effect of varying levels of sodium chloride in PBS/Tween wash buffer on 
the level of non-specific binding (NSB)
0.15M
PA.ag coated wells
Positive duck serum 0.81a
g
Negative duck serum ^•'^b
No duck serum (blank) 0.07
Wells not coated with PA.ag
Positive duck serum 0.27g
Negative duck serum - 0.25^
No duck serum (blank) 0.01
Molarity of NaCl in wash buffer
0.3M 1.0M 1.5M 2.0M
0.75 0.72 0.70 0.72
0.25 0.21 0.22 0.24
0.08 0.06 0.06 0.06
0.09 0.04 0.04 0.04
0.08 0.04 0.04 0.04
0.01 0.01 0.01 0.01
a Absorbance values measured at 450nm for a 1:100 dilution of sample in the ELISA 
b Absorbance values for wells receiving only the RADIg, conjugate and substrate incubates
Table 3 .3
Optimisation of duck serum dilution and P. anatipestifer antigen 
concentrations incubated in the presence of fixed concentrations of RADIg 
(1:600) and enzyme-labelled conjugate (1:4,000). The enzyme substrate 
reaction was allowed to proceed for 30 mins at 22°C.
Reference Dilution of P. anatipestifer antigen
Serum
Dilution Undiluted 1:2 1:4 1:8 1:16 1:32
1 10 0.27a 0.33 0.35 0.23 0.32 0.29
1 100 0.53 ^ 0.51 0.49 v 0.48 ^ 0.49- 0.48 r
1 200 0.49 - 0.48 - 0.44 ^ 0.46 ^ 0.43 - 0 .4 0 -
1 400 0.35 0.34 0.34 0.30 0.33 0.28
1 800 0.24 0.23 0.21 0.23 0.22 0.18
1 1,000 0.22 0.20 0.19 0.18 0.19 0.17
1 2,000 0.03 0.03 0.02 0.03 0.03 0.01
Blanks
(no serum) 0.03 0.05 0.05 0.05 0.05 0.03
a Values indicate the difference in the mean absorbance measurement of the 
positive and negative control pools after these had been corrected for NSB of the 
RADIg and conjugate in the antigen coated wells.
Table 3 .4
Optimisation of rabbit anti-duck Ig and enzyme-labelled conjugate 
concentrations incubated in the presence of optimum concentrations of 
positive duck sera (1:100) and P. anatipestifer antigen (1:8). The enzyme- 
substrate reaction was allowed to proceed for 30 minutes at 22°C.
Dilution
of
conjugate 1:200 1:400
1:2,000 0.75a 0.76
1:3,000 0.66 0.60
1:4,000 0.61 0.55
1:5,000 0.50 0.42
1:6,000 0.41 0.41
1:600 1:800 1:1,000 NSB
0.76 0.80. 0.78 0.09
0.63 0.60 0.59 0.05
0.55 0.53 0.51 0.04
0.48 0.46 0.46 0.02
0.40 0.41 0.40 0.02
g
Values indicate the difference in the mean absorbance measurement of the 
positive and negative control pools after these had been corrected for NSB of 
conjugate in the antigen coated wells.
3 .3 .5 .  Optimisation of rabbit anti-duck Iq and enzyme-labelled conjugate
preparations
Table 3.4. shows that a decrease in absorbance at 450nm was obtained in 
the presence of increasing dilutions of conjugate. This was accompanied by a 
reduction in the levels of NSB to a constant value of 0.02 absorbance units. The 
data also shows that the greatest discrimination in absorbance for the positive and 
negative reference sera was obtained using a 1:2,000 dilution of conjugate; however, 
using this dilution of conjugate produced unacceptably high blank values. 
Therefore, a 1:4,000 dilution of conjugate was chosen for which a more acceptable 
NSB value of 0.04 absorbance units was obtained, whilst still allowing a good 
positive to negative sera response discrimination in the ELISA.
A 1:4,000 dilution of enzyme-labelled conjugate incubated in each of 
a series of RAD Ig dilutions ranging from 1:400 to 1:800 recorded only a slight 
variation in absorbance differences for the positive and negative reference sera. 
Therefore, a 1:600 dilution of RAD Ig was chosen for use in the subsequent assay 
procedures.
3.3.6. Effect of incubation time upon the enzyme-substrate reaction
Fig. 3.2. shows that only a slight increase in colour was recorded 
following an incubation at 22°C (+0.2°C) for longer than 45 minutes. Therefore, 45 
minutes was chosen as a suitable time at which to stop the enzyme substrate 
reaction.
3.3.7. Prediction curve
Fig 3.3. shows the serum dilution curves of samples from nineteen ducks 
which were assayed by end-point titration from an initial 1:100 dilution of sample in 
the ELISA. Using this information, the prediction curve (Fig 3.4.) was derived. This
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Fig. 3.5. Precision-dose profile over the analytical range of the 
assay (Mean + SE).
curve shows a graph of the measured absorbances obtained for each of the nineteen 
samples when assayed at a 1:100 dilution in the ELISA versus the corresponding log2  
end-point titre  value. A linear relationship (y = 0.13X + 0.09 ) was subsequently
demonstrated between these two parameters which were subsequently shown to be 
highly correlated (r = 0.99).
3.3.8. Precision-dose profile
Fig 3.3. shows the overall precision of the measurements obtained over
the analytical range of the assay following the assay of the three Q.C. duck serum 
pools at a 1:100 dilution in the ELISA. The data shows that only a slight variation in 
precision over the working range for the assay was found, indicating that a rugged 
and practical procedure had been developed.
3.3.9. Reproducibility
The data shown in Table 3.5. illustrates the reproducibility of the 
method. Within-assay CVs of 3.2%, 4.9% and 6.3% respectively were found for the 
three duck serum QC pools representing high, mid-range and low concentrations of 
antibodies to P. anatipestifer following assay at a 1:100 dilution in the ELISA. The 
absorbance measurements obtained over six consecutive assays had a between-assay 
CV of 6.8%, 8.3% and 8.6% for the same high, mid range and low antibody QC pools.
3.3.10. Specificity
Table 3.6. shows that the ELISA detected antibodies to P. anatipestifer 
in the birds vaccinated with this organism only. Serum samples obtained from the 
ducks immunised with the following bacterial antigens: S. typhimurium, S. anatum, 
E. coli (078), A. calcocaceticus and P. multocida, and shown to contain agglutinating 
antibodies to these organisms, gave no reaction which exceeded 0.15 absorbance 
units, the detection limit of the assay, when assayed in the ELISA.
Table 3.5.
Within and between assay co-efficients of variation (%CV) for three duck 
serum QC pools representing high, mid-range and low levels of antibodies to 
P.anatipestifer.
Serum Pool Within-assay Between-assay
% CV % CV
High positive pool 
Mid range positive pool 
Low positive pool
3.2 
4.9
6.3
6.8
8.3
8.6
Table 3.6.
Absorbance measurements a t 450nm of sera assayed at a 1:100 dilution in the 
ELISA and known to contain agglutinating antibodies to other heterologous 
antigens.
Serum sample Absorbance 450nm
anti - P. anatipestifer type 2 antiserum 0.543a (+ve)
anti - P. anatipestifer type 1 antiserum 0.623 (+ve)
anti - S. typhimurium antiserum 0.08
anti - S. anatum antiserum 0.12
anti - P. multocida antiserum 0.09
anti - A. calcoaceticus antiserum 0.08
anti - E. coli (078) antisgrum 0.08
Negative control serum 0.09
aSamples demonstrating a response greater than the detection limit of 0.13 
absorbance units for the assay were taken as positive to anti-P anatipestifer 
antibodies.
bReplacement negative duck serum pool and having no levels of detectable 
antibodies in the ELISA.
ITable 3.7.
Comparison of ELISA, RSA and AGP methods for the detection of antibodies 
to P. anatipestifer in five ducks following vaccination with P. anatipestifer 
type 2.
Assay Days following vaccination with P. anatipestifer type 2
method 0 4 7 10 14 21
ELISA 0.4a(0)b 0.5(2) 2.04(5) 4.16(5) 5.0(5) 3.48(5)
RSA (0) (0) (0) (2) (4) (2)
AGP (0) (0) CO) (0) (1) (0)
g
^ELISA log 2  serum mean titres were based on positive samples only.
Figures in brackets refer to the number of ducks in group of five positive for 
antibodies to P. anatipestifer in the assay method used.
3.3.11. Comparison of ELISA, RSA and AGP methods for the detection of
antibodies to P. anatipestifer^
The concentrations of circulating antibodies in each of the five ducks 
vaccinated with P. anatipestifer type 2 are shown in Fig. 3.6. The resultant values 
are expressed as log2  end-point titres obtained by reference to the prediction curve 
shown in Fig 3.4.
The group mean serum titres obtained over the period following 
vaccination are summarised in Table 3.7., which also shows the results for the 
individual samples when assayed by the RSA and AGP methods. Four days following 
vaccination, antibodies to P. anatipestifer were just detectable in two of the five 
birds examined using the ELISA. Three days later, sera obtained from each of the 
five birds where shown to contain antibodies by this method, however, in these same 
samples, no agglutination or precipitating antibodies were detected by RSA and 
AGP.
Peak serum titres were obtained in three of the five birds 10 days after 
vaccination by the ELISA, subsequently, agglutinating antibodies were also 
detectable in two of these birds by RSA. Serum obtained from the fourth bird of the 
group 4 days later was shown to contain high concentrations of antibodies to 
P. anatipestifer and furthermore, precipitating antibodies were shown to be present 
in this sample by AGP. However, it was noted that the precipition lines were barely 
discernable even when stained using Coomassie Brilliant Blue. After 3 weeks, a 
decline in serum antibody concentrations was recorded in the five birds in the 
vaccinated group as shown by the ELISA technique.
No antibodies to P. anatipestifer were detected in sera samples obtained 
from the four unvaccinated control birds over the period of 41 days of age by any of 
the assay methods used. However, 7 days later, low levels of antibodies were
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detected in this group by the ELISA. These birds did not shown any clinical signs of 
infection and were sacrificed for post-mortem examination^ These did not reveal 
any lesions and attempts to isolate the organism from the brain and heart muscle of 
these birds by culture were unsuccessful.
3.4. DISCUSSION
The ELISA procedure described in these present studies was based on a 
modification of that described by Voller e t  al. (1974). However, during the various 
stages of assay development, it became clear that factors effecting the 
performance of the assay had to be overcome if the procedure was to become a 
simple and practicable one for the detection of antibodies to P. anatipestifer in the 
duck.
The choice of the solid phase for the immobilisation of antigen in the 
ELISA is an important factor which may greatly influence the future reproducibility 
and precision of the system. Denmark and Chessum (1978) reported the tendency of 
some microtitration plates to absorb more protein in the peripheral wells than those 
of the interior, resulting in the so-called 'edge effect'. Oliver J3t al. (1981) suggested 
that thermal gradients may be responsible for this effect and recommended the 
employment of forced-air type incubators for the incubation of immunoreaction 
stages in the ELISA. For this reason, in the absence of suitable incubators, it is not 
uncommon for some investigators to avoid using the outer 36 wells of the. plate. 
McLaren et al. (1981) have stated that considerable variations have been observed in 
batches of plates obtained from the same manufacturer and they recommended the 
testing of each batch of new plates prior to use. In these studies, therefore, several 
different types of plates were evaluated; of these, the Nunc Immunopiate II was 
found to be the most suitable, under the conditions of the assay described. The 
decision has since been confirmed following the batch to batch consistency of the 
plates used in this assay over the period of these studies.
Following the ELISA methods reported by other workers for the 
detection of antibodies to other avian diseases, (Evans et aL 1983; Solano et aL 
1983) resulted in high NSB of duck serum proteins to the wells of the assay plate. 
S laght et al. (1979) reported similar problems associated with the high NSB of 
chicken serum proteins found during the development of an ELISA for the detection 
of antibodies to reovirus. These workers subsequently circumvented the problem by 
pre-treating the plates with calf serum. However, Case et al. (1982) found that the 
inclusion of NaCI in the wash and incubation buffer to a final concentration of 1.0M 
reduced the NSB of chicken sera to an acceptable level in an ELISA for the 
quantification of avian IBV antibodies. In agreement with the findings of Case, this 
cheap and simple alternative was found to be extremely effective in reducing the 
NSB of duck serum protein to the wells of the assay plate in the P. anatipestifer 
antibody ELISA.
During the period of assay development, commercial preparations of 
enzyme-labelled anti-duck immunoglobulins were not obtainable. For this reason, 
the detection of duck antibodies in the ELISA required the use of RAD Ig antiserum 
as bridging antibody between the immunobilised duck Ig’s and enzyme-labelled DAR 
IgG antibodies. However, horseradish peroxidase - labelled antibodies are now 
commercially available but the presence of the anti-IgM immunoglobulins in the 
RADIg preparation (Nordic Immunologicals, personal communication) was considered 
to increase the ability of the assay to detect the early IgM antibody response. 
Subsequently, the possible adoption of the procedure using direct binding of the 
horseradish peroxidase-labelled RAD IgG antibodies to bound duck antibodies in the 
ELISA was not investigated in these studies.
Incubation times of 1 hour at 37°C were allowed for the various 
immunoreaction stages of the assay and are consistent with those reported for other 
avian ELISAs (Mockett and Derbyshire, 1981, Briggs and Skeeles, 1983). Results for
the levels of P. anatipestifer antibodies in test samples were expressed as log2  
end-point titres, obtained by reference to a prediction curve derived from the 
titration of some nineteen duck sera of varying antibody concentrations. The use of 
a prediction curve for converting the absorbance of a 1:100 dilution of sample in the 
ELISA to an end-point titre  was justified by the high degree of correlation between 
those two parameters, over the range investigated, demonstrating the lack of 
cross-over effects from the constructed dose-response curves for these samples. 
This enables data to be expressed as a quantitative, easily understood measure of 
the serum antibody levels, whilst conserving reagents, time, as well as allowing an 
increased sample output and a larger number of birds to be screened.
The assay was shown to be reproducible both within and between assays 
and compares favourably with previously published ELISA's for the detection of 
antibodies to other avian diseases. (Garrett et al. 1983; Smart and Grix, 1985). The 
precision-dose profile showed only a slight variation over the analytical range 
investigated, indicating the ruggedness of the system. The degree of specificity of 
the assay was demonstrated in that antisera known to contain agglutinating 
antibodies to other bacterial antigens commonly found in the duck, gave no response 
exceeding the base line cut-off point for the assay. Sandhu and Harry (1981) 
demonstrated the existence of cross reactions between homologous P. anatipestifer 
antiserum to some P. anatipestifer antigens in the AGP method although they found 
no type 1 and 2 cross reacting precipitating antibodies. However, P. anatipestifer 
type 1 antiserum was shown to react with the P. anatipestifer type 2 antigen, used 
as coating antigen in the ELISA, indicating the existence of cross-reacting non- 
precipitating type antibodies not demonstrated by the AGP test.
These studies have shown that both ELISA and RSA methods are rapid to 
perform, but the RSA is less sensitive as only agglutination antibodies are detected. 
Similar findings were made by Marshall et al. (1981), who reported the ELISA to be
superior to microagglutination tests in the detection of antibodies to P. multocida. 
The findings reported in these studies have shown that the humoral antibody 
response following the vaccination of ducklings with an alhydrogel-absorbed 
P. anatipestifer bacterin, can be detected very much earlier by the ELISA than 
either RSA and AGP: 4 to 7 days in the case of ELISA v 10 to 14 days for RSA and 
after 14 days for AGP.
3.5. CONCLUSIONS
As part of the initial assay development, the Nunc Immunoplate II was 
shown to be the most suitable of the plates investigated for the immobilisation of 
P. anatipestifer antigen in the ELISA.
The inclusion of NaCl in the wash and incubation buffer to a final 
concentration of 1.0M, was found to reduce the NSB of duck serum proteins to the 
wells of the assay plate and consequently, increase assay sensitivity and precision.
The assay was shown to be specific and only detected antibodies in ducks 
either exposed to or following vaccination with P. anatipestifer. Sera containing 
agglutinating antibodies to other heterologous bacterial antigens gave no detectable 
response in the ELISA.
The reproducibility of the assay was demonstrated with between-assay 
CV of 6.8%, 8.3% and 8.6% obtained for the QC pools representing high, mid-range 
and low concentrations of antibodies to P. anatipestifer.
The ELISA procedure developed during these studies was demonstrated 
to be a much superior method to RSA and AGP tests in measuring antibody 
responses to exposure against P. anatipestifer type 2.
Chapter 4
Chapter 4
Passive immunisation of ducklings to Pasteurella anatipestifer . 
and resistance to homologous challenge.
4.1 INTRODUCTION
Asplin (1956), in a series of laboratory trials, investigated the clinical 
and pathological effects^ in groups of Khaki Campbell ducklings infected via 
different routes wi&rr P«- onotipcotifor. He found that the disease was readily 
transmitted via wounds or punctures of the skin, whilst ducklings infected orally or 
intranasally with the organism neither died nor showed clinical signs of disease. 
Subsequent investigators have chosen the i.m. (Harry and Deb, 1979) and s.c. 
(Layton and Sandhu, 1984) routes for the experimental infection of ducklings in 
order to assess the protective effects of various vaccination regimes against the 
disease. Harry and Deb (1979) found that a 0.5ml dose of P. anatipestifer type 1 
caused 90% mortality when given i.m. to a group of 14-day-old White Pekin 
ducklings, whilst Layton and Sandhu (1984) chose a much higher dose level 
(>10^cfu) for the i.m. infection of three-week-old ducklings. Both groups of 
workers subsequently demonstrated the efficacy of inactivated P. anatipestifer 
vaccines to protect ducklings following i.m. infection with the organism. 
Furthermore, significant reductions in mortality caused by the disease were found 
following the application of these vaccines in the field. However, Harry and Deb as 
well as Layton and Sandhu made no attempts to establish the humoral immune status 
of the experimental and field birds prior to challenge or vaccination respectively. 
Furthermore, the magnitude of the humoral immune response following vaccination
was not investigated. In view of the economic importance of this pathogen to the |
I
poultry industry, together with the fact that vaccines are reportedly effective \ 
against the disease, there exists clearly, a need to investigate the mechanisms of ^  
immunity to P. anatipestifer. y
The development and validation of ELISA methodology for the detection 
of antibodies to P. anatipestifer in duck sera is described in Chapter 3. However, 
P. anatipestifer antibody titres are of limited value unless a correlation between
antibody titre  and resistance to P. anatipestifer challenge can be established.
' The following experiments were therefore undertaken to establish 
whether a dose - response relationship exists following the i.m. infection of 
ducklings with graded dose levels of P. anatipestifer type 2, and if so, whether this 
information can be used to evaluate the protective capacity of humoral antibody to 
i.m. challenge.
in special isolation units were used in this study(see section 2.4.1). Sera obtained 
from these birds, prior to commencement of these investigations, were shown to 
have no detectable antibodies to P. anatipestifer by the ELISA.
The origin and strain of P. anatipestifer used in the experimental
b 4 4
infection system is described in section 2.3.1.1
4.2. METHODS
4.2.1. Experimental birds.
Unless stated otherwise, White Pekin ducklings raised to 16 days of age
p
4.2.2. Strain of P. anatipestifer.
4.2.3. Preparation of challenge dose.
The various doses of virulentP. anatipestifer were prepared using the
, . .• „ n -z c P 4 ^ 9 ' i (Smethod described in section 2.3.1.3, \ ‘ . ^
4.2.4. Enzyme-linked immunosorbent assay.
Sera were assayed for antibodies to P. anatipestifer by the ELISA 
described in Chapter 3.
4*2.5. Dose-response relationship to virulent P. anatipestifer challenge.
Fifteen ducklings were allocated randomly to three groups of five birds 
each. Each group of birds was injected i.m. into the thigh with one of the following
7 o g
dose levels of P. anatipestifer; 10 , 10 and 10 cfu. Following infection, all groups 
of birds were observed daily over a period of 7 days for any clinical signs of disease. 
Birds which died during these investigations or those killed jn extremis were 
removed from the isolators and subjected to post-mortem examination. Samples of 
brain and heart muscle were then removed for the re-isolation of P. anatipestifer by 
culture. ■ '  /JWvtytvS*
4.2.6. Preparation of the allogeneic anti-P. anatipestifer antiserum pool.
A group of seven White Pekin ducks a t 40 days of age were injected i.m. 
with a 1ml dose containing approximately 10^ cfu of P. anatipestifer. Sera obtained 
from these birds 14 days later were shown to contain high levels (>log2  11.92) of 
antibodies to P. anatipestifer by the ELISA. These sera were therefore pooled, and 
following heat inactivation at 56°C for 30 minutes, were filtered throught a 0.45 ym 
cellulose acetate filter (Oxoid). The antiserum pool was then checked for sterility 
and also screened for endotoxin contamination using the E-Toxate kit (Sigma). The 
pooled antiserum was found to have an end-point titre  of 12.5.
4.2.7. Intramuscular versus intraperitoneal routes of passive immunisation.
Attempts to administer antiserum i.v. via the medial metatarsal and 
brachial veins of 16-day-old ducklings showed these routes to be unpracticable: the 
fragile nature of the veins in birds of this age prevented the assurance of total dose 
retention. Consequently, the rate of uptake of antibodies into the peripheral 
circulation was compared following the a) i.m. and b) i.p. route of injection. Eight 
ducklings at 16-days-of age were divided equally to form the two groups. One group 
of birds was given 2ml of antiserum i.m. , into the thigh of the right leg, and the
other the same volume i.p. Blood samples were then obtained via the brachial vein 
from both groups of birds at intervals of i ,  1, 2, 4, 8, 10, 24, 36 and 48 hours 
following injection. The sera were harvested and stored at -20°C until required for 
determination of antibodies to P. anatipestifer.
4.2.8. Passive immunisation and determination of resistance to challenge.
Twenty-five ducklings were allocated to five groups, each consisting of
five birds. Groups 1, 2 and 3 were injected i.p. with 1 ml, 2.5 ml, and 4.0 ml of the
antiserum pool respectively. The birds in Group 4, the immunised/unchallenged
controls, were also given 4.0ml of antiserum whilst the birds in Group 5 were
designated the unimmunised/infected controls. Each group of birds was kept
separate from the others. Twenty-four hours following passive immunisation, groups
1, 2, 3 and 5 were challenged i.m. into the thigh with a 1ml dose containing 
9approximately 10 cfu of virulent P. anatipestifer. Blood samples were collected 
from all five groups of birds at daily intervals following challenge, and the sera 
harvested and assayed on the same day of collection for determination of 
P. anatipestifer antibody levels. On the fourth day following challenge, no 
antibodies to P. anatipestifer were detected in any of the birds in groups 1, 2 and 3. 
These birds were then given a further i.m. challenge of 10 cfu of P. anatipestifer 
and blood samples collected over a period of 10 days following re-infection. Birds 
which died over the duration of these investigations were subjected to post-mortem 
examination and the appropriate samples removed for the attempted re-isolation of 
P. anatipestifer by culture, (see section 4.2.5.)
4.3. RESULTS
4.3.1. Dose-response relationship to P. anatipestifer challenge.
9The ducklings in Group 5 receiving the dose containing 10 of 
P. anatipestifer all showed signs of diarrhoea accompanied by nervous signs and
incoordination at two days following infection. Symptoms persisted until three of 
these birds died one day later, at the same time the remaining two birds of this
o
group were killed jn extremis. Decreasing the dosage to 10 cfu of P. anatipestifer 
resulted in only one death, 4 days post-infection; however, two of the remaining 
four birds of this group showed signs of diarrhoea, but recovered over the 7 day 
period of study. No deaths were recorded in the group given 10^ cfu of 
P. anatipestifer. Diarrhoea was noted in only one bird of this group, while the 
remaining four birds failed to develop any clinical symptoms. All dead birds were 
autopsied and found to have severe pericarditis, together with thickening and 
congestion of the airsacs. The re-isolation of the infecting strain of P. anatipestifer 
from the brains and heart muscles of these birds confirmed the cause of death as 
acute P. anatipestifer septicaemia.
I
4.3.2. Intramuscular versus intraperitoneal routes of passive immunisation.
Figures 4.1. and 4.2. show the group mean log2  antibody titres following 
the i.m. and i.p. injection of ducklings with the antiserum pool. In the group 
injected i.m., into the thigh, low concentrations 0.6 log2  and log2  1.0 of antibodies 
to P. anatipestifer were first detected in the serum of two of the four birds in this 
group two hours later. However, maximal titres were found for each of the four 
birds when sampled 36 hours after injection. A group peak mean antibody titre  
value of log2  3.73 was recorded.
No detectable antibodies to P. anatipestifer were found in the serum 
samples obtained from the four birds two hours after the i.p. injection of 
antibodies. However, all four birds of this group were found to contain low 
concentrations of antibodies ranging in titre  from log2  0.3 to log2  1.2 when sampled 
at 4 hours following injection. The group peak mean antibody titre  (log2  4.35) was 
recorded 24 hours, after the initial injection. The half-life of the
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Fig. 4.1. Mean log2  circulating P. anatipestifer antibody titres 
following the i.m. injection of ducklings with 
allogeneic anti-P. anatipestifer antiserum.
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Fig. 4.2. Mean log2  circulating P. anatipestifer antibody 
titres following the i.p. injection of ducklings with 
allogeneic anti-P.anatipestifer antiserum.
anti-P. anatipestifer antibodies when giveflvia the i.m. and i.p. routes was found to 
be 9,6 and 11.4 hours respectively.
4.3.3. Passive immunisation and determination of resistance to challenge.
The mean log2  antibody titres obtained for the passively 
immunised/challenged groups of birds, 1, 2 and 3, together with the fourth group, 
the immunised/unchallenged controls, are shown in figure 4.3. Immediately prior to 
challenge, groups 1, 2 and 3 were found to have mean log2  antibody titres of 2.62, 
4.49 and 7.81 respectively. At the same time, the birds in Group 4 were found to 
have a mean titre  of log^ 6.81, whilst no antibodies were detected in the fifth group, 
the unimmunised/challenged controls.
Twenty-four hours following i.m. injection with P. anatipestifer, the 
mean log2  antibody titres of groups 1, 2 and 3 had fallen to 0.62, 1.08 and 2.08 
respectively. Over the same 24 hour period, despite the slight decrease in mean 
antibody titre  recorded for the birds in Group 4 as the antibodies were eliminated, 
the actual level was fajund to be significantly higher (P<0.05) than the mean titre  
values of the other three groups of birds.
Five days after the injection of the antiserum pool, no antibodies to 
P.anatipestifer were detected in any of the birds in groups 1, 2 and 3, whilst sera 
obtained from each of the immunised/uninfected control birds were found to still 
contain antibodies to P. anatipestifer. However, no antibodies could be detected in 
sera obtained from the same birds 4 days later. Over the first 4 day period 
following the first infection of groups 1, 2 and 3, no deaths were recorded. In 
contrast, the five unimmunised/infected controls all died or were killed in extremis 
at 3 days after infection.
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Following the re-infection of groups 1, 2 and 3, two deaths were 
recorded in Group 2 and one death in the third group 3 days later. No mortalities 
were recorded in Group 1 over the fifteen day period of study. Sera obtained from 
each of the survivors of the three groups at 4 days following re-infection were found 
to contain high concentrations of antibodies to P. anatipestifer. The mean antibody 
titres continued to rise sharply in the surviving two birds in the second group, but 
only a slight change was found in the other two groups over the same period. 
Following the final sampling at 31 days of age, a gradual decline in the mean 
antibody titre  values for all three groups was demonstrated. At the same time, no 
antibodies were detected in any of the unimmunised/control birds. All birds which 
died following re-infection were found to have the gross lesions characteristic of 
infection by P. anatipestifer (see section 4.3.1.). Furthermore, the organism was 
isolated by culture from the brain and heart muscle removed from each of these 
birds.
4.4 DISCUSSION
Similar to experiments undertaken by Fahey et al. (1983) on ILT 
infection in the fowl, the present studies have also employed the standardisation of 
those factors important in an experimental infection system including, a) assessment 
of humoral antibody status of experimental groups of ducklings prior to challenge; 
b) route of infection; c) age of bird, and d) dose levels of the infecting strain of 
P. anatipestifer.
The findings of the dose-response studies described in section 4.3.1.
indicate that the immunity of ducklings to i.m. challenge decreased significantly
8 9when the dose was increased from 10 to 10 cfu of P. anatipestifer per ml. It is 
apparent from the published data (Harry and Deb, 1979; Layton and Sandhu, 1984) 
(see section 4.1.) and from those findings of these studies that investigators fail to
agree on the magnitude of the challenge dose required to produce high levels of 
mortality in White Pekin ducklings. It is suggested that the infection systems 
employed by the various investigators may have been different with respect to the 
type of ducklings used, the immune status of the bird prior to challenge and the 
virulence of the infecting strain of P. anatipestifer.
It is unrealistic to expect that ducklings raised in commercial husbandry 
systems would be infected at any one time with the excessive challenge doses used 
in these present studies. These observations may suggest a loss of virulence of the 
infecting strain under the experimental conditions employed. However, the strain of 
P. anatipestifer used was known to be highly virulent and the cause of unacceptable 
losses in commercially raised ducklings. It is probable therefore, that the combined 
effects of various stress factors including, high stocking densities, environmental 
influences and exposure to other diseases present on these particular poultry 
premises may increase the susceptibility of commercially raised ducklings to the 
disease.
Previous investigators have attempted to establish the protective effect 
of passively transferred antibodies against other diseases in the avian species 
including, E. coli 078 (Arp, 1980), IBV virus (Macdonald, e t al. 1981) M. qallisepticum 
(Lin and Kleven, 1983) and DVE (L in^t al. 1984). However, prior to immunisation of 
the experimental groups of ducklings in the present studies the efficacy of the i.m. 
and i.p. routes for injection of the anti-P. anatipestifer antiserum pool were 
compared. Specific antibodies were detected earlier following injection by the i.m. 
route than the i.p. route, however, the i.p. route resulted in a quicker attainment 
of maximal antibody titres. In addition, the i.p. route resulted in a longer half life 
(11.6 vs. 9.6 hours) although why this should be so is not known. The i.p. route was 
therefore chosen for the subsequent passive immunisation investigations. Leslie
and Clem (1970), using radioiodination procedures, showed that chicken IgG and IgM 
had biological half lifes of 4 J  days and 1^7 days respectively^ It is possible 
therefore, that the rapid clearance of antibodies found in these studies may have 
been influenced by the lack of vascular equilibrium and subsequent binding of duck 
serum immunoglobulins to lymphatic tissue/organs, circulating lymphocytes, 
macrophages, tissue localisation etc.
The findings of the experiments described in section 4.3.3. indicate that 
humoral immunity functions as an important mechanism in the protection of 
ducklings following i.m. challenge with the homologous strain of P. anatipestifer. 
Furthermore, it is apparent from the data (see Fig. 4.3.) that low levels of 
circulating antibodies (log2  2.62) protect against the disease. Thus, it is envisaged 
that the magnitude of the antibody response in ducklings to vaccination can be used 
to evaluate pce&ieeriy the effectiveness of the vaccine and the regime
employed. Moreover, P. anatipestifer antibody titres can be used to determine how 
soon and the extent to which birds are immune following vaccination. This is an 
important consideration owing to the relatively early age at which losses from 
resultant P. anatipestifer infection occur. Similar applications of ELISA 
methodology have been described by previous workers for predicting the immune 
status to Pasteurella multocida infection in chickens (Briggs e t al. 1984; Dick and 
Johnson, 1984) and turkeys (Marshall e t al. 1981) following immunisation against the 
disease.
The data shows (Fig. 4.3.) that the antibody levels of the survivors in 
groups 1, 2 and 3 rose to high levels following the second challenge, whilst 4 days 
earlier none were detectable by the ELISA. In contrast, Group 3, the
unimmunised/challenged controls, which were shown to have no antibodies present 
at the time of challenge, all died within 3 days following infection. These findings
suggest that the formation of the antigen/antibody complex in vivo was itself able 
to effect an immunological memory owing the probable presence of free 
non-antibody bound antigenic determinants in the complex. From the data, it could 
be argued that Group 1 was the most protected of the three treatment groups, 
indeed the lower the saturation of P. anatipestifer antigen with antibody in this 
instance possibly resulted in a more effective-stimulation of the hosts immune 
system. However, from these findings it is difficult to establish firmly the relative 
protective merits of the between group treatments against a second challenge for 
the reasons including: 1) too few birds used in the experimental design; 2) small 
differences in final mortalities between groups; 3) similarity between the mean 
antibody titre  values found in groups 1 and 3 after re-challenge; together with the 
fact that Group 2 gave the greatest antibody response over the period following the 
second challenge.
On the basis of these observations it was therefore decided to undertake 
further experimental work to compare the level of protection afforded by 
preparations of the antigen/antibody complex against challenge. The results of 
these investigations are described in Chapter 3.
4.5. CONCLUSIONS
Under the conditions of the experiments described, it was concluded that
g
the i.m. injection of ducklings with high dose levels (>10 cfu) of P. anatipestifer 
was necessary for the establishment of infoot4en and conscquoBfrly high mortality.
These studies have shown that the i.p. injection of ducklings with anti- 
P. anatipestifer antibodies not only resulted in higher final concentrations of 
circulating antibodies but also the maximal titre  values were attained more rapidly 
than injection by the i.m. route.
From the findings of the immunisation/challenge investigations, it was 
concluded that humoral immunity functions as an important mechanism in the 
protection of ducklings infected i.m. with virulent P. anatipestifer. Furthermore, 
the formation of the antigen/antibody complex in vivo following the first challenge 
of the immunised groups of ducklings was shown to effect an immunological 
memory, indicated by a degree of protection afforded to ducklings when 
rechallenged at a time when no specific antibodies were detected.
Chapter 5
Chapter 5
Immunisation of ducklings with pre-formed preparations of 
antigen/antibody complex and determination of resistance to subsequent 
challenge with virulent Pasteurella anatipestifer
t
5.1 INTRODUCTION
In the results discussed in section 4.4., there was some evidence to 
suggest that the birds receiving the smallest dose of antiserum before the first 
challenge (Group 1) were the most protected of all the treatment groups against a 
subsequent second challenge. In this instance, it was suggested that the greater 
preponderance of non-antibody bound determinants on the partially 
immunoneutralised challenge organism probably themselves effected a greater 
priming of the immune system. However, because too few birds were used in the 
experiment described in section 4.2.8., it was not possible to establish firmly the 
relative protective merits of the various group treatments against the second 
challenge.
The studies described in this chapter were therefore undertaken to test 
and compare the level of protection afforded by preparations of the pre-formed 
antigen/antibody complex in ducklings challenged with virulent P. anatipestifer.
5.2. METHODS
5.2.1 Experimental ducks.
A total of forty female ducklings, raised to 16 days of age in isolation 
and each weighing approximately 1 Kg at the s ta rt  of the experiments, were used in 
these studies. These birds were shown to contain no detectable antibodies to 
P. anatipestifer, and randomly assigned to each of the six treatment groups.
5.2.2 Strain of P. anatipestifer.
Similar to those experiments undertaken previously, P. anatipestifer type 
2 was used as the challenge organism in the experimental infection system described 
here.
5.2.3. Preparation of the challenge dose.
P. anatipestifer type 2 was grown in tryptose soya broth to give a
9
concentration of approximately 10 cfu per ml. Full details of this procedure are 
given in section 2.3.1.5.
5.2.4. Enzyme-linked immunosorbent assay.
Concentrations of antibodies to P. anatipestifer in sera obtained from 
the experimental groups of ducklings were determined by the ELISA described in 
section 3.2.5.
5.2.5. Preparation of the allogeneic anti-P. anatipestifer antiserum pool.
Since there was insufficient of the antiserum pool used in the previous
studies (see section 4.2.8.) available to enable these investigations to be undertaken, 
a fresh sample pool was prepared using the procedures described in section 4.2.6. 
After pooling of the appropriate individual high titred antisera, the new serum pool,
designated Batch no. 2, was found to have an end point titre  of log2  11.6.
5.2.6. Preparation of the antigen/antibody complex.
In order to simulate the formation of the antigen/antibody complex m
vivo in the birds of Groups 1 and 3 of experiment 4.2.8., two different 
antigen/antibody complexes were prepared for these studies, using the following 
procedures. Ten ml of the tryptose soya broth culture containing approximately
Table 5.1.
Experimental design to compare the respective protectivities 
of the A and B antigen antibody complexes in ducklings challenged with
P. anatipestifer.
Treatment groups 
1 2 3 4 5 6
No. of birds 10 10 5 5 5 5
Complex A x
Complex B x
4ml antiserum x
lm l antiserum x
Challenge x x x x x no
910 cfu of P. anatipestifer were added to 40 ml of the P. anatipestifer antiserum 
pool (Batch no. 2). This preparation was designated the A complex and represented 
antigen saturated with antibody. Similarly, 10ml of the same broth culture were 
added to an equal volume of the same antiserum pool, this preparation was referred 
to as the B complex and represented antigen only partially saturated with antibody. 
Both antigen/antibody preparations were then mixed by vortexing for 15 seconds 
followed by an incubation at 37°C for 30 minutes. Both preparations were made 
1 hour before injection.
5.2.7. Passive immunisation and response to challenge.
The various treatments assigned to each of the six groups of ducklings 
are shown in Table 5.1.
Each of the birds in Group 1 were injected i.p. with 5ml of the A
complex. Similarly, the birds in Group 2 were each given 2 ml of the the B complex
via the same route. In this way, the birds in groups 1 and 2 received the same
amounts of P. anatipestifer but differing amounts of antiserum. Groups 3 and 4
received the same volumes of antiserum as groups 1 and 2 respectively, but
without any P. anatipestifer and represented antiserum controls. Groups 5 and
6 were two further control groups which received no antiserum nor antigen/antibody
complex. All groups of birds were bled daily over the period of 5 days following the
immunisation of groups 1, 2, 3 and 4. Immediately following the fifth bleed, groups
1, 2, 3, 4 and 5 were challenged i.m., into the thigh, with a lm l dose of
9P. anatipestifer containing approximately 10 cfu per ml. Group 5 was a challenge 
control group whilst Group 6 was a unimmunised/uninfected control group. All 
groups of birds were then bled at intervals of 4, 7, 10 and 14 days following 
challenge and observed daily for any clinical signs of disease. Dead birds or those 
killed in extremis were subjected to post-mortem examination and samples of brain 
and heart muscle removed for the attempted isolation of P. anatipestifer by culture.
5.2.8. Body weights of ducksi
The weights of the remaining birds in each of the six groups were 
determined after the final bleed given at 35 days of age.
5.3. RESULTS.
5.3.1. Clinical signs and mortalities.
In Group 1, one mortality was recorded at 10 days following infection. 
The two other birds of this group which developed signs of disease recovered over 
the duration of these studies. Three of the birds in Group 2 developed signs of 
infection over the period of four days following challenge; however, no deaths 
resulted. All five birds in each of groups 3 and 4 showed symptoms of diarrhoea; 
subsequently, one death was recorded in Group 3 and three deaths in Group 4. In 
Group 5, the challenged control birds, three of the five birds died 4 days after 
challenge. However, two weeks after the initial challenge, no disease signs were
observed in any of the remaining birds. No disease signs or mortalities were 
recorded in the unimmunised/uninfected control groups of birds over the duration of 
these studies. The results of these observations are summarised in Table 5.2.
5.3.2. Gross lesions and isolation of the challenge organism.
Each of the birds which died over the period following infection was 
found to have a severe pericarditis and inflammation of the airsacs. P. anatipestifer 
was isolated, in pure culture, from the brain and heart muscle removed from each of 
these birds.
5.3.3. Passive immunisation and response to challenge.
The mean ELISA loq9antibody titres obtained for groups 1, 2, 3, 4 and 5
" ' a.!;6
over the period of these studies are shown in Figure 5.1. j  No antibodies to
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P. anatipestifer were detected in any of the birds belonging to groups 1 and 2 
following the i.p. injection of the respective antigen/antibody complexes. In 
contrast, peak mean antibody titres of 6.24 and log2  1.54 were found twenty- 
four hours after i.p. injection of groups 3 and 4 with antiserum only. No antibodies 
were detected in the birds of groups 5 and 6 over the five day period before 
challenge.
Following challenge of groups 1 and 2, a steady increase in antibody 
concentrations were found in these birds 4 and 7 days later. However, no significant 
differences (P>0.05) were found between the mean titre values obtained for these 
two groups over this period. Samples obtained from the Group 3 birds immediately 
before challenge were found to contain low concentrations of antibodies; 
subsequently, only one death was recorded over the period allowed for infection. 
However, Group 4, representing the lm l antiserum controls, were challenged when 
antibody concentrations had fallen below detectable limits, consequently, three of 
the five birds of this group died following infection. Similarly, three of the five 
challenge control birds, which were also infected in the absence of circulating 
antibodies to P. anatipestifer, died after  infection. However, comparisons between 
the group mean titres indicated that the survivors of groups 4 and 5 gave the 
greatest antibody response to challenge. Following the final sampling at 35 days of 
age, an increase in the mean titres was demonstrated in groups 3, 4 and 5 indicating 
re-exposure to P. anatipestifer, probably resulting from excretion of the organism in 
the faeces.
No antibodies to P. anatipestifer were detected in sera obtained from 
the unimmunised/uninfected control birds over the duration of these studies.
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5.3.4^ Body weights of ducksi
The weights of the individual birds at the completion of these
experiments, together with the group weights are shown in Table 5.3. The mean 
weights for groups 1  and 2 were not significantly different (P>0.05); however, the 
mean weight of Group 2 was found to differ significantly (P<0.05) from that of 
Group 6 , the unimmunised/uninfected control value. In each of groups 1  and 2, a 
poor correlation, r= CL35 and CL30, was found between the individual bird response to 
challenge and final weight.
Of the six groups investigated, the lowest mean weights of 2,160 and 
2,010 were recorded for groups 4 and 5 respectively, but for two individuals only in 
each case. In comparison with the uninfected/unchallenged controls, a reduced 
mean weight of 2310g was also found for the third group of birds a t  the completion 
of these studies.
5A  DISCUSSION.
To pursue those observations discussed in section 4.4., concentrations of
antiserum and live antigen used in the preparation of the antigen/antibody 
complexes (see section 5.2.6.) were selected based on those procedures and 
immunoreactant concentrations employed in experiment 4.2.8. However, the data 
shows (Fig. 5.1) that no antibodies to P. anatipestifer were detected in the sera 
obtained from the ducklings injected with the A and B antigen/antibody complexes, 
indicating complete immunoadsorption of antibodies by the live antigen in these 
instances. In contrast, work undertaken in the previous studies (Fig. 4.3.) shows that 
low concentrations of passively transferred antibodies were still detectable in sera 
obtained from each of groups 1, 2 and 3 a t 24 hours following challenge. This 
observation suggests that the challenge dose given to the immunised groups of birds 
in the previous studies may have been reduced prior to contact with circulating
antibodies, possibly as a consequence of stimulating a local inflammatory response 
a t the site of injection! It is evident therefore, that consideration must be given to 
the possible involvement of the other mechanisms of the combined immune system 
prior to commencement of the type of experiments described here. In retrospect, 
the percentage saturation of antigen with antibody should have been established 
prior to injection of the complex. This could have been determined using an 
immunoperoxidase staining procedure and subsequent comparison of the intensity of 
antigen staining against that of the appropriate control preparations.
Although the injection of the pre-formed antigen/antibody complexes has 
failed to simulate the reaction m vivo between antigen and antibody of experiment 
4 . 2 . 8 ., it is still possible from the findings of these experiments to establish the 
protective function of the pre-formed complex, based on the concept of the free 
epitope, and subsequent stimulation of immunity.
The data shown in Fig. 5.1. illustrates that groups 1 , 2, 4 and 5 were all 
challenged in the absence of detectable antibodies to P. anatipestifer. These 
findings indicate that neither the A nor B antigen/antibody complexes used in these 
studies effected a detectable primary humoral antibody response over the period 
prior to challenge. Rowley et al. (1973) postulated that passively transferred 
antibody act as a t the level of the B-cell receptor site, thus effecting a blocking of 
antigen/antibody binding with resultant suppression of the antibody response. 
Therefore, the lack of antibody expression found following injection of the 
antigen/antibody complex is explainable.
Over the period following challenge, only one death was recorded in 
Group 1 and none in Group 2. In contrast, three deaths occurred in each of groups 4 
and 5 after challenge. The Group 3 birds receiving the 4ml dose of P. anatipestifer
antiserum and representing the high dose antiserum controls, were challenged at a 
time when low concentrations of antibodies were still shown to be present. The 
protective effect of passively transferred P. anatipestifer antibodies against 
virulent homologous challenge in the duck has been established earlier in these 
investigations (see section 4.3.3.), thus the loss of only one bird in this group was not 
unexpected. Clearly, therefore, these studies have demonstrated the efficacy of the 
pre-formed antigen/antibody . complexes in the protection of ducklings challenged 
i.m. with virulent P. anatipestifer. However, from the data shown in Fig. 5.1., the 
greatest antibody response to challenge was found in the survivors of groups 3, 4 and 
5 i.e. the groups receiving no injection of antigen/antibody complex. Previous
standardised infection systems used in these studies have shown that the i.m.
9injection of ducklings with a dose containing 10 cfu of P. anatipestifer results in 
high mortality (100%). However, in these experiments, birds were challenged at 21 
days old, thus the resultant lower losses found in groups 4 and 5, when challenged in 
the absence of detectable P. anatipestifer antibodies, may suggest an age related 
immunity (Seto, 1981). The increased level of protective resistance found in groups 
1  and 2  probably resulted from an increased priming of the cellular immune systems 
without concommitant expression of antibody.
Unfortunately, due to an oversight, the weights of the individual birds 
were not determined prior to commencement of these experiments, but this should 
not invalidate the findings described here. The loss of body weight found in the 
survivors of group 4 and 5 indicate that the performance of the bird can be severely 
reduced by P. anatipestifer. In Group 3, the presence of very low concentrations of 
antibodies to P. anatipestifer prior to challenge failed to eliminate clinical signs of 
disease, although a reduction in mortality was noted. Subsequently, reduced body 
weights were recorded in two of the four birds of this group. Comparisons between 
the mean body weights obtained for each of groups 1 and 2 with those of the Group
6 , the unchallenged controls, may tentatively suggest that Group 1 was the most 
protected against challenge. On the other hand, one death was recorded in Group 1, 
whilst no deaths were recorded in Group 2. Furthermore, the lowest individual body 
weight of 1980 gms was found in Group 1. It would seem apparent therefore, that 
from the data shown in Table 5.3. there is no firm evidence which suggests that the 
injection of the A antigen/antibody complex afforded a greater protection to 
challenge than the B complex or vice versa. Moreover, none of the other 
observations made over the period of challenge, including clinical signs and antibody 
response to infection provide clear evidence to indicate possible difference existing 
between the relative protective merits of the A and B antigen/antibody complexes 
used in these experiments.
5.5. CONCLUSIONS.
The injection of ducklings with pre-formed preparations of 
antigen/antibody complexes, consisting of partially immunoneutralised challenge 
organism, was shown to induce a high level of protective immunity in the recipients 
against subsequent i.m. challenge with P. anatipestifer. However, based on those 
observations made during the investigations, there was little evidence to suggest 
that the designated B complex, representing the preparation least saturated with 
antibody, exerted a greater protective influence than that of the A complex.
No antibodies to P. anatipestifer were detected in sera obtained from 
treatment groups 1 and 2 when sampled 24 hours after injection of the A and B 
antigen/antibody complexes respectively, thus indicating complete 
immunoadsorption of antibodies by the live antigen in these instances. As a 
consequence, it is reasonable to conclude therefore, that the presence of 
non-antibody bound epitopes effected a stimulation of the hosts combined immune 
mechanisms with resultant protection to subsequent challenge. Furthermore, the
lack of humoral antibody expression found in groups 1  and 2  over the period 
following challenge possibly indicated that cell mediated immunity performed a 
function in protective resistance in this instance.
Chapter 6
Chapter 6
The influence of the route of infection of Pasteurella anatipestifer 
on the clinical and immune responses of White Pekin Ducks,
6.1 Introduction
In a previous section of these studies (section 4.2.5.) experimental work 
was undertaken which showed conclusively that high dose levels of P. anatipestifer
g
( > 1 0  cfu), given i.m. to ducklings at 16 days of age, were necessary to produce high 
mortality. Several investigators (Hendrickson and Hilbert, 1932; Asplin, 1955; Harry 
- unpublished observations) have attempted to establish the transmissibility of the 
disease by different routes, but attempts to standardise the appropriate infection 
systems have been generally ignored, with the result that the published data remains 
unclear and conflicting.
The disease was first isolated and characterised by Hendrickson and
Hilbert (1932) on Long Island Farms in the USA. These workers found that the
disease could be readily produced following i.v. injection of infected tissue to ducks,
however, attempts to produce the disease by oral administration were unsuccessful.
Asplin (1955) reported the successful transmission of the disease in two of five
ducklings dosed orally, and in three of five ducklings infected intranasally. In a
subsequent report, one year later, Asplin (1956) presented data which showed the
total absence of clinical signs in groups of ducks infected orally or intranasally.
None of these reports state the dose levels of P. anatipestifer used. Harry
(unpublished findings) infected ducklings at 5 and 6  weeks of age by projecting a fine
8spray containing approximately 10 cfu of P. anatipestifer into the oral cavity.
Data was presented which showed that variations in mortality of between 6  and 80%
had occurred in the unvaccinated orally challenged control groups of birds.
Moreover, Harry infected three groups each of 17 ducklings, and a further group of
812 ducklings with 0.5ml dose containing 10 cfu of P. anatipestifer by the insertion
of an automatic pipette 5 cm into the trachea. Infection by this route, by the 
method employed, produced mortalities in all groups exceeding 80%.
The following investigations were therefore carried out to establish the 
clinical and pathological effects following the attempted infection of ducks via 
different routes with P. anatipestifer. Furthermore, the humoral and local tracheal
responses following administration by these routes were also investigated.
(x. bp$^j /U>v r/ tV> /©-to C d J
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6.2. MATERIALS AND METHODS
6.2.1. Experimental ducks
White Pekin ducks reared to 16 days of age and each weighing 
approximately 1  kg at the start of treatm ent were used in these investigations. 
Prior to the commencement of these studies, their sera were shown to contain no 
detectable antibodies to P. anatipestifer by the ELISA.
6.2.2. Strain of P. anatipestifer
All challenge experiments were performed using the strain described in 
section 2.3.1.
6.2.3. Preparation of challenge dose
A stock culture preparation of P. anatipestifer containing approximately 
1 0 ^  cfu per ml was prepared using the procedure described in section 2.3.1.5. This 
preparation was used undiluted for the infection of ducklings via the i.m. and 
intranasal routes. .
Three ml of this preparation were diluted, using molten Agar number 3 
(Oxoid) cooled to 30°C as diluent, to give a final concentration of approximately 10 
cfu of P. anatipestifer per ml. This agar preparation was allowed to gel in three - 
5 ml syringes and designated as the oral challenge inoculum.
6.2.4. Infection of ducks and collection of samples
The potency of the challenge dose was assessed by injecting five 
ducklings i.m. with 0.1ml of the stock culture preparation. A further forty-five 
ducklings were divided to form three groups each consisting of fifteen birds. One of 
these groups was infected intranasally by injecting 0 . 1  ml of the stock culture 
preparation through a nebuliser into the intranasal orifices. The second group of 
birds was infected by administering 1  ml of the agar preparation into the oral 
cavity. The remaining group of birds were used as the uninfected controls. Each 
group of birds was kept separate from the others and observed daily for any signs of 
disease following challenge. At 4, 7, 10 and 14 days after infection, three birds 
were removed from each of the three groups and blood samples obtained. These 
birds were then sacrificed by i.v. injection of pentabarbitone Sodium BP (Ceva Ltd., 
Watford) and the tracheas removed and washed using the method of Hawkes £ t  al. 
(1983). In brief, the lumen of the trachea after removal was filled with 1.0 ml of 
PBS/Tween 80 buffer (pH 7.0) and the contents gently washed by injecting and 
aspirating the wash fluid using a Pasteur pipette. The tracheal washings were 
expressed into a glass tube, cleared by centrifugation a t 1 , 0 0 0  x g for 1 0  minutes 
and the tracheal wash fluid supernatant collected. The deposits were examined and 
any samples contaminated with red blood cells were discarded. Both sera and 
tracheal wash samples were stored at -20°C until required for titration of antibodies 
to P. anatipestifer. Each bird sacrificed at the time interval indicated was 
autopsied, scored for lesions if present, and samples of brain, airsacs, spleen 
collected for the attempted re-isolation of P. anatipestifer by culture.
6.2.5. Preparation of allogeneic anti-P. anatipestifer antiserum pool
The same antiserum pool, used in experiment 4.2.8. and known to contain 
high levels (>log2  11.9) of antibodies to P. anatipestifer type 2 was used in these 
present studies.
6.2.6. Passive immunisation
A group of fifteen ducklings were injected i.p! with 2^5 ml of the 
antiserum pool. A similar group of fifteen birds receiving no antiserum were 
included as the unimmunised controls. At intervals of 1, 2 and 5 days after the 
injection of antiserum, five birds were removed from each of the two groups. Blood 
samples were obtained from the brachial veins of each of these birds which were 
then sacrificed. The tracheas were removed and washed as described in section
6.2.4. These samples were stored at -20°C until required for P. anatipestifer 
antibody determinations.
6.2.7. Enzyme-linked immunosorbent assay for use with tracheal washings
Sera were assayed for antibodies to P. anatipestifer by the ELISA 
described in Chapter 3. However, in order to determine the concentration of 
antibodies present in the tracheal wash fluid, it was necessary to establish the 
optimum concentration of diluted tracheal wash fluid for use in the assay. A 
positive tracheal wash sample pool was obtained following the washing of tracheas 
removed from five commercially raised ducks showing clinical signs of infection. 
Subsequent post-mortem and bacteriological examination of the affected birds 
confirmed the presence of P. anatipestifer. The tracheas from five, 16-day-old 
ducklings reared in isolation were washed and combined to form the negative sample 
pool. Both the positive and negative pools were used neat and diluted from 1:2 to 
1:32 in PBS/Tween buffer. Each dilution of the positive and negative pools were 
added in duplicate to coated and uncoated wells of the assay plate and the ELISA 
performed using the same concentrations of anti-species immunoglobulins as 
described for the assay of antibodies in sera (see section 3.3.5.). (^i
6.2.8. Prediction curve
A prediction curve for the conversion of the measured absorbance of the 
undiluted tracheal wash sample into a log2  end-point titre  value was derived as
follows. Samples of tracheal washings obtained from the intranasally infected group 
of birds were diluted in log2  steps and assayed by the ELISA. The end-point titre  
value for the sample was determined where the dilution curve intercepted the limit 
of detection for the assay. The detection limit for the assay was defined as the 
mean absorbance value, plus two standard deviations, of the undiluted tracheal wash 
samples obtained from the group of nine uninfected ducks. A further graph of the 
measured absorbance determined for undiluted tracheal wash fluid versus its 
end-point titre  was then constructed.
6.3. RESULTS
6.3.1. Administration of the oral and intranasal challenge dose.
No practical difficulties were found in ensuring retention of the 
challenge doses when given orally or intranasally to birds using the procedures 
described in section 6.2.4. Care was taken with the technique used for intranasal 
administration to see that it did not also result in oral administration of the 
challenge organism: likewise care was also taken in the oral administration to ensure 
that the trachea was not damaged in the process.
6.3.2. Clinical signs and mortality
The potency of the stock culture of P. anatipestifer used in these
9
experiments was confirmed by the death of all five birds challenged i.m. with 1 0  
cfu of this preparation within 3 days of infection. In the intranasally challenged 
group, diarrhoea was recorded 4 days later in two of the remaining twelve birds. 
Three days later, three of the birds in this group were noted to have lost weight. No 
signs of respiratory distress or ataxia were recorded in any of the birds in this same 
group over the duration of these investigations. In the orally infected group, no
u)e*e
clinical signs of infection or weight lossADbserved. The results of observations 
following oral and intranasal challenge are summarised in Table 6.1.
Cl
in
ic
al
 s
ig
ns
 
an
d 
le
sio
ns
 
in 
du
ck
s 
fo
llo
wi
ng
 
a) 
or
al
 a
nd
 
b) 
in
tra
na
sa
l 
in
fe
ct
io
n 
wi
th 
P. 
an
at
ip
es
tif
er
.
.2 o
COcn-H u o 
O .2
i i i  i i i  i i i  i i i
0
cnc
0
"co
JZo
COco o  o*30
_J
,
0_QG co LA•— c r—1
.2 cn O
u  ”
*D TD TD TJ O O O  O O O  i—I CD |—I *—I <—IQ
Li. Li- Li- Li-
On
O
VO KN
O O
0t-,
O
cn
.Ea
1.1Hj 4Ja s
£■ =to
Q
in
s  EZJcCD
E0c .2 o
SCO COcn —i t- o
O .2
to
C
.2’co
0
(On CJ £ 0
£  S>
u  «
cnc
5rac o o
O o
0
£ 0
CO
Q
t-. 
0 jQ TD C
•- D
CD C
H N tn < r ia  vo I"- 00 ON O I—I CM fA tA
+  I +
TJ
cm
Li.
TDCN
Li.
TJ TD TDCM CN r-|Ldo Ld td TJ Ll.O O O O O O TJ LiTD CM IA
Q Q
L. Li.*o «“!
Q
TD TD -a  H H h  
Ll.  Ll.  *+-
TJCM
U
TDCM
G
LAi—I
o CM<
On
IACD
VO
r-i
CO
IA
O
H  CM IA la vo I—  0 0  On O H N IA < f LA
>>CO
CLO4—)ZJ
0
o
no
0
04->
0
0
II
L_
aSu
ZJ
TJ
"coczcfc*oc
II
ottN
0cc
c
E
II
r—1
4->SIcn
"co TD0II 4-J
CM_0"o0 CO4->0 4J
C - , O0 cTD
co 2  'I
co >  IAo O . .
T J  * j  I'
o -H1
0
0 
>  
cn QJ
0 co
g m * 0  a 
£ 5 i! o
II
0Ot-.
°  TJ
"-2 . ^  O
TD CJ 
0 0 4-> C-.
iH «
O 10 
.2 £
£ □  «  E £
■g'Ji - 8 . 2  
•- t! -  {= 2D m 0  ^  E(hm .2 0 c p  o 
^  II II 2
I -  <  O  CD
\
E
II o
+ Z
i n  } .
0  -Q G TJ 0
Table 6 .2
Optimisation of tracheal wash sample dilution incubated in the presence 
of fixed concentrations of rabbit anti-duck Ig (1:600) and enzyme- 
labelled conjugate (1:4,000). The enzyme-substrate reaction was 
allowed to proceed for 45 minutes at 22°C.
Sample Dilution of tracheal wash sample
Pool Undiluted 1 : 2 1:4 1 : 8 1:16 1:32
positive 1 . 2 1 . 0 2 0.81 0.60 0.41 0.29
negative 0.09 0.06 0.05 0.04 0.04 0.05
NSB 0.05 0.07 0.05 0.05 0.06 0.06
Corrected
Values
i . i i a 0.96 0.76 0.56 0.37 0.24
Values indicate the difference in the mean absorbance measurement of the 
positive and negative control pools a fter  these had been corrected for NSB of the 
RADIg and conjugate in the antigen coated wells.
6.3.3. Gross Lesions
Two of the three birds killed at 7 days following intranasal challenge 
were autopsied and found to have a fibrinous pericarditis, salpingitis and gross 
lesions associated with both the thoracic and abdominal airsacs. No gross lesions 
were found in the birds sacrified at 10 and 14 days following challenge. In the orally 
challenged group, slight enlargement of the spleen was recorded in four of the six 
birds examined over the period of 10 to 14 days; however, no other lesions were 
found.
6.3.4. Isolation of P. anatipestifer
P. anatipestifer was isolated in pure culture from the brain and heart 
muscle of the five birds challenged i.m.. In the intranasally challenged group, the 
organism was recovered from the brains in two of three birds examined and also 
from the airsacs of one of these birds a t 7 days after infection. Attempts to isolate 
the organism from the brain, spleen and airsacs of each of the birds examined in the 
orally challenged group were unsuccessful.
6.3.5 Optimisation of tracheal washings in the ELISA
The results show (Table 6.2.) that the use of undiluted tracheal washing 
gave the greatest discrimination between the positive and negative sample pools 
after these had both been corrected for NSB. For this reason, it was decided not to 
dilute tracheal fluids further for use in the assay.
63.6 .  Prediction-curve
The limit of detection value for the assay of tracheal wash fluids in the 
ELISA was found to be 0.18 absorbance units. Figure 6.1. shows the sample dilution 
curves for the tracheal washings from nine ducks when assayed by serial titration, in
log2  steps, by the ELISA. This information was used to derive the prediction curve
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Calculation of the log2  end-point titre for tracheal wash fluids 
assayed by the ELISA. The titre is given by the intercept of the 
serum dilution curve with the base line representing the limit of 
detection of the assay.
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Fig. 6.2. Relationship between the absorbance of undiluted tracheal wash 
fluid, as determined by the ELISA, and the corresponding end­
point titre.
A
n
ti
b
o
d
y
 
ti
tr
e
Oral ly  i n f e c t e d  I n t r a n a s a l ly  in fec ted
c j
•O B
-tT TT
aj s e ru
G-
5-
3-
2
MQML. OB
V i
6
5-
3
2
1
b j t r a c h e a l  washings
—r-
~7 i o  1 4
Oays fallowing challenge
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(b,d) from ducks following oral or intranasal infection with 
P. anatipestifer. Each symbol represents the end-point t i t re  for 
each bird killed a t the time indicated. The solid line represents 
the mean sample end-point titre.
(Figure 6,2.) which shows a graph of the measured absorbances obtained from these 
samples versus the corresponding log^ end-point titrei Since the data did not lie on 
a straight line, several quadratic equations were solved in an a ttem pt to determine 
the line of best fit. However, an equation of the form y=a + bx, solved by the 
method of least squares regression analysis, was found to give the highest measure 
of correlation (r=0.97) between the two parameters.
6.3.7. Iq antibodies in sera and tracheal washings
Figure 6.3. shows that circulating antibodies to P. anatipestifer were 
first detected at 7 days in sera obtained from two of the three ducks examined in 
the intranasally challenged group. Three days later, high levels of serum antibodies 
were found in only one of the three ducks sacrificed at this time point. At 14 days, 
no circulating antibodies were detected in the remaining three birds. Antibodies 
were first detected 4 days after intranasal instillation in the tracheas of two of 
three birds examined. At 7 days, increased concentrations of antibodies (log2  4.83 
and log2  6.33) were found in the tracheas of two of three birds examined. Over the 
period 1 0  to 14 days, antibodies were detected in the trachea of five of six birds, 
ranging in end-point titre  value from loq^ 1.42 and log2  4.30. At 14 days, two of the 
three birds examined were still found to contain antibodies in the trachea, despite 
the fact that no circulating antibodies were detected in the serum of the same birds. 
In the orally challenged group, circulating antibodies were found in only one bird of 
this group as shown in Figure 6.3. Over the period of 7 to 14 days after challenge, 
end-point titre values ranging from log2  0.17 to log2  4.5 were measured in the 
tracheal washings obtained from five of the nine remaining ducks in this group.
A poor correlation (r=0.30) was found to exist between the levels of 
antibodies in the tracheal washings and those in the sera.
Table 6.3
Levels of antibodies to P. anatipestifer in tracheal washings and sera, 
expressed to log7  end-point titres, for the group of fifteen birds 
administered anti-P. antipestifer antiserum intraperitoneally which 
were bled and sacrificed 1 , 2  and 5 days after immunisation in lots to
five each.
Days after serum administration 3
Bird Sample 1 2 5
1 TWb 3.42° 1.33 0.17
Serum 5.46d 2.62 0.92
2 TW 0.23 1.75 0.25
Serum 3.69 2.92 1.08
3 TW 3.25 0.17 0.92
Serum 2.46 3.00 1 . 0 0
4 TW 6.17 0.33 <0 . 1
Serum 5.54 1.85 1.23
5 . TW 4.17 1.75 0.25
Serum 4.15 3.23 1.08
Mean TW 3.24 + 2.13e 1.07 + 0.77 0.40 + 0,
Serum 4.26 + 1.29 2.72 + 0.54 1.06 + 0 ,
3  Five birds were killed at each of the time intervals indicated 
k Tracheal washing 
c d’ Log« end-point titre values for tracheal washings and sera when assayed 
undiluted and a t  a dilution of 1:100 respectively in the ELISA
6  Mean + standard deviation.
6.3.8. Passive immunisation
The levels of P. anatipestifer antibodies detected in the tracheal 
washings and sera of ducks passively immunised with the antiserum pool are shown 
in Table 6.3. Twenty-four hours following immunisation, all five of the birds 
examined were shown to have antibodies to P. anatipestifer present in the tracheal 
washings as well as in their sera. The mean log2  end-point titre for the tracheal 
washings and sera obtained from this sub-group of birds was log2  3.24 and 4.26 
respectively. Over the period of two to five days, the mean serum end-point titres 
had fallen from Iog2  2.72 to log2  1.06. A similar decline in the mean tracheal 
antibody titre was recorded over the same period. However, at 5 days in contrast to 
the situation following oral and intranasal challenge, tracheal antibodies were barely 
detectable in four of the remaining five birds examined although detectable levels 
were found in the serum. No antibodies to P. anatipestifer were found in the 
trachea and sera obtained from the unimmunised control group of ducks.
6.4 Discussion
A previous section of these studies (section 3.2.7.) describes the 
derivation of a prediction curve for the expression of antibody concentrations in 
sera as log2  end-point titre values based on the absorbance reading in the ELISA of a 
fixed dilution of the serum sample. However, because the ELISA for the detection 
of antibody in tracheal wash fluids had to be re-optimised with respect to the 
concentration of the test sample, a further prediction curve was constructed for this 
purpose. Figure 6.1 shows that unlike the sera samples, generalised parallelism 
•between the constructed dose-response curves for the nine tracheal wash samples 
was not found; its employment was justified, however, by demonstrating a high 
measure of correlation (r=0.97) between the measured absorbance of the ELISA 
reading for the sample and its end-point titre.
These present studies have described the standardisation of those 
factors which possibly influence the establishment of infection in experimental 
groups of animals. Subsequently, all ducklings used in these investigations were 
obtained from the same batch and reared in separate pens, in purpose designed 
isolation units. Furthermore, all birds used in these studies were shown to be free of 
humoral antibodies to P. anatipestifer at the s tart of the experiment in which they 
were used.
These experiments have shown that the clinical and pathological 
responses in the duck vary considerably, depending on the route of infection by the 
organism, despite the high pathogenicity of the serotype used. The virulence of the 
infecting strain was demonstrated following the 1 0 0 % mortality found in the group 
given the organism i.m. In contrast, no signs of disease were noted in the orally 
challenged group of birds. These findings are in agreement with those of 
Hendrickson and Hilbert (1932) and Asplin (1956), but not with those of Asplin (1955) 
and Harry (unpublished observations) (see section 6.1). However, these 
investigations have shown that the establishment of infection and, subsequently 
disease signs, can occur in ducklings following challenge by the intranasal route. 
Evidence of an established infection in this group was demonstrated by the 
successful isolation of the challenge serotype from the brains of two of the three 
birds examined at 7 days post infection. Further evidence of infection, indicated by 
the presence of serum antibodies, was recorded in two of the six remaining birds in 
the intranasally challenged group; however, no gross lesions were found at necropsy 
with these birds.
Antibodies were detected in the tracheas in nine of twelve birds 
examined following intranasal challenge, whilst serum antibodies were detected in 
only four of these birds. These observations suggest that not only were antibodies 
present in the trachea as a consequence of active synthesis in that organ but also
prevented, to a degree, penetration of the respiratory mucosa by the infectious
n o  t~
agenti Unfortunately, anti-duck IgA class specific antisera are ' obtainable
A
commercially: therefore, the possible expression of IgA at the respiratory mucosal 
surface could not be demonstrated with the particular assay system employed. The 
data shows (Fig 6.2) that circulating antibodies were only detected in one of the 
fifteen birds examined following oral challenge. It is suggested that the pH of the 
gizzard, 2.33, and that of the proventriculus, 3.41 (Sturkie 1954) in the duck may 
have an influence on the survival of the organism. However, the presence of 
lymphoid tissue in the lamina propia of the proventriculus and the gut (Payne, 1971) 
may suggest that other immune mechanisms are also involved in the protection 
against systemic infection by this route. The presence of tracheal antibodies found 
in five of the birds in this group indicated a level of respiratory exposure, possibly 
by contamination of the respiratory trac t  during dosing or following excretion of the 
organism in the faeces.
These studies have also shown that the i.p. injection of ducklings with 
P. anatipestifer antiserum results in a rapid transfer of serum antibodies to the 
surface of the tracheal mucosa. In contrast to these findings, Hawkes et al. (1983), 
using an ELISA for the detection of antibodies to IBV, reported a lack of detectable 
levels of viral specific antibodies in the tracheas of chickens given IBV antiserum. 
However, it is considered that the method employed by these investigators to 
establish the limit of detection of the assay based on the mean absorbance value of 
dilutions of normal tracheal washes, multiplied by a factor of 2.7, may have reduced 
the sensitivity of the assay procedure. The reasons for the usage of a multiple of 
2.7 was not specified. The findings of these present studies suggest that immunity 
at the tracheal mucosal surface may be enhanced by the presence of circulating 
antibodies. Furthermore, the local inflammatory response associated with infection 
of ducklings via the respiratory route may effect an increased transudation of serum 
antibodies to the surface of the tracheal mucosa. It is suggested, therefore, tha t
the i.m. vaccination of ducklings should not only be of benefit in reducing systemic 
infection but also reduce, to a degree, the severity of respiratory lesions.
6.5. Conclusions
Under the conditions of the experiments employed in these studies, it is 
concluded from the ' clinical and pathological data, that infection with 
P. anatipestifer via the i.m. route is a major portal of entry for the subsequent 
establishment of infection and high mortality in the White Pekin duck.
Comparisons between the humoral and local tracheal antibody responses 
noted in the experimental ducklings infected intranasally with the organism, 
indicated that local produced antibody restricted, to a degree, the spread of 
infection. The lack of humoral antibody expression found in the orally challenged 
group over the period of study, indicated that the establishment of infection does 
not normally occur following the attempted transmission of the disease by this 
route.
From the results of passive immunisation studies, it was concluded, that 
antibodies present on the tracheal mucosal surface can also be derived from 
antibodies given intraperitoneally.
Chapter 7
Chapter 7
Assessment of the efficacy of a combined formalised inactivated 
Pasteurelia anatipestifer - Escherichia coli vaccine in White Pekin Ducklings
7.1 INTRODUCTION
Timms and Marshall (1988) have reported the sensitivity of the 
P. anatipestifer ELISA for the detection of the humoral antibody response in 
ducklings to an experimental vaccine. However, previous workers have ignored the 
application of immunological methods to establish the efficacy of vaccines used 
against the disease.
These present studies (see section 4.3.3.) have shown that humoral 
immunity performs an important role in the protection of ducklings following i.m. 
challenge with virulent P. anatipestifer. It was envisaged that these findings should 
be of value in establishing the immune status of ducklings immunised against the 
disease.
Several workers (Harry and Deb, 1979; Sandhu, 1979; Layton and Sandhu, 
1984) have described the efficacy of formtflised inactivated P. anatipestifer 
vaccines in the control of the disease in the field (see section 1.4.2.9.). However, 
Sandhu and Layton (1984) reported the findings following the first employment of a 
combined formalised inactivated P. anatipestifer-E. coli vaccine in the control of 
these diseases in the White Pekin duck. The vaccine was subsequently shown by 
these workers to produce significant reductions (P<0.05) in mortalities compared 
with those findings following the usage of a vaccine containing formolised 
inactivated P. anatipestifer immunogen only. On the basis of the findings of Layton 
and Sandhu, it was therefore decided to include the E. coli 078:K80 strain, endemic 
on the farms on which these present studies were undertaken, into the vaccine. 
Similarly, extensive monitoring of the P. anatipestifer serotypes present on these
commercial premises established that P. anatipestifer type 2 was by far the most 
predominant, although strains 1  and 8  were very occasionally found over the period 
of examination. For this reason, it was decided therefore, to incorporate the 
P. anatipestifer type 2 strain only into the preliminary batches of experimental 
autogenous vaccine.
The following investigations were therefore undertaken to establish the 
magnitude of the humoral antibody response to the P. anatipestifer immunogen 
following the vaccination of ducklings with a vaccine to P. anatipestifer E. coli. 
Other parameters including mortalities, causes of deaths and condemnations were 
also monitored to assess the efficacy of the various vaccination schedules employed 
in these studies.
7.2. Methods
7.2.1. Flocks
These experiments were carried out on commercial poultry premises, 
each having a history of endemic P. anatipestifer disease. The first experiment (see 
section 7.2.3.1) was conducted on premises geographically separated from the 
principal grower site on which experiments 2, 3 and 4 were performed. The White 
Pekin ducklings, originating from parent flocks of the same genotype, were 
dispatched from the companies commercial hatchery to the farms and subsequently 
reared on deep litter for the first 12 to 14 days of life. They were then transferred 
into the adjacent fattening sections. Flocks were usually dispatched for processing 
at around 6 \  to 7 weeks of age.
The designs of the first four preliminary experiments evaluated in these
«
studies are described in section 7.2.3.
7.2.2. Vaccine
A combined formalised inactivated P. anatipestifer type 2 - E. coli
078:K80 vaccine was used. This was manufactured and supplied by M.A.F.F.,
Central Veterinary Laboratory, Weybridge. The vaccine was'prepared, from a strain
of P. anatipestifer type 2 isolated from a commercial flock infected with the
g
disease. The vaccine was standardised to contain 10 cfu of P. anatipestifer and
p
10 cfu of E. coli/Q.5ml. Alhydrogel was added to give a final concentration of 25% 
v/v.
7.2.3. VACCINATION PROCEDURES
7.2.3.1. Flock experiment 1
This intake of ducklings was vaccinated at 14 days of age with 0.5 ml of 
vaccine injected s.c. into the back of the neck. A similar group of ducklings, 
originating from the same batch, were given no vaccine. Both groups of birds were 
raised in the same house, but kept separate from each other.
7.2.3.2. Flock experiment 2
A total of 3,050 ducklings was vaccinated at 14 days of age with 0.5ml of 
vaccine injected s.c. into the back of the neck. A similar group of ducklings, 
originating from the same batch, were given no vaccine. Both groups of birds were 
raised in the same house, but kept separate from each other.
7.2.3.3. Flock experiment 3
One half of a flock of 6,700 ducklings were vaccinated in the nursery
section at 10 days of age with 0.5ml of vaccine given i.m. into the thigh. Both
groups of birds were subsequently raised in the same house in separate pens.
7.2^3.4. Flock experiment 4
A group consisting of 3,300 ducklings, identified by toe slits on the outer 
web of the right foot, were divided equally and placed in the two outermost of four 
pens within the nursery section. The remaining two central pens were each occupied 
by a similar number of ducklings without toe-slits obtained from the same original 
batch. The ducklings identified by toe slits were vaccinated in the nursery section 
at 10 days of age using 0.5 ml doses of vaccine given i.m. into the thigh. Two days 
later, the appropriate pens were removed to form the two groups of mixed 
vaccinated and unvaccinated birds. These were subsequently transferred at 14 days 
old into two separate, but adajcent pens within the grower unit.
7.2.4. Sera samples
Twenty blood samples were collected from each of the flocks 
immediately before vaccination. A similar number of samples were collected, a t 
weekly intervals, from each of the vaccinated and unvaccinated groups of birds over 
a period of three weeks thereafter, unless otherwise stated. The sera were 
harvested on the same day of collection and stored at -20°C until required for the 
determination of P. anatipestifer antibody titres.
7.2.5. ELISA
This was performed as described in section 3.2.5. The prediction 
equation y = 0.13X + 0.09 was used to convert the measured absorbance of a 1:100 
dilution of sample in the ELISA to a log7 end-point titre  value. The derivation and 
justification for this equation is explained in section 3.3.7. Serological profiles for 
each of the vaccinated and unvacccinated groups of birds were obtained using a 
method of data expression similar to that described by Snyder e t al. (1985). Thus, 
the individual serum log^ antibody titres obtained over the sampling period for each 
of the flock experiments were organised into the appropriate log2  t i tre  level i.e. 0
to <0.5, >0.5 to < li0  >6.5 to <7.0, and presented graphically in the form of a
bar chart.
The group mean antibody response was calculated for each experiment 
and where appropriate, tests of significance were carried out on this data using the 
Student's t-test.
7.2.6. Mortalities
Losses occuring in each of the vaccinated and unvaccinated groups of
birds were recorded separately and monitored daily over the rearing period to
market age.
Unless stated otherwise, the Chi-square test was used to examine the 
differences in mortalities caused by a) P. anatipestifer, b) E. coli and
c) P. anatipestifer and E. coli between the vaccinated and unvaccinated groups.
7.2.7. Post-mortem examinations
Unless otherwise stated, all birds which died or were culled during the
course of these investigations were submitted on a daily basis for post-mortem
examination. Separate records were maintained for the vaccinated and un 
vaccinated groups of ducklings.
Other bacterial diseases, for example, some strains of Group D
Streptococci, cause inflammatory responses in ducklings which may be confused 
with a P. anatipestifer septicaemia (R. R. Henry, personal communication), 
therefore, samples of brain and heart muscle were removed from all ducklings 
showing gross pathological changes for the attempted isolation of the causative 
agent by culture.
7.2.8. Serotypinq of P. anatipestifer isolates
Presumptive isolates of P. anatipestifer were stained by the Gram 
method and serotyped, by R5A, using type specific antisera supplied by 
Dr. G. W. Harry.
7.2.9. Condemnations
With the exception of flock experiment 1 (see section 7.3.1.3.), the 
vaccinated and unvaccinated groups of flock experiments 2, 3 and 4 were processed 
separately. Ducklings of non-saleable quality were rejected during processing by 
qualified public meat inspectors (PMI's) and the figures subsequently submitted to 
the laboratory for comparison.
The differences in rejections found between the vaccinated and 
unvaccinated groups of flocks 2, 3 and 4 were examined using the Chi-square test.
7.3. RESULTS
The temporal immunological data, mortalities, post-mortem findings and 
condemnation data will be discussed separately for each of the four experiments.
7.3.1. Flock experiment 1
7.3.1.1. Immunological responses
Sera obtained from this flock immediately before vaccination were 
shown to contain no detectable maternal antibodies to P. anatipestifer by the ELISA 
(see Fig. 7.1). However, one week after  vaccination, 25% and 5% of the birds 
sampled from the vaccinated and unvaccinated groups respectively, were found to 
be positive for P. anatipestifer antibodies. Over the period of the following 8 to 14 
days, an increased incidence of P. anatipestifer antibody positive birds was noted in 
both the vaccinated (75%) and unvaccinated (45%) groups. Fourteen days a f te r
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Fig. 7.1. Temporal distribution of P. anatipestifer antibody titres for the 
vaccinated and unvaccinated groups of flock experiment 1 
following sampling at 7, 14 and 21 days after vaccination. The 
numbers above each bar represent the number of samples 
falling within each titre  range indicated on the abscissa.
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Fig. 7.2. Temporal distribution of P. anatipestifer antibody titres for the
vaccinated and unvaccinated groups of flock experiment 2 
following sampling at 7, 14 and 21 days after vaccination. The 
numbers above each bar represent the number of samples 
falling with each titre range indicated on the abscissa.
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Fig. 7.3. Temporal distribution of P. anatipestifer antibody titres for the 
vaccinated and unvaccinated groups of flock experiment 3 
following sampling at 7, 14 and 21 days after vaccination. The 
numbers above each bar represent the number of samples 
falling with each titre  range indicated on the abscissa.
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Fig. 7.4. Temporal distribution of P. anatipestifer antibody titres for the
vaccinated and unvaccinated groups of flock experiment 4 
following sampling at 7, 14 and 21 days after vaccination. The 
numbers above each bar represent the number of samples 
falling within each titre range indicated on the abscissa.
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Fig. 7.5, Incidence of positive P. anatipestifer isolations by culture 
following the post mortem examination of daily mortalities 
found in each of the vaccinated and unvaccinated groups of 
flock experiment 1. The daily incidence of mortality caused by 
E. coli is also shown.
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Fig. 7.6. Incidence of positive P. anatipestifer isolations by culture
following the post mortem examination of daily mortalities 
found in each of the vaccinated and unvaccinated groups of 
flock experiment 2. The daily incidence of mortality caused by 
E. coli is also shown.
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Fig. 7,7. Incidence of positive P. anatipestifer isolations by culture
following the post mortem examination of daily mortalities 
found in each of the vaccinated and unvaccinated groups of 
flock experiment 4. The daily incidence of mortality caused by 
E. coli is also shown.
immunisation, no significant differences (P>0.05) were found between the 
vaccinated (log2 1'87) and unvaccinated (log2 2,23) group mean ti tre  responses (see 
Table 7.1). Following the final sampling at 35 days of age, a fall in the incidence of 
positive samples to a value of 40% was observed in the vaccinated group. In 
contrast, circulating P. anatipestifer antibodies were detected in 85% of the birds 
examined in the unvaccinated group.
7.3.1.2. Mortalities and causes
[X'lAO
Table 7.2. shows that the greatest incidence of P. anatipestifer losses 
found in each of the vaccinated (0.64%) and unvaccinated (1.79%) groups occurred 
over the period of two weeks following immunisation. At completion of rearing, 
total confirmed P. anatipestifer losses of 0.64% and 1.81% were found for the 
vaccinated and unvaccinated groups respectively. These differences were 
subsequently shown to be highly significant (P<0.001). All P. anatipestifer isolates 
recovered from both the vaccinated and unvaccinated ducklings at necropsy were 
shown, by RSA, to be of the P. anatipestifer type 2 strain (Fig. 7.5).
Gross lesions caused by E. coli infection were first observed in one of the 
vaccinated birds submitted for post-mortem examination 21 days after  
immunisation, however, over the remaining grow-out period, only a further five 
deaths caused by the disease, resulting in a total E. coli loss of 0.16%, were found in 
this group. In comparison with these findings, a highly significant increase (P<0.001) 
in the incidence of E. coli (2.13%) losses was recorded in the unvaccinated controls.
On the final day of rearing, at 46 days old, combined P. anatipestifer - 
E. coli losses of the unvaccinated group were also shown to be significantly greater 
(P<0.001) than those of the vaccinated group (3.97% vs 0.77%). The total grow-out 
losses for the vaccinated and unvaccinated ducklings were found to be 3.73% and 
7.17% respectively.
7 .3 J .3 . Condemnations
Unfortunately, due to an oversight, rejections were not recorded 
separately for the vaccinated and unvaccinated groups on this occasion. However, 
airsacculitis and septicaemia-toxemia condemnations were only 1.62% of the total 
flock processed. No ducklings were rejected for reasons of lesions at the site of 
immunisation.
7.3.2. Flock experiment 2
7.3.2.1. Immunological responses
Fig 7.2. shows that maternal antibodies were not detected in any of the 
sera obtained from the batch of twenty ducklings sampled from this flock prior to 
vaccination. Seven days after immunisation, 85% and 70% of the birds examined in 
the vaccinated and unvaccinated groups respectively were shown to contain 
antibodies to P. anatipestifer; however, at this time, no significant differences 
(P>0.05) between the vaccinated (log2 2.29) and unvaccinated (log2 1.81) group mean 
antibody titre  responses were found (see Table 7.1). One week later, peak group 
mean antibody titres of log2 3.06 and log7 2.41 were found for the vaccinated and
days of age, the group mean antibody titre  had declined to a value of log2 2.2 in the 
vaccinated group and 1.57 log2 in the unvaccinated group. No significant 
differences (P>0.05) were found between these values.
7.3.2.2. Mortalities and causes
Total mortalities in the unvaccinated (4.39%) group were found to be 
significantly greater (P<0.001) than those of the vaccinated (2.43%) group (see Table
7.3.); however, no significant differences (P>0.05) in P. anatipestifer losses were 
found between the two groups. Subsequent serological examination of the 
P. anatipestifer isolates indicated that both the vaccinated and unvaccinated 
ducklings had been exposed to the P. anatipestifer type 2 and type 8 strains (Fig.
unvaccinated groups of birds respectively. Following the final bleed at 35
7.6.).
At completion of the grow-out, E. coli losses were found to be 1.97% and
0.10% for the unvaccinated and vaccinated groups respectively. These differences
were subsequently shown to be highly significant at the 0.1% level.
7.3.2.3. Condemnations
Following slaughter of this flock at 46 days old, the differences between 
airsacculitis and septicaemia-toxemia condemnations for the vaccinated (2.72%) and 
unvaccinated (3.22%) groups just failed to be significant at the 5% level. No 
ducklings were rejected for reasons of inflammatory responses occuring a t the site 
of vaccine injection.
7.3.3. Flock experiment 3
7.3.3.1. Immunological responses
Fig. 7.3. shows that no P. anatipestifer antibodies were detected in sera 
obtained from a batch of twenty ducklings selected at random immediately before 
vaccination at 10 days of age. Seven days later, a very low incidence of samples 
positive for antibodies to P. anatipestifer was found in the vaccinated (15%) and 
unvaccinated (10%) groups. Over the period of the following 8 to 14 days, a similar 
number of positive samples were found in each of the vaccinated (60%) and 
unvaccinated (65%) groups. At this time the mean antibody titres of log2 1.49 and 
log2 1*95 recorded for the vaccinated and unvaccinated groups respectively were 
shown not to be significantly different at the 5% level. However, it became 
apparent from the mortality data and from those of subsequent post-mortem 
findings, that this flock had become infected with the P. anatipestifer type 8 strain 
different from that strain used in the vaccine (see section 7.3.3.2.). For this reason 
it was decided to discontinue further blood sampling of this flock.
1 3 3 ,2 ,  Mortalities and causes
Fourteen days after immunisation, substantial losses of 2.6% were 
observed in the vaccinated group (Table 7.4). During this interval, cumulative 
presumptive P. anatipestifer losses amounted to 1.43% in the vaccinated group and 
subsequently, the organism was isolated a t necropsy from more than half of the 
birds examined (Table 7.4). Over the same period, a total mortality of 1.37% was 
recorded in the unvaccinated ducklings. The major cause of death found in both 
groups during the initial rearing period was due to infection by P. anatipestifer type 
8. Thus, it become apparent that the inclusion of the P. anatipestifer type 2 strain 
in the vaccine failed to provide an adequate degree of immunity to ducklings 
following exposure to the heterologous P. anatipestifer type 8 strain. For this 
reason, further post-mortem examinations were discontinued.
Over the six week rearing period, the total mortalities, on this occasion, 
were found to be significantly greater (P<0.01) in the vaccinated than the 
unvaccinated group (6.09% vs. 4.84%).
7.3.3.3. Condemnations
Following submission of the PMI's findings, the levels of airsacculitis and 
septicaemia-toxemia condemnations were found to be significantly greater (P<0.05) 
in the vaccinated than the unvaccinated group (6.04% vs. 4.74%).
The i.m. injection of vaccine, into the thigh, caused no lesions at the site 
of immunisation.
7.3.4 Flock experiment 4
7.3.4.I. Immunological responses
As with the other flocks investigated during these studies, no maternal 
antibodies were detected in samples obtained from this flock before injection of the
vaccine. Seven days after vaccination, 50% and 20% of the birds sampled from the 
vaccinated and unvaccinated groups respectively were found to contain antibodies to 
P. anatipestifer. During this time mean antibody titres of log^ 1.27 and log2 0.79 
were established for the vaccinated and unvaccinated groups respectively: no 
significant differences (P>0.05) were found between these values. Samples obtained 
from both groups a t 14 and 21 days after  vaccination indicated a steady increase- in 
the incidence of birds positive for P. anatipestifer antibodies. Peak mean antibody 
titres for both the vaccinated (log2 2.18) and unvaccinated (log2 2.44) groups were 
recorded following the final sampling at 31 days of age.
7.3.4.2. Mortalities and causes
Similar to those finding of flock experiments 1, 2 and 3 the highest losses 
caused by P. anatipestifer were found in both groups over the period of fourteen 
days following immunisation (see Table 7.5.). However, the differences in confirmed 
P. anatipestifer losses for the vaccinated (0.58%) and the unvaccinated (1.48%) 
group were found to be highly significant at the 0.1% level. P. anatipestifer strains 
2 and 8 were subsequently isolated a t necropsy from both groups of ducklings; 
however, P. anatipestifer type 8 was isolated with the greatest frequency (Fig. 7.7.).
The unvaccinated group experienced a substantial increase in E. coli 
mortality commencing at 23 days of age (Fig. 7.7.). The resultant E. coli loss of 
3.88% recorded in this group was significantly greater (P< 0.001) than the 0.61% loss 
caused by the disease in the vaccinated group.
The total grow-out losses obtained for each of the vaccinated and 
unvaccinated groups were subsequently shown to be significantly different a t  the 
0.1% level (3.58% vs 8.48%).
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7.3.4.3. Condemnations
No significant differences (P>0.05) were found between the levels of 
airsacculitis and septicaemia-toxemia condemnations obtained for each of the 
vaccinated (3.74%) and unvaccinated (3.94%) groups after processing. Similar to 
those findings of flock experiment 3, no ducklings were rejected for reason of 
lesions at the site of vaccine injection.
7.4. DISCUSSION
Commercial pressures dictated the rapid employment of a combined 
P. anatipestifer E. coli vaccine in the control of these diseases on those farms on 
which these studies were undertaken. This action was implemented based
principally on those findings of Sandhu (1984) described in section 7.1. of this 
Chapter. However, it is considered appropriate that those finding of Sandhu should 
have been confirmed in these investigations following the employment of a vaccine 
containing the P. anatipestifer immunogen only/7 ^  /O  - 1 °  ^
In flock experiments 1, 2 and 3, the efficacy of vaccination was assessed 
simply by monitoring the performance of the vaccinated and unvaccinated groups of 
birds reared in the same house but in separate adjacent pens. However, on occasion, 
significant variations in mortality are found in adjacent pens within the same house. 
The reason for these observations are unclear since the possible interactions 
involved in disease transmission are varied and complex for example,
environmental/nutritional influences, residual in-house levels of exposure, erratic or 
failure of maternal antibody transfer, vertical transmission of the disease. 
Nevertheless, the effects of these possible influences could have been minimised
following the employment of a randomised block design within the house; however,
split-house vaccinations were implemented during the preliminary trials principally 
for reasons of commercial pressures, together with the fact that in a commercial
grower house the re-arrangement of drinkers, feed hoppers etc. would have 
presented practical difficulties^ The design of the fourth experiment described in 
section 7.2.3.4. was, however, undertaken in an attempt to overcome the various 
parameters which may have influenced, to a degree, the outcome of flock 
experiments 1, 2 and 3.
Losses caused by P. anatipestifer were observed in both the vaccinated 
and unvaccinated groups of flock experiments 1 and 2 within one week after 
placement into the grow-out section. It was therefore decided in subsequent trials 
to vaccinate a t  10 days of age in an attem pt to increase the level of protective 
resistance over the early rearing period. Moreover, it was suggested that the 
vaccination of ducklings immediately following the move into the rearing unit would 
result in excessive stress and thus, increase the risk of predisposing the birds to the 
disease. However, the lack of sizeable muscle bed found in the 10-day-old duckling 
prevented an effective vaccination of large numbers of birds by s.c. injection, thus 
it was decided to administer the vaccine i.m., into the thigh. Sandhu and Layton 
(1984) made reference to an earlier report by Sandhu (1979) suggesting the 
unsuitability of alhydrogel as adjuvant for use in ducklings because of the 
persistence of lesions at the site of injection. However, Sandhu (1979) clearly 
reported that alhydrogel did not produce lesions at the immunisation site, whilst the 
inoculation of ducklings with a P. anatipestifer vaccine containing multiple oil 
emulsion (MOE) as adjuvant effected a severe inflammatory response at the 
injection site. Similar findings were reported by Reid and Blackhall (1986), who 
compared different adjuvants for use in an inactivated Coryza vaccine. They found 
that chickens injected with vaccine containing MOE developed severe 
granulomateous swellings at the injection site, but birds given vaccine containing 
alhydrogel as adjuvant did not. In agreement with those findings of Sandhu (1984) 
and Reid and Blackhall (1986), the combined vaccine, containing alhydrogel as 
adjuvant, used for evaluation in these present studies caused no lesions a t the site of 
immunisation.
The inhibitory effect of maternal antibodies upon the immune response 
to live vaccines is well documented (Biggs et al. 1980; MacDonald et aL 1982). 
Similarly, Bennejean et al. (1978) reported suppression of the antibody response to 
an inactivated oil-adjuvant ND vaccine in chicks shown to have high levels of 
maternal antibodies to the disease prior to immunisation. Thus it was necessary in 
these present studies to establish the maternal antibody status of the experimental 
groups of ducklings prior to immunisation. Subsequently, no maternal antibodies to 
P. anatipestifer were found in sera obtained from either 10 or 14-day-old ducklings 
prior to vaccination. Nevertheless, there exists a need to further investigate the 
serological status of breeder flocks to the disease in order to establish the 
possibility of high maternal antibody transfer to progeny so that vaccination 
programmes may be altered accordingly.
Harry and Deb (1979), in a series of laboratory trials, compared the 
efficacy of various types of inactivated P. anatipestifer vaccines, and concluded 
that the performance of the vaccine was not improved by the addition of alhydrogel, 
as adjuvant. However, the findings of Rowley et al. (1969) suggest that adjuvant 
may be beneficial if vaccination schedules are implemented in the presence of 
passively transferred antibodies. Rowley et al. (1969) showed that the antibody 
response was suppressed in rats given anti-sheep erythrocyte antiserum prior to 
challenge with sheep erythocytes. However, the suppressive effect of antiserum 
was prevented or partially prevented following the injection of erythocytes to which 
adjuvant was added. Subsequently, Rowley e t al. showed that the presence of 
passive antibody had no effect on the rate  of proliferation of antibody producing 
cells that did respond, whilst the addition of adjuvant effected a substantial increase 
in cell doubling times.
Samples obtained one week after the vaccination of flocks 1, 3 and 4 
indicated that a poor antibody response had occured. However, the findings shown
in Figs. 7.1. to 7.4. indicate that the incidence of samples positive for 
P. anatipestifer antibodies over the first 7 days after vaccination was always 
greater in the vaccinated groups than that of the corresponding unvaccinated 
control ducklings. Moreover, the variability in the individual bird antibody titre  
response found over the same period suggests that the vaccinated groups of flock 
sets 1, 3 and 4 were primed against the disease, thereby increasing the efficacy of 
the antibody response following field exposure to the organism. However, it is 
difficult to explain fully the high incidence of positive samples noted in both the 
vaccinated (83%) and unvaccinated (70%) groups of flock experiment 2 when 
sampled 7 days after vaccination (see Fig. 7.2.). Moreover, comparison of the 
unvaccinated group mortalities found over the grow-out period indicate that the 
lowest mortalities occured in the unvaccinated group of flock 2. It is possible that 
the presence of other infectious agents, hitherto unidentified, may be suppressing 
the immunological responsiveness of certain flocks to P. anatipestifer infections. 
Furthermore, the findings of previous laboratory trials (see section 4.2.3.) indicate
o
that high dose levels (>10 cfu) of P. anatipestifer given i.m. to ducklings a t 16-days 
old are necessary for the establishment of infection and consequently high 
mortality. It is considered unlikely that ducklings raised on commercial grower 
premises would be infected with these levels of organisms. These observations 
further suggest the existence of other factors which increase the susceptibility of 
commercially raised ducklings to the disease.
In flock experiments 1 and 4, a single injection of combined vaccine 
given either s.c. or i.m. to ducklings at 14 and 10 days of age respectively, effected 
a highly significant (P<0.001) reduction in losses caused by P. anatipestifer type 2. 
In the second trial, a very low incidence of confirmed P. anatipestifer losses was 
found in each of the vaccinated (0.26%) and unvaccinated (0.16%) groups: these 
differences were subsequently shown to be non-significant at the 5% level. 
However, the overall incidence of mortality caused by the disease in these trials
were uncharacteristically low for the particular farms on which these experiments 
was conducted and levels of 5 to 10% are not uncommon (Hatfield; personal 
observation). Moderate losses caused by the disease were however noted in the 
vaccinated group of experiment 3. P. anatipestifer type 8 was subsequently shown 
to be the cause. The immunogens included in the preliminary batches of combined 
vaccine were selected on the basis of findings following extensive serological 
determination of those serotypes of P. anatipestifer predominant on the premises on 
which these studies were undertaken. It was subsequently shown that 
P. anatipestifer type 2 was by far the predominant serotype although, types 1 and 8 
were also very occasionally isolated a t  necropsy over the period of examination. 
However, there is some evidence to suggest from the mortality data that the usage 
of the combined vaccine, containing the P. anatipestifer type 2 immunogen, 
effected an increase in the incidence of P. anatipestifer type 8 isolations possibly 
resultant from a reduced competitive antagonism. Thus, further autogenous 
vaccines should also include the P. anatipestifer type 1 and 8 immunogens.
Highly significant (P< 0.001) reductions in E. coli mortalites were found 
in each of the vaccinated groups of flocks 1, 2 and 4. The efficacy of the E. coli 
component of the vaccine in stimulating the process of immunity active against the 
disease is not yet established. Parry and Porter (1981) indicated that infections 
caused by E. coli are usually secondary to a primary infection and suggested that 
control of the primary infection should eliminate the problem. However, the 
findings of Sandhu (1984) would suggest that the E. coli component of the vaccine 
performs a function in protective resistance against the disease. The non­
significant (P>0.05) differences in P. anatipestifer losses, but significantly greater 
(P< 0.001) E. coli mortality found in the unvaccinated groups of flock experiment 2 
would also suggest that there is a need for the inclusion of the E. coli antigen in the
combined vaccine used in these present studies. However, there is some evidence to
|z> I 'Q'A
suggest from the mortality data shown in Table 7.4 ythat the stresses of
P. anatipestifer infection were sufficiently severe to overcome the possible
°  ,protective mechanisms aqainst E. coli induced by the combined vaccine on this - 
occasion. Clearly, therefore, there exists a need for a method of high sensitivity 
and practicability to determine the magnitude of the antibody response to the 1
E. coli component of the vaccine, and further establish whether antibody titres can
be correlated with protection against the disease. Work is presently being 
undertaken at the Cherry Valley Veterinary Laboratory to develop an ELISA for 
detection of antibodies to E. coli in duck sera. Deb and Harry (1978) used tube 
agglutation and haemagglutination inhibition tests to monitor the antibody response 
in broilers vaccinated against E. coli Q2:K1. These investigators were unable to 
establish a correlation between O and K serum agglutinating antibodies and 
protection against challenge. However, the test procedures used by these
investigators are insensitive detecting only agglutinating antibodies and
consequently fail to reflect the protective capacity of the total circulating antibody 
populations.
Statistical examination of the condemnation data indicate that the 
combined vaccine used in these studies does not significantly (P>0.05) reduce the 
levels of airsacculitis and septicaemia-toxemia rejections.
7.3 CONCLUSIONS
A single injection of combined P. anatipestifer-E. coli vaccine given to 
ducklings via the s.c. or i.m. routes a t 14 and 10 days of age respectively, effected 
significant (P< 0.001) reductions in losses caused by P. anatipestifer type 2 and 
E. coli. Poor protection was afforded to immunised ducklings infected with the 
heterologous P. anatipestifer type 8 strain.
Sequential data obtained for three of the four flock experiments 
indicated a poor antibody response to the vaccine. It was concluded that the
combined bulk vaccine effected in these instances a priming of the hosts immune 
mechanisms, thus increasing the efficacy of the active immune response following 
exposure to P. anatipestifer type 2 in the field.
The levels of airsacculitis and septicaemia-toxemia condemnations were 
not significantly (P>0.05) reduced following employment of the combined vaccine.
Chapter 8
Chapter 8
General discussion, conclusions and 
prospects for future investigations.
The studies described here have been primarily aimed at the 
development and validation of a method to replace the AGP and RSA tests presently 
used for the detection of antibodies to P. anatipestifer in duck sera. These la tter  
two methods depend on the presence of precipitating antibodies for their operation; 
however, recent findings have suggested that the duck is deficient in the production 
of these particular antibodies (Higgins, 1988), consequently, the sensitivity of these 
methods for the quantification of the antibody response in this species is doubtful.
A review of the avian literature indicated that many of the methods 
previously employed for the detection of antibodies to infectious agents are being 
replaced by heterogeneous enzyme immunoassay methodology. Thus the ELISA, 
which detects not only non-agglutinating and non-precipitating antibodies, but also 
those of the precipitating type, became the obvious candidate for development in 
these present studies.
The ELISA methodology developed in these investigations was 
subsequently shown to be simple, sensitive and practicable. The detection limit was 
set at 0.15 absorbance units and established from the mean absorbance value of 
'negative' sera plus two standard deviations. Consequently the P. anatipestifer 
ELISA has been adopted as the assay procedure for the immunological monitoring of 
breeder and grower flocks to the disease, utilizing computer assisted technology for 
rapid retrieval and analysis of flock data (R. R. Henry, personal communication). 
The method has also been reported by other workers to be a sensitive one for the
detection of maternal antibodies to P. anatipestifer and those resulting from 
vaccination and challenge (Timms and Marshall, 1988X
The practicality of the procedure owes much to the adoption of 
micro-titration plates for adsorption of the P. anatipestifer antigen; however, it was 
shown that the choice of plate can greatly influence the precision and sensitivity of 
the assay. Of the plate types examined in these studies, the Nunc Immunoplate II 
was found to give the greatest overall precision (CV = 5.5%) and moreover, no edge 
effect was noted. The decision to use this particular plate was further substantiated 
by the batch to batch consistency of this plate over the duration of these studies.
The application of previously described ELISA methodologies for the 
detection of antibodies to infectious agents in the fowl (Garrett et al. 1983; Piela 
and Yates, 1983) and the duck (Evans et al. 1983) resulted in high NSB of duck serum 
proteins to the wells of the assay plate. In their own studies, these workers failed to 
specify the level of NSB in the appropriate test systems; however, the absorbance 
value of 0.26 obtained following the assay of a 1:128 dilution of 'negative1 sera in the 
ELISA described by Piela and Yates (1983) is suggestive of high NSB. In the current 
studies, NSB was simply and effectively overcome by the inclusion of sodium 
chloride in the wash and incubation buffer at a final concentration of 1.0M as 
advocated by Case et al. (1982).
The validity of the heterogeneous P. anatipestifer ELISA has been 
established . The systems reproducibility and sensitivity was demonstrated. The 
procedure was also shown to be specific insofar as antibodies raised against other 
bacterial agents commonly associated with the duck failed to produce responses 
exceeding the limit of detection for the assay procedure. However, it was shown 
that the P. anatipestifer type 2 strain used as coating antigen also detected the 
presence of antibodies raised against the heterologous P. anatipestifer type 1 strain.
This observation has since been confirmed by other workers (Timms and Marshall, 
1988)i These findings indicate that the two P. anatipestifer serotypes possess 
common epitopes. The possible employment of MCAb’s with view to increasing the 
serotype specificity of the assay is discussed later in this Chapter.
From the findings of further investigations, undertaken as part of the 
validation process, it was concluded that the P. anatipestifer ELISA is far superior 
to AGP and RSA tests' for the detection of antibodies to the organism. Moreover, 
antibodies were capable of being detected by the ELISA before clinical signs of 
disease become apparent, thus providing a much earlier warning of the onset of 
infection than either of the other methods.
Like the experiments undertaken by Fahey et al. (1983) on ILT infection
in the fowl, these present studies have described the first employment of a
standardized infection system in the epidemiology of the disease in the White Pekin
duck. It was shown that high dose levels (>10 c.f.u.) of P. anatipestifer given i.m. to
16-day-old ducklings were necessary for the establishment of infection and
subsequent high mortality. Resistance to the disease was found to increase
7 8considerably following infection with either 10 or 10 c.f.u. of the organism. 
Commercially raised ducklings are unlikely to be infected in the field with the high 
loadings described in these experiments. It is probable therefore, that 
environmental stress factors, together with exposure to other diseases encountered 
in the intensive husbandry system, increase the susceptibility of ducklings to the 
disease.
The information gained in the dose response studies was used to establish 
whether humoral antibody titres, as measured by the ELISA, could be correlated 
with protection against challenge. Comparisons between the i.p. and i.m. routes for 
the injection of the allogeneic anti-P. anatipestifer antiserum pool, showed that the
i.p. route resulted in a higher and more rapid attainment of circulating antibody 
concentrations. The injection of antibodies via the Tpi route was subsequently found 
to protect ducklings against the lethal effects of virulent i.m. challenge. In 
contrast, ducklings given no antibodies all died within 3 days after infection. It was 
concluded therefore, that humoral antibodies function as an important immune 
mechanism in resistance to P. anatipestifer infection via the i.m. route.
In the experiments discussed above, the formation of the 
antigen/antibody complex jn vivo following challenge of passively immunised 
ducklings was shown to effect an immunological memory to the organism. This was 
indicated by the protective resistance afforded to ducklings following re-infection 
at a time when antibodies had fallen below the limit of detection for the assay. 
Moreover, there was some evidence to suggest that the group given the least volume 
of antiserum prior to the first challenge was the most protected of the treatm ent 
groups against subsequent re-challenge.
It was possible that the greater preponderance of free, non-antibody 
bound epitopes associated with the formation of the antigen/antibody complex in 
this group effected a greater stimulation of the humoral immune function. 
However, subsequent experimentation undertaken to compare the relative 
protective effects of preparations representing antigen saturated or partially 
saturated with antibody showed that this was not the case. Both preparations were 
shown to induce a similar high level of protective resistance in the recipients 
against challenge. The high antibody response to challenge noted in the control 
group survivors, but lack of antibody expression found in the group given 
antigen/antibody complex, suggested the involvement of the other immune systems 
in protective resistance in this instance. It is known that immunoglobulins are 
potent modulators of the combined immune function: antibody facilitates the 
function of macrophages, T-cells and killer cells which have receptors for the Fc
portion of the immunoglobulin molecule (Fox and Solomon, 1981): it is suggested 
therefore, that the immunological complex effected a stimulation of cellular 
immune function without concommitant expression of antibody.
The lack of standardisation of the appropriate infection systems 
described by previous workers has resulted in confusing and conflicting data in the 
literature. This is due in part to the use of crude methods of dose administration 
and failure to establish the potency of the infecting preparations. These 
observations necessitated further investigations to determine the influence of the 
route of infection on the clinical and immune responses in the duckling. It was 
envisaged that this information should provide a clearer understanding of the disease 
epidemiology, essential for effective immunophylaxis and immunodiagnosis. These 
studies have shown that transmission of the disease does not normally occur via the 
oral route. It is considered that non-specific immune factors for example, the low 
pH of gizzard (2.33) and that of the proventriculus (3.41) may have an influence on 
the survival of the organisms entering by this route. The presence of lymphoid 
tissue in the gut may also suggest the involvement of other immune mechanisms. 
Similarly, no deaths were recorded following intranasal challenge although 
widespread lesions indicative of a systemic infection were occasionally noted at 
necropsy.
These findings suggest the need for further experiments to establish 
whether the occurence of other diseases found in enclosed rearing systems 
predispose and/or increase the susceptibility of ducklings to P. anatipestifer 
infection via the respiratory route. From the findings of the epidemiological 
investigations described here, it was concluded that ducklings are most susceptible 
to the disease following entry of the organism via the i.m. route.
Previous workers have described the first appearance of Ig antibodies in 
the tracheae of chickens at 7 days following intranasal infection with IBV (Hawkes 
e t al. 1983). In the present studies, using a modified ELISA methodology, antibodies 
were detected in the tracheal washings as early 4 days after intranasal instillation. 
Moreover, several of the birds sampled over the period following infection were 
shown to have antibodies present in the trachea, but not in the serum. It is possible 
therefore, that locally produced antibody effected a reduction in the severity of 
systemic infection noted in these experiments. However, the involvement of 
cell-mediated immunity in protective resistance against respiratory infection by 
P. anatipestifer is not known. Tracheal antibodies were shown to be present in nine 
of the twelve birds examined in the orally challenged group, but at levels barely 
exceeding the limit of detection for the assay. It is considered that these were 
produced as a result of accidental contamination of the respiratory trac t  during 
dosing.
Workers fail to agree on whether antibody present on respiratory 
surfaces can be derived from those given passively. Holmes (1973) detected very 
low concentrations of specific neutralising antibodies in the nasal secretions of 
chickens injected with IBV antiserum. Although the ELISA is reportedly more 
sensitive than the serum neutralisation test for IBV (Mockett and Darbyshire, 1981), 
Hawkes e t al. (1983) detected IBV antibodies by the ELISA in the trachea of only one 
of twelve chickens given high-titred antiserum. However, suitable buffer additives 
were not used by those workers to overcome the problem of high NSB encountered in 
avian enzyme immunoassay systems. Moreover, the base-line value set at the mean 
absorbance of 'normal1 tracheal washings multiplied by 2.7, may have reduced the 
sensitivity of the assay procedure. In the present studies, however, it was clearly 
shown that antibodies present on the surface of the tracheal mucosa can also be 
derived from those given passively via the i.p. route. In view of the fact that serum 
antibodies are particularly effective in the immunoneutralisation of the organism, it
is suggested that the use of a killed vaccine administered i.m. may be of value in 
reducing the severity of respiratory lesions.
In view of the epidemiological and immunological data described in these 
studies, it was envisaged that the ELISA should provide a sensitive method for 
evaluating the immune status of ducklings vaccinated against P. anatipestifer in the 
field. Timms and Marshall (1988) have recently described the sensitivity of the 
method for the quantification of the antibody response following the vaccination of 
14-day-old ducklings with an experimental P. anatipestifer vaccine. In the 
experiments reported here, ducklings were also initially vaccinated at 14 days of 
age, but losses caused by the disease over the early rearing period necessitated an 
earlier vaccination given at 10 days of age. In contrast to the findings of Timms and 
Marshall (1988), significant numbers of ducklings failed to produce detectable 
antibody responses to the P. anatipestifer component of the combined vaccine used 
in these experiments. An increase in antigenic competition by the inclusion of the
E. coli component or the presence of other infectious diseases, may have depressed 
the antibody response of the neonate to the vaccine. However, in the presence of 
exposure to P. anatipestifer, a greater immunoresponsiveness was noted in the 
vaccinated ducklings. Moreover, these groups were shown to be protected against 
disease caused by P. anatipestifer type 2. It was concluded therefore, that the 
vaccine effected a priming of the neonates humoral immune function thereby 
increasing the efficacy of the active antibody response following exposure to the 
disease in the field.
In view of these findings, further studies need to be undertaken to 
establish the effect of age upon immunocompetence in the duckling. It is considered 
that protection against the disease could be improved following the implementation 
of vaccination regimes in ducklings at a later age. It is possible that the vaccination 
of parent flocks and subsequent transfer of maternal antibodies to the neonate may
increase the duration of immunity. The levels of antibodies transferred would be 
determined by the ELISA so that the appropriate vaccination programmes could be 
implemented.
These studies have confirmed the findings of Sandhu (1979) in that the 
P. anatipestifer type 2 component of the combined vaccine failed to protect 
ducklings infected with other strains of P. anatipestifer. Consequently, future 
batches of autogenous vaccines will also include the P. anatipestifer type 1 and 8 
immunogens. The increase in antigenic stimuli following the administration of this 
vaccine may result in a reduced immunological response in the neonate. There is 
therefore, a need to determine those antigens eliciting the protective immune 
response with view to the possible development of sub-unit vaccines against the 
disease. Such vaccines would eliminate the inclusion of cellular components not 
involved in the induction of protective immunity. In view of the fact that anti- 
P. anatipestifer type specific agglutinating antisera can be raised against the intact 
organism, suggests that cell wall components contribute to the elicitation of the 
protective immune reponses. The use of antisera raised against the various cell wall 
antigens would be useful in the identification of those which stimulate immunity.
The adsorption of cellular extracts to the wells of the microtitration 
plate may also increase the serotype specificity of the P. anatipestifer ELISA; 
however, optimal attainment of specificity would require the adoption of MCAb's in
with
MCAb's selected on the basis of specificity for a particular epitope. Antigen and 
test sample (duck sera) are then added to the reaction wells, and following 
incubation, another MCAb, labelled with HRPO added. Following incubation, the 
plate is washed and substrate added. If antibodies are present in the sample against 
the epitope, no enzyme will bind and consequently there will be no colour formation 
in the system.
the assay procedure. A suitable methodology) is to coat the walls of the plate
In conclusion, the employment of MCAb’s in the P, anatipestifer ELISA 
will provide additional information to the veterinary advisor and poultry manager 
for the maintenance of health care and improved flock performance.
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SUMMARY
An enzyme-linked immunosorbent assay (ELISA) for the detection 
of antibodies to Pasteurella anatipestifer in duck sera is described.
As part of the initial assay development, micro-titration plates from 
different manufacturers were assayed for their suitability to bind 
P. anatipestifer antigen. The Nunc Immunoplate II was chosen, on 
account of its overall reproducibility (5.5% coefficient of variation) 
and the absence of an edge effect. Optimum concentrations of re­
agents were determined and the inclusion of 1.0M NaCl in the wash 
buffer was found to reduce non-specific binding and increase assay 
sensitivity.
The assay is specific in that antibodies were detected only in those 
ducks either exposed to or following vaccination with P. anatipestifer; 
sera from ducks immunised with other heterologous bacterial antigens, 
and having agglutinating antibodies to them, gave no detectable re­
sponse in the ELISA. Between-assay coefficients of variation for the 
quality control serum pools representing high, medium and low levels 
of antibodies to P. anatipestifer were 6.8%, 8.3% and 8.6% respec­
tively. A precision-dose profile was derived. A graph of absorbance 
versus log2 serum end point titre showed a linear relationship (r = 0.99). 
over the range investigated. The derived regression line (P<0.001) 
was used to transform the absorbance measurement obtained for a 
single 1:100 dilution of serum into a log2 titre value.
It was demonstrated that the ELISA is a much superior method to 
rapid slide agglutination and agar gel precipitin tests in measuring 
antibody responses to exposure against P. anatipestifer type 2.
INTRODUCTION
Pasteurella anatipestifer , species incertae sedis, is responsible for an economically
Received 16 June 1986  
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important septicaemic disease o f commercially raised ducks (Anas platyrhynchos).
The disease was first reported in the United States by Hendrikson and Hilbert 
(1932), but it was not until 1969 that Harry differentiated between eight sero­
types o f P. anatipestifer (A-H), by their agglutinogens. Subsequently, Bisgaard 
(1982) suggested adopting the American system of nomenclature for denoting 
serotypes which uses Arabic numbers instead of letters. To date, serotypes'1 to 13 
• have been identified, o f which types 1 and 2 are the most commonly encountered 
in the UK (Sandhu and Harry, 1981). The poultry industry currently uses rapid 
slide agglutination (RSA) and agar gel precipitin (AGP) methods to detect anti­
bodies against this organism. Sandhu and Harry (1981) and Bisgaard (1982) have 
both reported the use of RSA and AGP methods for serotyping P. anatipestifer 
antigens isolated from commercially raised, clinically diseased, white Pekin ducks. 
These procedures are easy to perform, but are insensitive and only detect aggluti­
nating or precipitating antibodies. There is a need to develop a rapid, sensitive, 
and reproducible method, capable of screening large numbers of sera for antibodies 
to P. anatipestifer in the duck.
Since the enzyme-linked immunosorbent assay (ELISA) was introduced by Engvall 
and Perlmann (1971) for the detection and quantitation of rabbit immunoglobulin 
G, research workers and diagnosticians have applied the procedure to detect the 
presence o f antibodies to many infectious agents (Glynn and Ison, 1978; Briggs 
and Skeeles, 1983; Terpstra et al., 1985).
This communication describes the first development and validation of an ELISA 
for the detection o f antibodies to P. anatipestifer in duck sera.
MATERIALS AND METHODS 
Preparation o f  P. anatipestifer antigen.
P. anatipestifer type  2 was grown on blood agar base (Oxoid Ltd, Wade Road, 
Basingstoke, Hampshire) enriched with 5% sheep blood for 18 hours at 37°C. 
The cells were harvested into sterile saline (0.85%), washed and recovered by 
centrifugation at 3,000 x g  for 30 min. Washing was repeated until a clear super- 
natent was obtained. Following the final centrifugation, the pellet was resuspended 
in carbonate-bicarbonate pH 9.6 buffer (1.5 g Na2C 03 and 2.39 g NaHC03, 
made up to 1 litre with distilled water), and the cells further diluted in the same 
buffer to give an absorbance o f 1.0 at 540 nm using a Pye Unicam SP600 Spectro­
photometer. The extract contained 50 mg protein/100 ml as determined by the 
Kjeldahl method. The suspension of cells was divided into aliquots o f 25 ml and 
subjected to three slow freeze/thaw treatments from room temperature down to 
-20°C (±1°C). These stock antigen preparations were stored at -20°C until required.
Positive and negative reference sera
Eight 1-day-old ducklings, originating from a parent flock with no history of 
P. anatipestifer infections, were raised in isolation on a medicated diet (Sulpha- 
quinoxaline 400 parts/106). Four of these birds were injected in the neck with 
1 ml of an Alhydrogel (Superfos Kemi A-S, Fryeniundsvej 30, DK 2950, Vedbaek, 
Denmark) absorbed, formolised P. anatipestifer type 2 vaccine given at 23 days 
and 48 days after hatching. The remaining four birds were not vaccinated and 
designated as negative controls. Blood samples were taken from the vaccinated 
birds via the brachial vein 10 days following the second vaccination and allowed
ELISA for Pasteurella anatipestifer antibodies 125
to clot for 1 hour at 37°C. The serum was harvested and samples having detectable 
levels o f agglutinating antibodies to P. anatipestifer, as shown by RSA, were com­
bined to form the positive reference control pool.
Blood samples were collected from the four unvaccinated control birds at 32 
days after hatching. These sera were assayed for the absence o f P. anatipestifer 
agglutinating and precipitating antibodies by RSA and AGP methods. Those sam­
ples showing no detectable antibodies were pooled to form the negative reference 
control pool. However, after the detection limit in the ELISA had been established, 
it became apparent that this pool did, in fact, contain a low level o f non-precipi­
tating antibodies to P. anatipestifer. This pool was therefore replaced by a fresh 
serum pool obtained from birds reared in special isolation units and having no 
detectable antibodies as determined by ELISA.
Rabbit anti-duck Ig antiserum (RADIg).
This was obtained from Nordic Immunological Laboratories, Maidenhead, Berk­
shire.
Conjugate and substrate.
The conjugate used was horseradish peroxidase-labelled donkey anti-rabbit IgG 
(Guildhay Antisera, University of Surrey, Guildford). The substrate solution was 
made up immediately before use and consisted o f 40 mg of orthophenylenediamine 
(Sigma Chemical Company Limited, Fancy Road, Poole, Dorset) in phosphate- 
citrate buffer, pH 5:0 (24.3 ml 0.1 M citric acid, 25.7 ml 0.2 M Na2HP04 , 50 ml 
H20  and 40 jul 30% I^C^)- The substrate is light-sensitive and therefore is pre­
pared in a dark bottle covered in aluminium foil. 2.5 M H2S 0 4 was used to stop 
the enzyme-substrate reaction.
Assessment o f  micro-titration plates.
Several types o f micro-titration plates from different manufacturers were assessed 
for their suitability in the P. anatipestifer ELISA i.e. (I )  Nunc Immunoplate II 
(Gibco U.K. Ltd., Renfrew Road, Paisley, Renfrewshire, Scotland. Cat. no. 4- 
42404A); (2) Falcon Micro-test III (Becton and Dickinson UK Ltd, Between Towns 
Road, Cowley, Oxford. Cat. no. 3912); (3) Flow Laboratories non-treated PVC 
(Flow Laboratories, Irvine, Scotland. Cat. no. 76-364-05); (4) Flow Laboratories 
treated PVC (Cat. no. 77-172-05) and (5) Linbro EIA plate (Flow Laboratories. 
Cat. no. 76-381-04). The Flow treated plates (Cat. no. 77-172-05) had been given a 
negative surface charge by the manufacturers. This, the manufacturers claim, 
improves the coating efficiency of the plate. The Flow non-treated plate type 
(Cat. no.76-364-05) was identical in construction but had received rto treatment 
by the manufacturers.
The plates were washed once before use in carbonate-bicarbonate buffer pH 9.6. 
100 jul o f freeze/thawed P. anatipestifer antigen, diluted 1:8 in the same buffer, 
were then added to all the 96 wells of each plate and incubated overnight at 4°C. 
The following morning the plates were washed 6 times with PBS/Tween 80 buffer 
pH 7.0 (0.01 M Na2HP04 , 2.5 mM NaH2P 0 42H20 , 0.1 M NaCl, 0.1% gelatin 
and 0.05% Tween 80). 100 jul o f the positive reference serum pool, diluted to 1:
1,000 in PBS/Tween buffer, were added to the antigen-coated wells. The ELISA 
was then performed as described under ELISA procedure. The overall percentage 
coefficient o f variation (%CV) o f each plate was calculated from the standard 
deviation of the individual absorbance measurements obtained for the 96 wells.
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The absence o f an edge effect was investigated by using Student’s r-test to test the 
level of significance between the mean absorbance measurements o f the outer 
36 wells and inner adjacent 28 wells o f each plate.
Investigation o f  the effect o f  sodium chloride concentration in PBS/Tween wash 
buffer on the level o f  non-specific binding.
Following a report that a high molarity NaCl concentration in the wash and in­
cubation buffer reduced non-specific binding (NSB) in an ELISA for antibodies 
to avian infectious bronchitis virus (Case et al., 1982), it was decided to investigate 
the effects of varying concentrations o f NaCl in PBS/Tween wash and incubation 
buffer upon the level of NSB of duck sera to the wells of the assay plate (Nunc 
Immunoplate II, Gibco U.K. Ltd.).
Positive and negative reference sera were diluted to 1:100 in each of a series of 
PBS/Tween 80 buffers containing varying concentrations o f NaCl ranging from 
0.15 M to 2.0 M. Washing buffers of the same composition as the incubation 
buffers were used in each test. 100 jul o f each diluted reference serum were added, 
in duplicate, to both the coated and uncoated wells of the assay plate and the 
ELISA performed. NSB was evaluated as the amount o f colour developed in the 
absence of antigen.
ELISA procedure.
This was based on the method originated by Engvall and Perlmann (1971) and 
adopted for microplate assay by Voller et al. (1974). The principle o f the indirect 
double sandwich ELISA which was used in these investigations for the detection 
o f antibodies to P. anatipestifer is illustrated in Text-fig. 1. Optimum concentrations
Horse Radish
PA Duck DC Rabb it  DC Peroxidase
Ag PA Ig Duck Ig label led
Donkey DC
Rabbit IgG
Enzyme
S u b s t r a t e
wash wash wash w ash
Text-fig. 1. Illustration o f  the stages involved in the ‘double sandwich’ enzyme- 
linked immunosorbent assay (ELISA) for detecting antibodies to P. anati­
pestifer; ^ = solid phase, Ag = P. anatipestifer antigen, a = anti.
of antigen and duck serum dilution in the P. anatipestifer ELISA were deduced 
by chequerboard titration using the following procedure. Stock P. anatipestifer 
antigen was diluted 1:2. 1:4, 1:8, 1:16 and 1:32 with carbonate-bicarbonate 
buffer pH 9.6 and 100 jul aliquots o f each dilution dispensed into the wells of a 
microtitration plate in duplicate. The antigen was allowed to adsorb on to the plate 
by incubation overnight at 4°C in a humid atmosphere, provided in a sandwich 
box. Unadsorbed antigen was removed by washing the wells 6 times with PBS/ 
Tween 80 wash buffer containing 1.0 M NaCl, using a manual 8 channel Titertek 
plate washer (Flow Laboratories). Positive and negative duck reference control
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sera were diluted over a range o f 1:10 to 1:2,000 in the same PBS/Tween buffer 
and 100 jul aliquots o f each serum dilution incubated in duplicate against each 
antigen concentration. The plates were covered with a lid and transferred to a water 
jacketed incubator for 1 hour at 37°C (±0.5°C). The plates were then washed as 
before, with PBS/Tween buffer and 100 jul o f RADIg, diluted to 1:600 in the same 
buffer, were added to each reaction well. After a further 1 hour incubation at 37°C, 
the plates were washed to remove excess RADIg, and 100 jul o f horseradish peroxi­
dase-labelled donkey anti-rabbit IgG diluted to 1:4,000 in PBS/Tween buffer 
added. The plates were re-incubated at 37°C for 1 hour. Excess enzyme-labelled 
conjugate was removed by washing in PBS/Tween buffer followed by a further 
washing 6 times using distilled water. 100 jul o f freshly prepared substrate were then 
added to each well. The plates were covered in foil to keep out the light and in­
cubated for 30 min, in an incubator maintained at 22°C (±0.2°C). The enzyme- 
substrate reaction was stopped after exactly 30 min by the addition o f 100jul 
of 2.5 M H2S 0 4 to the assay wells. The absorbance was measured using a Multiskan 
ELISA reader (Flow Laboratories) set at 450 nm and zeroed on the empty wells of  
the micro-titration plate. The mean absorbance measurement was recorded for 
each of the duplicated assay well incubates in the ELISA minus the absorbance 
for NSB.
Standardisation o f  rabbit anti-duck Ig and conjugate concentrations.
Using the predetermined optimal concentration of antigen (1:8) and duck serum 
diluted 1:100, optimal concentrations of RADIg and enzyme-labelled conjugate 
for use in the ELISA were determined by a similar chequerboard titration. Dilu­
tions of RADIg in PBS/Tween buffer, ranging from 1:200 to 1:1,000, were evaluat­
ed against dilutions of conjugate, diluted 1:2,000 to 1:6,000 in the same buffer. 
The NSB of the enzyme-labelled conjugate was evaluated by incubating each 
dilution of conjugate in the presence of antigen only.
Substrate reaction time.
100 jul aliquots of a 1:100 dilution of the positive serum reference pool were 
added in quadruplicate to the coated wells o f a micro-titration plate and the ELISA 
performed. Reactions were allowed to proceed for exactly 15, 30, 45 and 60 min 
at 22°C(±0.2°C). At the end o f the precise time interval, the foil covering the 
plate was lifted away from the appropriate target wells and 100 jul o f 2.5 M H2S 0 4 
added, taking care not to allow light to enter the remaining reaction wells. When all 
the reactions had been stopped, the foil covering the plate was removed and ab­
sorbance measurements taken.
Prediction curve
Measured absorbances obtained with 1:100 dilutions o f duck sera, in the ELISA, 
were converted to antibody titres using a prediction curve derived as follows. 
Nineteen sera obtained from a variety o f sources, and having varying levels o f  
antibodies to P. anatipestifer, as determined in the ELISA, were diluted to 1:100 
in PBS/Tween buffer. These were then titrated in doubling dilutions, in duplicate, 
at log2 l intervals down to log27. Endpoint titres were then calculated for these 
samples where the serum dilution curve intercepted the base line (cut-off point). 
The base line for the assay was established as being the mean absorbance o f a 1:100 
dilution of a group of sera having no levels o f detectable antibodies to P. anati­
pestifer in the ELISA, plus two standard deviations. This was found to be 0.15 
absorbance units. A graph of the measured absorbance of a 1:100 dilution o f
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sample in the ELISA versus its endpoint titre was then constructed. The predic­
tion curve was derived using the method o f least squares regression analysis to 
construct the line o f best fit through the data.
Reproducibility o f  the ELISA
Three duck serum quality control (QC) pools representing high, mid-range and 
low levels of antibodies to P. anatipestifer, as determined by ELISA, were diluted 
to 1:100 in PBS/Tween buffer and added randomly to 10 antigen-coated wells 
of the assay plate. The ELISA was then performed. From the standard deviation 
of the individual absorbance measurements, the within-assay CV was derived for 
the serum QC pools. The between-assay CV was derived by assaying the same QC 
pools in the ELISA over sue consecutive assays (n = 60, where n = the total number 
of absorbance measurements obtained for each QC pool).
Precision-dose profile
The mean CV for the three duck serum QC pools of varying antibody activity was 
plotted against the log2 mean antibody titre. This titre was derived from the 
mean absorbance measurement (n = 60, replicates in six assays, where n = total 
number of observations obtained for each of the three serum QC pools) using the 
prediction curve (Text-fig. 4).
Specificity o f  the ELISA
Twenty-seven days after hatching, seven ducks having no levels o f detectable 
circulating antibodies to P. anatipestifer, as determined by the ELISA, were vaccin­
ated with one of the following bacterial antigens: P. anatipestifer types 1 and 2, 
Salmonella typhimurium, Salmonella anatum, Escherichia coli (078), Acinetobacter 
calcoaceticus and Pasteuzella multocida. Blood samples were collected from each 
bird 14 days after vaccination and shown to contain agglutinating antibodies to the 
homologous antigen by RSA. All were then assayed for detectable levels of anti­
bodies in the ELISA.
Rapid slide agglutination (RSA) test
This was performed as described by Sandhu and Harry (1981).
Agar gel precipitin (AGP) test
The same P. anatipestifer preparation used to coat the wells of the microtitration 
plate in the ELISA was used to detect P. anatipestifer precipitating antibodies in 
the AGP method of antibody assay. This method was performed as described by 
Heddleston (1975). Plates were incubated in a humid atmosphere, in a sandwich 
box, and allowed to react for 72 hours at room temperature. The agar plates were 
then washed for 20 min in 5% sodium citrate and then kept overnight in saline. 
They were stained for 1 hour with 0.1% Coomassie Brilliant Blue in 10% methanol/ 
5% acetic acid, and then decolourised with three washes o f a methanol/acetic 
acid solution.
Comparison o f  ELISA, RSA and AGP for detecting anti-?, anatipestifer antibodies 
Nine 1-day-old ducklings, obtained from a parent flock having no history of expo­
sure to P. anatipestifer, were wing-banded and raised in a specially prepared isola­
tion unit on medicated feed. Twenty-seven days after hatching, five of the group 
were injected subcutaneously in the neck with 1 ml of an Alhydrogel absorbed 
formalised vaccine, containing 109 P. anatipestifer organisms/ml. The remaining 
four birds received no vaccination treatment and were designated as negative 
controls. Blood samples were taken from both groups of birds immediately prior
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to vaccination and afterwards at intervals over a period of three weeks. Serum 
samples were stored at -20°C until required for assaying by ELISA, RSA and AGP.
RESULTS 
Preparation o f  P. anatipestifer antigen
This organism was found to grow very easily on blood-enriched agar, and following 
incubation, a sufficient yield of cells was obtained from six heavily seeded plates 
to produce approximately 1 litre of stock antigen for use in the ELISA. This 
antigen preparation, which was stored before use at -20 C(±l C), had been used 
continually over a period of 6 months without any loss of immunoreactivity in 
the ELISA.
Assessment o f  micro-titration plates
The Flow treated plate was found to have an overall CV of 8.75% with CVs of  
9.17% and 9.40% respectively for the outer 36 wells and adjacent inner 28 wells 
of this plate. The Linbro EIA, Falcon Micro-test III and Flow non-treated plates 
showed respective overall CVs of 11.34%, 13.05% and 10.26%. Therefore, these 
plates, having an overall CV in excess o f 10%, were rejected as being unsuitable 
for use in the assay, under the conditions described. Of all the types of plates 
examined, only with the Falcon-Microtest III plate were significant differences 
(P<0.05) demonstrated between the mean absorbance measurements for the 
outer and adjacent inner wells.
Table 1. Assessment o f  micro-titration plates from different manufacturers for 
their suitability as solid phase in the ELISA
Manufacturer Plate 
type Code number
Overall % CV 
for 
96 wells
% CV of 
outside 
36 wells
% CV of 
inner 
28 wells
P
Significance 
outside versus 
inside
Gibco UK Ltd.
Nunc Immunoplate II 
4-42404 A.
5.5 5.4 6.9 NSa
Becton and Dickinson 
Falcon Microtest III 
3912.
13.05 15.44 12.1 P<0.05b
Flow Labs.
PVC non-treated 
77-172-05
10.26 10.64 9.04 NS
Flow Labs. 
PVC treated 
76-364-05
' 8.75 9.17 9.40 NS
Flow Labs. 
Linbro EIA 
76-381-04
11.34 15.77 8.35 NS
a NS = Non-significant differences between means, 
k Significant differences between two means.
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In contrast to the above, the Nunc Immunoplate II was found to have an overall 
CV of only 5.5% with CVs of 5.4% and 6.9% for the outer and inner wells. These 
plates were found to have a variation of ±0.005 absorbance units for the empty 
uncoated wells. For these reasons, the Nunc Immunoplate II was chosen as the 
most suitable of the plates investigated for use in the ELISA for the detection 
of antibodies to P. anatipestifer. The results o f these investigations are summarised 
in Table 1.
Reduction o f  non-specific binding in the ELISA
The results show (Table 2) that using 1:100 dilutions o f positive and negative 
reference sera, a concentration of 0.15 M NaCl in PBS/Tween wash buffer did not 
prevent serum proteins binding non-specifically to the uncoated wells o f the assay 
plate, resulting in unacceptable high blank values. However, it was found that by 
increasing the NaCl concentration of the wash and incubation buffer progressively 
from 0.15 M to 1.0 M, the NSB was reduced to a constant value of 0.04 absorbance 
units. Increasing the molarity o f the NaCl to 2.0 M did not decrease the NSB any 
further.
Table 2. Effect o f  varying levels o f  sodium chloride in PBS/Tween wash buffer 
on the level o f  non-specific binding (NSB)
Molarity o f  NaCl in wash buffer
0.15M 0.5M 1.0M 1.5M 2.0M
PA.ag coated wells 
Positive duck serum  
Negative duck serum  
N o duck serum (blank)
0 .8 1 a 
0 .3 7 a 
0.07^
0.75
0.25
0.08
0.72
0.21
0.06
0 .70
0 .22
0 .06
0.72
0.24
0.06
Wells not coated w ith PA.ag 
Positive duck serum  
Negative duck serum  
No duck serum (blank)
0 .2 7 a
0 .2 5 a
0 .0 1 b
0.09
0.08
0.01
0 .04
0 .04
0.01
0.04
0.04
0.01
0.04
0.04
0.01
a Absorbance values measured as 450 nm of a 1:100 dilution of sample in the ELISA.
D Absorbance values for wells receiving only the RADIg, conjugate and substrate incubates.
This reduction in NSB with increasing NaCl concentration was also accompanied 
by a reduction in the absorbance measurements of the sera samples incubated in 
the antigen-coated wells, although this effect was not as marked as was produced 
in the uncoated wells. A constant absorbance was also achieved from 1.0 M on­
wards. Additionally, with at least 1.0 M NaCl in the wash and incubation buffer, 
there was minimal binding of RADIg and enzyme-labelled conjugate in the antigen- 
coated wells and virtually no binding of these reagents to the uncoated wells. 
The inclusion of NaCl to the PBS/Tween wash and incubation buffer to give a final 
concentration of 1.0 M was used for all further work.
Optimisation o f  duck serum and antigen concentrations
The results show (Table 3) that the 1:100 dilutions of positive and negative refer­
ence sera gave the greatest difference in absorbance at 450 nm after these had been
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corrected for NSB. For this reason a 1:100 dilution of duck serum was chosen 
as optimal for use in the ELISA.
The same table records a linear response for the difference in absorbance using 
the optimal dilutions o f reference sera incubated in the presence o f antigen diluted 
1:4, 1:8, 1:16 and 1:32. Therefore, to ensure future assay reproducibility and 
precision, a 1:8 dilution of antigen was chosen.
Optimisation o f  rabbit anti-duck Ig and enzyme-labelled conjugate concentrations 
A decrease in absorbance at 450 nm was obtained with increasing dilutions o f  
conjugate (Table 4). This was accompanied by a reduction in the level o f NSB to 
a constant value o f 0.02 absorbance units. The greatest discrimination for the 
positive and negative reference sera was obtained using a 1:2,000 dilution of  
conjugate; however, at this dilution of conjugate, high blank values were obtained. 
Therefore, a 1:4,000 dilution of conjugate was chosen for which a more accep­
table NSB level of 0.04 absorbance units was obtained, whilst still allowing a good 
positive to negative sera response discrimination in the ELISA.
A 1:4,000 dilution of enzyme-labelled conjugate incubated in each of a series of 
RADIg dilutions ranging from 1:400 to 1:800 recorded only a slight variation in 
absorbance differences for the positive and negative sera. Therefore, a 1:600 
dilution of RADIg was chosen as the most suitable dilution in the ELISA.
Table 3. Optimisation o f  duck serum dilution and P. anatipestifer antigen concen­
trations incubated in the presence o f  fixed concentrations o f RADIg 
(1:600) and enzyme-labelled conjugate (1:4,000). The enzyme substrate 
reaction was allowed to proceed for 30 min at 22 C.
Reference
serum
dilution
Dilution of P. anatipestifer antigen
Undiluted 1:2 1:4 1:8 1:16 1:32
1:10 0.27a 0.33 0.35 0.23 0.32 0.29
1:100 0.53 0.51 0.49 0.48 0.49 0.48
1:200 0.49 0.48 0.44 0.46 0.43 0.40
1:400 0.35 0.34 0.34 0.30 0.33 0.28
1:800 0.24 0.23 0.21 0.23 0.22 0.18
1:1,000 0.22 0.20 0.19 0.18 0.19 0.17.
1:2,000 0.03 0.03 0.02 0.03 0.03 0.01
Blanks 
(no serum) 0.05 0.05 0.05 0.05 0.05 0.05
a Values indicate the difference in the mean absorbance measurement of the positive and nega­
tive control pools after these had been corrected for NSB of the RADIg and conjugate in the 
antigen coated wells.
Effect o f  incubation time upon the enzyme-substrate reaction 
Text-fig. 2 shows that only a slight increase in colour was recorded following 
incubation at 22°C(±0.2°C) for longer than 45 min. Therefore, 45 min was chosen 
as a suitable time to stop the enzyme-substrate reaction.
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Table 4. Optimisation o f  rabbit anti-duck Ig and enzyme-labelled conjugate con­
centrations incubated in the presence o f  optimum concentrations o f  
positive duck sera (1:100) and P. anatipestifer antigen (1:8). The enzyme- 
substrate reaction was allowed to proceed for 30 min at 22°C.
Dilution
of
conjugate
Dilution of rabbit anti-duck Ig
1:200 1:400 1:600 1:800 1:1,000 NSB
1:2,000 0.75a 0.76 0.76 0.80 0.78 0.09
1:3,000 0.66 0.60 0.63 0.60 0.59 0.05
1:4,000 0.61 0.55 0.55 0.53 0.51 0.04
1:5,000 0.50 0.42 0.48 0.46 0.46 0.02
1:6,000 0.41 0:41 0.40 0.41 0.40 0.02
a Values indicate the difference in the mean absorbance measurement of the positive and nega­
tive control pools after these had been corrected for NSB of conjugate in the antigen coated 
wells.
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Text-fig. 2. Effect o f  incubation time upon the enzyme-linked reaction.
Prediction curve
Text-fig. 3 shows the serum dilution curves o f samples from 19 ducks which were 
assayed by end-point titration from an initial 1:100 dilution of sample in the 
ELISA. Using this information, the prediction curve was derived (Text-fig. 4) 
which shows a graph of the absorbance measurements obtained for these samples 
at the 1:100 dilution versus log2 serum end-point titre, for which a linear relation­
ship was demonstrated (r = 0.99).
Reproducibility
The ELISA was demonstrated to be reproducible (Table 5). Within-assay CV of 
3.2%, 4.9% and 6.3% respectively were found for the three duck serum QC pools 
representing high, mid-range and low levels o f antibodies to P. anatipestifer when 
assayed at a 1:100 dilution. Absorbance measurements obtained over 6 consecutive 
assays had a between-assay CV of 6.8%, 8.3% and 8.6% for the same high, mid­
range and low antibody serum pools.
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Text-fig. 3. Calculations o f the log2 serum end point titres for nineteen duck sera 
assayed in the ELISA. The titre is calculated where the serum dilution curve crosses 
the base-line.
09t
S oe
04-
02-
0 1 2 53 4 6 1
Log2 en d -p o in t t i t r e
Text-fig. 4. Relationship between the absorbance in the ELISA o f  a 1:100 dilution 
o f  sample and its end-point titre for the nineteen duck sera. The resulting corre­
lation enables the end-point titre to be predicted from the absorbance measure­
ments o f  a 1:100 dilution o f  sample in the ELISA.
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Table 5. Within and between-assay co-efficient o f  variation (%CV) for three duck 
serum QC pools representing high, mid-range and low levels o f  antibodies 
to P. anatipestifer.
Serum pool Within-assay %CV Between-assay %CV
High positive pool 3.2 6.8
Mid-range positive pool 4.9 8.3
Low positive pool 6.3 8.6
Precision-dose profile
Text-fig. 5 shows the overall precision o f the measurements obtained over the 
analytical range of the assay for samples assayed at a 1:100 dilution. Dnly a slight 
overall variation in precision was found, indicating that a practical and rugged 
assay has been developed.
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Text-fig. 5. Precision-dose profile over the analytical range o f  the assay investi­
gated wi thstandard err o ra  t^each'ddta-pointr
Specificity
The results show (Table 6) that the ELISA detected antibodies to P. anatipestifer 
in serum samples obtained from birds vaccinated with antigen prepared from 
that organism only. Samples from ducks known to contain agglutinating anti­
bodies to the following heterologous bacterial antigens: S. typhimurium, S. anatum, 
E. coli (078), A. calcoaceticus and P. multocida gave no reaction which exceeded 
0.15 absorbance units, the detection limit of the assay, when assayed in the ELISA.
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Table 6. Assessment o f  specificity in the ELISA.
Absorbance measurements at 450 nm of sera assayed at a 1:100 dilution in the • 
ELISA and known to contain agglutinating antibodies to other heterologous 
antigens.
Serum sample Absorbance 450 nm
a a — P. anatipestifer type 2 antiserum 
a —P. anatipestifer type 1 antiserum 
a — S. typhimurium  antiserum 
a — S. anatum antiserum 
a —P. multocida antiserum 
a —A. calcoaceticus antiserum 
a  — E. coli (078) antiserum 
Negative control serumc
0.643b (POS) 
0.625b (POS) 
0.08 
0.12 
0.09 
0.08 
0.08 
0.09
a a  = anti
b Samples demonstrating a response greater than the detection limit of 0.15 absorbance units 
for the assay were taken as positive to anti-P. anatipestifer antibodies.
c Replacement negative duck serum pool and having no levels of detectable antibodies in the 
ELISA.
Comparison o f  ELISA, RSA and AGP fo r detecting anti-P. anatipestifer antibodies 
The individual levels of circulating antibodies to P. anatipestifer in the five ducks 
vaccinated with P. anatipestifer type 2 are shown in Text-fig. 6. Values are express­
ed as log2 serum end-point titres obtained from the prediction curve using a 1:100 
dilution o f sample in the ELISA. The mean serum titres are summarised in Table 7, 
which also shows the results for the individual samples when assayed by the RSA 
and AGP methods o f antibody assay. Four days after vaccination, antibodies to 
P. anatipestifer were just detectable in two of the five birds in the P. anatipestifer 
vaccinated group. Three days later, antibodies were detected by the ELISA in all 
five of the inoculated birds; however, no agglutinating or precipitating antibodies 
were detected by the RSA or AGP in any of these samples.
Table 7. Comparison o f  ELISA, RSA and AGP methods for the detection o f  anti­
bodies to P. anatipestifer in five ducks following vaccination with P. anati­
pestifer type 2.
Method 
of assay
Days following vaccination with P. anatipestifer type 2
0 4 7 10 14 21
ELISA
RSA
AGP
< 0 .4 a(0)b
(0)
(0)
0.5(2)
(0)
(0)
2.04(5)
(0)
(0)
4.16(5)
(2)
(0)
5.0(5)
(4)
(1)
3.48(5)
(2)
(0)
a ELISA log2 serum mean titres were based on positive samples only.
b Figures in brackets refer to the number of ducks in the group of five positive for antibodies to 
P. anatipestifer in the assay method used.
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Peak serum titres were recorded in three o f the five birds 10 days after vaccination 
by the ELISA, with agglutinating antibodies then detectable by RSA in two of 
these birds. Serum obtained from the fourth bird, 4 days later, gave high levels of 
anti-R anatipestifer antibodies when assayed in the ELISA and precipitating anti­
bodies were shown to be present in this sample by AGP. However, precipitation 
lines were barely discernable even when stained using Coomassie Brilliant Blue. 
After 3 weeks, a decline in serum titre in three o f the five birds in the vaccinated 
group was recorded.
No antibodies were detected in samples obtained from the four unvaccinated 
control birds at 41 days o f age by any of the methods of antibody assay used. 
However, 7 days later, low levels o f antibodies were detected in this group by 
ELISA. No agglutinating or precipitating antibodies were detected in these samples 
by RSA and AGP. These birds did not show any clinical signs o f infection and were 
sacrificed for post-mortem investigations. These did not reveal any lesions and 
attempts to isolate the organism by culture were unsuccessful.
Bird 1 Bird 2 Bird 3
3 -
T T
t i t r e s
Bird 4
o 4  7  10 14 21
Bird 5
o 4 7  10 14 21
D ay s  a f t er  v a c c i n a t i o n
Text-fig. 6. Individual levels o f  circulating antibodies to P. anatipestifer in the five 
ducks vaccinated with P. anatipestifer type 2. Values were end-point 
titres obtained from the prediction curve.
DISCUSSION
The ELISA system reported in this communication, which is a modification of 
that described by Voller e t al. (1974), was found to be a sensitive, reproducible 
and specific assay for the detection of antibodies to P. anatipestifer. However, 
a number of factors were found to affect its performance. McLaren et al. (1981) 
have stated that considerable variations have been observed in batches of plates 
from the same manufacturer and they recommended the testing o f each new 
batch of plates before use. Of the different types o f plates examined, the Nunc
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Immunoplate II was found to be the most suitable in the ELISA for the detection 
o f antibodies to P. anatipestifer. This decision has since been confirmed by the 
batch-to-batch consistency of the plates used in the assay .
The initial assays, following previously published methods for the detection of 
other avian diseases (Evans eta l., 1983; Solano et al., 1983), resulted in high NSB 
o f duck serum proteins to the wells of the assay plate. Slaught et al. (1979) des­
cribed the high affinity of chicken serum proteins for the wells of the microtitra­
tion plate, and found that NSB was mostly eliminated by a pre-treatment o f the 
plate using calf serum. However, in agreement with the findings of Case et al. 
(1982), the investigations reported here have shown that the inclusion of NaCl 
in the wash buffer and diluent at a final concentration of 1.0 M reduced the level 
o f NSB and so increased the sensitivity of the assay.
Commercial preparations of enzyme-labelled anti-duck immunoglobulin antibodies 
are presently unobtainable. Therefore, the detection of duck antibodies in the 
ELISA required the use of a rabbit anti-duck Ig antiserum as a bridging antibody 
between the immobilised duck Ig and the enzyme-labelled donkey anti-rabbit 
IgG antibodies.
Incubation times of 1 hour at 37° C were allowed for the various immunoreac- 
tion stages of the assay and are of general application in several reported ELISAs 
(Mockett and Derbyshire, 1981; Briggs and Skeeles, 1983). Results for the levels 
o f antibodies to P. anatipestifer in test samples were expressed as log2 end-point 
titres, obtained by reference to a prediction curve derived from the titration of 
some 19 duck sera of varying antibody concentrations. The use of a prediction 
curve for converting the absorbance of a 1:100 dilution of sample in the ELISA to 
an end-point titre was justified by the high degree of correlation between these 
two parameters, demonstrating the lack of cross-over effects from the constructed 
dose-response curves for these samples. This enabled data to be expressed as a 
1 quantitative, easily understood measure of the serum antibody levels, whilst con­
serving reagents, time and allowing increased sample output and a larger number 
of-birds to be screened.
The assay was shown to be reproducible both within and between-assays and 
compares well with previously published ELISAs for the detection of other avian 
diseases (Garrett et al., 1983; Smart and Grix, 1985). The precision-dose profile 
showed only a slight variation over the analytical range investigated, indicating 
the ruggedness of the system. The degree of specificity of the assay was demon­
strated in that antisera known to contain agglutinating antibodies to other generi- 
cally unrelated bacterial antigens, gave no responses exceeding the base line cut-off 
point for the assay. Sandhu and Harry (1981) demonstrated cross-reactions of 
homologous anti-P. anatipestifer antisera to some P. anatipestifer antigens in the 
AGP method, although they found no P. anatipestifer type 1 and 2 cross-reacting 
precipitating antibodies. However, anti-P. anatipestifer type 1 antiserum was shown 
to react with P. anatipestifer type 2 antigen in the ELISA, indicating the existence 
o f  cross-reacting non-precipitating antibodies not demonstrable by the AGP test.
It was demonstrated that the four unvaccinated birds at 47 days of age had levels 
o f antibodies exceeding the base line o f the assay, suggesting that accidental ex­
posure to P. anatipestifer had occurred in this group. No clinical signs o f infection 
were noted.
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ELISA and RSA methods are rapid to perform, but the RSA is less sensitive as 
only agglutinating antibodies are detected. Similar findings were made by Marshall 
et al. (1981), who reported the ELISA to be superior to microagglutination tests 
in the detection of Pasteurella multocida antibodies. This study shows that the 
ELISA is able to detect the incidence of infection to-P. anatipestifer very much 
earlier than either RSA or AGP, namely 4 to 7 days in the case of ELISA v. 10 to 
14 days for RSA and after 14 days for AGP. The antibodies are capable of being 
detected with the ELISA before any clinical symptoms of P. anatipestifer infection 
are apparent. Therefore the greater sensitivity of the ELISA is capable of providing 
a much earlier warning of the onset of infection than either of the other methods.
Acknowledgement
The authors wish to thank Ms Caron Aslin for her secretarial assistance in the 
preparation of this manuscript.
REFERENCES
Bisgaard, M. (1982). Antigenic studies on Pasteurella anatipestifer species incertae sedis, using 
slide and tube agglutination. A vian Pathology, 11: 341-350.
Briggs, D.J. and Skeeles, J.K. (1983). An enzyme-linked immunosorbent assay for detecting 
antibodies to Pasteurella multocida in chickens. Avian Diseases, 28: 208-215.
Case, J.T., Ardans, A A ., Bolton, D.C. and Reynold, B.J. (1982). Optimization of parameters 
for detecting antibodies against infectious bronchitis virus using an enzyme-linked 
immunosorbent assay: Temporal response to vaccination and challenge with live virus. 
Avian Diseases, 27:196-210.
Engvall, E. and Perlmann, P. (1971). Enzyme-linked immunosorbent assay (ELISA). Quanti­
tative assay of immunoglobulin G.Immunochemistry, 8: 871-874.
Evans, R.T., Chalmers, W.S.K., Woolcock, PJi., Farmer, H. and Taylor-Robinson, D. (1983). 
An enzyme-linked immunosorbent assay for the detection of chlamydial antibody in 
duck sera. Avian Pathology, 12:117-124.
Garrett, J.K., Davis, R.B. and Ragland, W.L. (1983). Enzyme-Iimked immunosorbent assay 
for detection of antibody to avian encephalomyelitis virus in chickens. A wan Diseases, 
28:117-130.
Glynn, A A . and Ison, C. (1978). Serological diagnosis of gonorrhea by an enzyme-linked 
immunosorbent assay (ELISA). British Journal o f  Venereal Diseases, 54: 97-102.
Harry, E.G. (1969). Pasteurella (Pfeifferella) anatipestifer serotypes isolated from cases of 
anatipestifer septicaemia in ducks. Veterinary Record, 84: 673.
Heddleston, K.L. (1975). Isolation and Identification of Avian Pathogens, 2nd Edition, pp. 14.
New York: American Society o f  Avian Pathologists.
Hendrickson, JM. and Hilbert, K.F. (1932). A new and serious septicaemia disease of young 
ducks with a description of the new causative organism. Pfeifferella anatipestifer. Cornell 
Veterinarian, 22: 239-252.
Marshall, M.S., Robinson, R A . and Jensen, M.M. (1981). Use of an enzyme-linked immuno­
sorbent assay to measure antibody response in turkeys against Pasteurella multocida. 
Avian Diseases, 25: 964-971.
McLaren, M.L., Lillywhite, J.E. and Andrew, C.S. (1981). Indirect enzyme-linked immuno­
sorbent assay (ELISA): Practical aspects of standardization and quality control.Medical 
Laboratory Sciences, 38: 245-251.
Mockett, AJ?A. and Darbyshire, J.H. (1981). Comparative studies with an enzyme-linked 
immunosorbent assay (ELISA) for antibodies to avian infectious bronchitis virus. Avian 
Pathology, 10:1-10.
Sand.hu, T.S. and Harry, E.G. (1981). Serotypes of Pasteurella anatipestifer isolated from 
commercial white pekin ducks in the United States. A vian Diseases, 25: 497-502.
Slaught, S.S., Yang, T.T. and Van der Heide, L. (1979). Adaption of enzyme-limked immuno­
sorbent assay to the avian system. Journal o f  Clinical Microbiology, 10: 698-702.
ELISA for Pasteurella anatipestifer antibodies 139
Smart, IJ . and Grix, D.C. (1985). Measurement of antibodies to infectious avian encephalo- 
mipelitis virus by ELISA. Avian Pathology, 14: 341-352.
Solano, W., Giambrone, J.J. and Papangala, V.S. (1983). Comparison of enzyme-linked immun­
osorbent assay and indirect haemagglutination test for quantitating antibody responses 
in chickens against Pasteurella multocida. Avian Diseases, 27:1034-1042.
Terpstra, W.J., Lighthart, G.S. and Schome, E.J. (1985). ELISA for the detection of specific 
IgM and IgG in human leptospirosis. Journal o f  General Microbiology, 131: 377-385. 
Voller, A., Bidwell. D., Huldt, G. and Engvall, E. (1974). A microplate method of enzyme- 
linked immunosorbent assay and its application to malaria. Bulletin o f  the World Health 
Organisation, 51: 209-211.
RESUME
Developpement d’un test immuno-enzymatique pour la detection des 
anticorps seriques vis-a-vis de Pasteurella anatipestfer
Un test immuno-enzymatique (ELISA) applique a la detection des anticorps 
vis-a-vis de Pasteurella anatipestifer chez la canard a ete mis au point. Au preal- 
able des microplaques de fabrication differente ont ete testees pour la fixation 
de l’antigene et le choix a concerne les immunoplaques NUNC II, en raison de 
le reproductib le (5,5% de coefficient de variation) et de l’absence d’effet de 
bordure, Les concentrations optimum de reactifs ont ete determiners et l’addition 
de 1,0 M de NaCl dans le tampon de lavage a reduit l’attachement non specifique 
et augment e la sensibilite.
Le test est specifique car les anticorps ne sont deceles que chez les canards infectes 
par ou vaccines contre Pasteurella anatipestifer',les serums de canards immunises 
avec d’autres antigbnes bacteriens heterologues et developpant des anticorps a 
leur encontre, n’ont pas donne de reponse decelable en ELISA. Les coefficients 
de variation du controle de qualite portant sur des pools de serums ayant des 
titres eleves, moyens et faibles en anticorps vis-a-vis dz Pasteurella anatipestifer 
ont ete respectivement de 6,8, 8,3 et 8,6%, Un profil de precision de dose a ete 
etabli. Un graph d’absorbance en log2 du titre limite du serum a montre une 
relation lineaire (r = 0,99) pour la plage etudiee. La ligne de regression derivee 
(P<0,001) a ete utilisee pour transformer la mesure d’absorbance pour une seule 
dilution a 1 /1 OOe du serum en valeur du titre en log2 .
II a ete demontre que la technique ELISA est nettement superieure a l’agglu- 
tination rapide sur lame et a la precipitation en milieu gelose pour mesurer la 
reponse immunitaire consecutive a l ’exposition a P. anastipestifer de type 2.
ZUSAMMENFASSUNG
Die Entwicklung eines Enzym-Immunosorbent Testes zum Nachweis von 
humoralen Antikorpern gegen Pasteurella anatipestifer
Ein Enzym-Immunosorbent Test (ELISA) zum Nachweis von Antikorpern gegen 
Pasteurella anatipestifer im Entenserum wird beschrieben. Zu Beginn der Testent- 
wicklung erfolgte die Uberprufung von Microtiterplatten verschiedener Hersteller 
auf ihre Eignung, P. anatipestifer-antigen zu binden. Die Nunc Immunoplatte II 
wurde wegen der insgesamt guten Reproduzierbarkeit (5,5% Variationskoef- 
fizient) und des Fehlens eines Kanteneffektes ausgewahlt. Die optimalen Reagenz- 
konzentrationen wurden bestimmt. Die Beigabe von 1,0M NaCl zum Waschpuffer 
reduzierte die nichtspezifische Bindung und erhohte die Testempfindlichkeit.
Der Test erwies sich insofern als spezifisch, als AntikSrper nur bei Enten nachge- 
wiesen werden konnten, die entweder mit P. anatipestifer infiziert oder geimpft 
worden waren. Seren von Enten, die mit anderen heterogenen bakteriellen Anti-
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genen immunisiert worden waren und gegen diese agglutinierende Antikorper 
besa/Sen, zeigten im ELISA keine nachweisbare Reaktion. Die Zwischenversuchs- 
variationskoeffizienten fur die Qualitatskontrolle von Serumpools mit hohen, 
mittleren und niederen Antikorpertitern gegen P. anatipestifer waren 6,8%, 
8,3% bzw. 8,6%. EinPrazisions-dosenprofil wurde abgeleitet. Eine graphische 
Darstellung der Absorbanz gegen log2 Serumendpunkttiter zeigte ein lineares 
Verhaltnis (r = 0,99) im untersuchten Bereich. Die abgeleitete Regressionslinie 
(P<0,001) wurde benutzt um den Absorbanzmesswert der fur eine einzige Serum- 
verdunnung 1:100 erhalten worden war, in einen log2 Titerwert zu transferieren.
Es konnte gezeigt werden, dajS der ELISA bei der Messung von Antikorperreak- 
tionen gegen eine Infektion mit P. anastipestifer Typ 2 der Schnellblutaggluti- 
nation und dem Agargelprazipitations-test weit uberlegen ist.
RESUMEN
Desarrollo de un ensayo de Inmunoabsorvente ligado a enzime para la 
deteccion de anticuerpos humorales contra Pasteurella anatipestifer
Se describe un ensayo de inmunoabsorvente ligado a enzime (ELISA) para la 
detecci6n de anticuerpos anatipestifer contra la Pasteurella en sueros de pato. 
Como parte inicial del desarrollo del ensayo, las placas de microtitulaci&n de 
diferentes manufacturadores fueron probadas desde el punto de vista de su con- 
veniencia paraunirse al antigeno de P. anatipestifer. Immunoplaca II Nunc escogida 
considerando su reproductibilidad sobretodo (5.5% de variation de eficiencia) y la 
ausencia de un efecto de bonde. Las concentraciones de los reactivos fueron 
determinadas y la inclusi&n de 1.0 M de NaCl en la soluci&n buffer de lavado 
redujo las uniones inespecificas y aumentb la sensibilidad de la prueba.
La prueba es especifica para aquellos anticuerpos los cuales fueron detectados 
solamente en aquellos patos expuestos a o como consecuencia de la vacunaci&n 
con P. anatipestifer; sueros de patos inmunizados con otros anttgenos bacterianos 
heterologos y que poseian anticuerpos aglutinantes contra ellos no dieron una 
respuesta detectable en ELISA. Los coeficientes de variaci&n de las pruebas 
de enmedio para el control de calidad de los pools de suero representando niveles 
altos medianos y bajos de anticuerpos contra la P. anatipestifer fueron el 6.8%, 
8.3% y 8.6% respectivamente de los cual se deriv& un perfil de dosis- precisi&n.
Una grafica de absorvencia versus log2 del suero en su titulo final mostro una 
relation linear (r = 0,99) sobre el rango investigado. La Tinea de regresion derivada 
(PC0.001) fue usada para transformar la medida de obsorvencia obtenida por 
una diluci6n sencilla de 1:100 del suero dentro de un valor de titulo log2 .
Se demostrb que la prueba de ELISA es un m&todo muy superior en comparacibn 
con la aglutinacibn r&pida en placa y la precipitation en agar para medir las 
respuestas de antisuerpos ante la exposicibn de la P. anatipestifer tipo 2.
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Influence of the route of infection of Pasteurella anatipestifer on 
the clinical and immune responses of White Pekin ducks
R. M. HATFIELD, B. A. MORRIS, Division o f  Clinical Biochemistry, Department o f  Biochemistry, 
University o f  Surrey, Guildford GU2 5XH
The clinical, pathological and immunological 
responses were compared in ducklings infected by the 
intramuscular, oral and intranasal routes with 
virulent Pasteurella anatipestifer. Intramuscular 
challenge resulted in clinical signs of infection and 
caused 100 per cent mortality within three days. No 
disease signs or death were observed in the orally 
challenged ducks. Whereas intranasal inoculation 
caused no deaths, signs of infection were observed in 
two of 12 birds four days later. In the orally 
challenged group, low concentrations of antibodies 
(0*17 log2 to 4*5 log2) were detected in the tracheal 
washes of five of nine birds examined using an 
enzyme-linked immunosorbent assay. Humoral anti­
bodies were detected in only one of these birds. In the 
intranasally infected group, serum antibody levels 
ranging in titre from 0*62 log2 to 6*2 log2 were found 
in four of nine birds examined over seven to 14 days 
following infection. Nine of the birds in this group 
were shown to have low concentrations of antibodies 
(0*50 log2 to 6 ‘33 log2) in the tracheal washings. The 
demonstration of antibodies in the tracheal washings, 
but not in the serum of nine birds examined, 
suggested that a local immune response had occurred. 
However, these studies have shown that antibodies 
present on the tracheal surface can also be derived 
from antibodies given intraperitoneally.
PASTEURELLA (Pfeifferella) anatipestifer, species 
incertae sedis, is responsible for an important septi- 
caemic disease in commercially raised ducklings. The 
onset of the disease is very rapid, with affected birds 
showing signs of occular discharge, diarrhoea and 
ataxia. Gross inflammatory responses associated with 
the brain, heart and air sacs are commonly found in 
the infected birds. However, the transmissibility of 
the disease by different routes remains unclear. 
Asplin (1956) was unable to reproduce the signs of 
disease in ducks given P  anatipestifer orally or intra­
nasally and demonstrated that wounds, particularly 
of the feet, were important in the transmission of the 
disease. Similarly epidemiological observations made 
during outbreaks of the disease by Leivobitz (1972) 
suggested that foot and leg lesions were associated in 
the transmission of infection. In contrast to these
reports, E. G. Harry (unpublished observations) 
demonstrated high mortality in ducks following intra­
muscular, intratracheal or oral administration of the 
organism. Vaccination against the disease has been 
shown to reduce mortality on farms where anati­
pestifer septicaemia was endemic (Harry and Deb 
1979, Layton and Sandhu 1984). Hatfield et al (1987) 
have described the development of an enzyme-linked 
immunosorbent assay (e l i s a ) for P  anatipestifer anti­
bodies and demonstrated the efficiency of the method 
in measuring the antibody response in ducks follow­
ing vaccination. However, information describing the 
magnitude of the immune mechanisms and their role 
in protection against the disease is lacking. This 
report describes the clinical and pathological observa­
tions following the attempted oral, intramuscular and 
intranasal infection of ducks with the organism. 
Furthermore, the humoral and local tracheal anti­
body responses following administration by these 
routes were investigated.
Materials and methods
Experimental animals
White Pekin ducks, reared to 16 days old in isola­
tion and each weighing approximately 1 kg at the start 
of treatment, were used in these experiments. Before 
these investigations, their sera were shown to contain 
no detectable antibodies to P  anatipestifer by the 
e l i s a  (Hatfield et al 1987).
Strain o f  P anatipestifer
P  anatipestifer type 2 was obtained from a com­
mercial flock infected with the disease. The isolate 
was serotyped using type specific antisera kindly 
supplied by E. G. Harry, Houghton Poultry Research 
Station. •
Preparation o f  infecting dose
P  anatipestifer was grown in 50 ml of tryptose soya 
broth (Difco) incubated at 37°C on a shaker 
apparatus, to give an optical density value of 1 - 0 at 
520 nm using a Corning 252 spectrophotometer. This
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TABLE 1: Clinical signs and lesions in ducks following oral and intranasal infection with P anatipestifer and recovery of the organism
Intranasal infection Oral infection
Bird Days after Clinical Organism Bird Days after Clinical Organism
number infection* s ig n st Lesionst isolation! num ber infection* s ig n s t Lesionst isolation!
1 0 _ 1 0 _
2 0 0/15 0 —  ■ 2 0 0/15 0 —
3 0 ■ — 3 0 —
4 0 — 4 0 —
5 4 A2/12 0 — 5 4 0/12 0 —
6 0 — 6 0 —
7 C2§,D2§,
E2§,F2§
+ 7 0 ' —
8 7 AB3/9 FI § —  • 8 7 0/9 0 —
9 C2§,D3§,
E2§,F2§
+ 9 0 —
10 FI § — 10 FI § —
11 10 B1/6 FI § — 11 10 0/6 0 —
12 D1§,F1§ — 12 F1§ ■ —
13 FI § — 13 F1§ —
14 14** 0 /3 FI § — 14 14** 0 /3 F1§ —
15 FI § - 15 0 -
* Three birds were removed at each time interval for necropsy 
+ A Diarrhoea, B W eight loss
t  C Heart, D Air sacs, E Oviduct, F Spleen
§ Grading lesions: 4 Severe, 3 M oderate, 2  Slight, 1 Minimal, 0 Normal
1 +  Organism isolated, — Organism not isolated a t necropsy
** No mortality w as recorded
broth culture was found to contain approximately 
1010 colony forming units (cfu) of P anatipestifer 
ml-1 as determined by the plate count method. A 
3 ml sample of this stock culture preparation was then 
diluted to give a final concentration of 109 cfu ml-1 of 
P  anatipestifer using molten Agar number 3 (Oxoid), 
cooled to 30°C, as diluent. The preparation was 
allowed to gel in three 5 ml syringes and designated as 
the oral challenge inoculum.
Infection o f  ducks and collection o f  samples
Five ducks were injected intramuscularly in the 
thigh with a 0* 1 ml dose of the tryptose soya broth 
culture containing 109 cfu of P  anatipestifer. A 
further 45 ducks were divided into three groups of 15 
birds each. One of these groups was infected intra- 
nasally by injecting 0-1 ml of the broth culture 
through a nebuliser into one of the nasal orifices. The 
second group was infected with 109 cfu of P  anati­
pestifer by administering 1 ml of the agar preparation 
into the oral cavity. The remaining 15 ducks were 
designated as uninfected controls. Each group was 
kept separate from the others and all groups of birds 
were observed daily for any signs of disease. At four* 
seven and 10 days after attempted infection, three 
birds were removed from each of the three groups and 
blood samples obtained. These birds were then killed 
by intravenous injection of pentobarbitone and the 
tracheas removed using the method described by 
Hawkes et al (1983). The lumen of the trachea was 
filled with 1 *0 ml of phosphate buffered saline (p b s ) /
Tween 80 buffer pH 7-0 (0-01 M Na2H P04, 2-5 mM 
NaH2P 0 4.2H20 , 1 - 0 M sodium chloride and 0-05 per 
cent Tween 80) and the contents gently washed by 
injecting and aspirating the wash fluid using a pasteur 
pipette. The tracheal washings were expressed into a 
glass tube, vortexed for 30 seconds, cleared by centri­
fugation at 1000 g for 10 minutes, and the tracheal 
wash fluid supernatant collected. The deposits were 
examined and any samples contaminated with red 
blood cells were discarded. Both sera and tracheal 
wash samples were stored at -  20°C until required for 
the determination of levels of antibodies to P  anati­
pestifer by the e l i s a . Each bird killed at the time 
interval indicated was autopsied and scored for any 
lesions that were present. In addition, samples of 
brain, heart muscle, air sacs and spleen were collected 
for the attempted isolation of P  anatipestifer by 
culture.
Preparation o f  allogeneic anti-P anatipestifer 
antiserum pool
Seven ducks were challenged at 40 days old with 107 
cfu of P  anatipestifer given intramuscularly; sera 
obtained from these birds, 14 days later, were shown 
to contain high levels (over 11*9 log2) of antibodies to 
P anatipestifer by the e l i s a . These sera were there­
fore pooled and, following heat inactivation at 56°C 
for 30 minutes, were filtered through a 0-45 /urn 
cellulose acetate membrane filter (Oxoid). The anti­
serum pool was checked for sterility and also screened 
for endotoxin contamination using the E-Toxate kit
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FIG 1: Calculation of the  log2 end-point titre for tracheal w ash fluids 
assayed by the  ELISA. The titre is calculated where the  sample 
dilution curve intercepts the  line representing the  limit of detection of 
the  assay
(Sigma). The pool was found to have an end-point 
titre of 12’5 log2.
orthophenylene diamine. However, to determine the 
levels of antibodies in tracheal wash fluid, it was 
necessary to re-optimise the e l i s a  in respect of the 
concentrations of test sample in the assay. A positive 
sample pool was obtained by washing the tracheas 
from five commercially raised ducks showing clinical 
signs of infection. Subsequent post mortem and 
bacteriological examination of the affected birds 
confirmed the presence of P  anatipestifer.
The tracheas from five, 16-day-old ducks reared in 
isolation were washed and the washings shown to 
contain no detectable levels of antibodies to P  
anatipestifer by the e l i s a . These washings were 
combined to form the negative sample pool. Both 
positive and negative pools were used neat and diluted 
from 1:2 to 1:32 in PBS/Tween 80 buffer. Each 
dilution of the positive and negative pools was added 
in duplicate to coated and uncoated wells o f the assay 
plate and the e l i s a  performed using the same 
concentrations of anti-species immunoglobulins as 
described for the assay of antibodies in sera. Non­
specific binding was evaluated as the amount of 
colour produced in the absence of antigen.
Prediction curve
A prediction curve for converting the measured 
absorbance produced by the undiluted tracheal wash
Passive immunisation
A group of 15 ducks was injected intraperitoneally 
with 2-5 ml of the anti-P anatipestifer antiserum 
pool. A similar group of 15 ducks receiving no anti­
serum was included as unimmunised controls. At 
intervals of one, two and five days following passive 
immunisation, five birds were removed from each of 
the immunised and control groups. A blood sample 
was obtained from each of the birds and the birds 
were then killed. The tracheas were removed and 
washed as described previously. Samples were stored 
at -20°C  until required for P  anatipestifer antibody 
determination by the e l i s a .
ELISA
The levels of antibodies to P  anatipestifer in the 
serum samples were measured using the e l i s a  
described by Hatfield et al (1987). In brief, sera were 
diluted to 1:100 in PBS/Tween 80 buffer pH 7-0 con­
taining 1 *0 M sodium chloride (Case et al 1982) and 
assayed in duplicate against fixed concentrations of 
antigen (1:8), rabbit anti-duck Ig antiserum (1:600) 
(Nordic Immunological Laboratories) and horse­
radish peroxidase labelled donkey anti-rabbit IgG 
(1:4000) (Guildhay Antisera) with a substrate of
0 -9 -
0 - 8 -
0 -7 -
0 - 6 -
8
I  0 -5 -  
o
0 -4 -
y =  0 * 1 7 + 0 -1 2 x  
r =  0-97
0 -3 -
0 - 2 -
71 2 3 5 60 4
Tracheal w ash sam ple dilution (log2)
FIG 2: Relationship betw een the  absorbance of undiluted tracheal 
w ash fluid, as determined by the  ELISA, and th e  corresponding end­
point titre. The derived prediction curve enables th e  end-point titre to  
be predicted from the absorbance m easurem ent of undiluted 
tracheal w ash fluid in the  ELISA
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TABLE 2: Optimisation of tracheal wash sample dilution incubated in the presence of fixed 
concentrations of rabbit anti-duck immunoglobulin (R A D Ig) (1 :6 0 0 )  and enzyme-labelled 
conjugate (1 :4 0 0 0 )
Sam ple pool Undiluted
Dilution of tracheal w ash sample 
1:2 1:4 1:8 1:16 1:32
Positive 1-2 1-02 0-81 0-60 0-41 0-29
Negative 0 0 9 0-06 0-05 0 0 4 0 0 4 0 0 5
NSB 0-05 0 0 7 0 0 5 0-05 0-06 0-06
Corrected values 1-11* 0-96 0-76 0-56 0-37 0-24
The enzym e-substrate reaction w as allowed to  proceed for 45 minutes a t 22°C 
* Values indicate the  difference in the  m ean absorbance m easurem ent of the  positive and 
Negative control pools after these  had been corrected for non-specific binding of the  RADIg and 
conjugate in the  antigen-coated wells 
NSB Non-specific binding
sample into a log2 end-point titre value was derived as 
follows. Samples of tracheal washings obtained from 
the intranasally infected group of birds were diluted 
in log2 steps and assayed by the e l i s a . The end-point 
titre was determined where the dilution curve inter­
cepted the baseline for the assay. The baseline was 
defined as the mean absorbance value, plus two 
standard deviations, for undiluted samples obtained 
from nine uninfected ducks. A further graph of the 
measured absorbance determined for undiluted 
tracheal wash fluid versus its end-point titre was then 
constructed.
Results
Administration o f  the oral and intranasal challenge 
dose
No practical difficulties were found in ensuring the 
retention of the challenge dose when given orally or 
intranasally to birds by the methods described.
Clinical signs and mortality
All five birds infected intramuscularly showed signs 
of incoordination, accompanied by diarrhoea at two 
days after infection. Signs persisted until these birds 
died one day later. In the intranasally challenged 
group, diarrhoea was recorded four days later in two 
of the remaining 12 birds. Three days later, three of 
the birds in the same group were noted to have lost 
weight. No signs of respiratory distress or ataxia were 
recorded in any of this group of birds over the 
duration of these investigations. In the orally infected 
group, no clinical signs of infection or weight loss 
were observed. The results of observations for the 
orally and intranasally challenged groups o f birds are 
summarised in Table 1.
Gross lesions
At post mortem examination, severe pericarditis,
thickening of the air sacs and salpingitis were found in 
the intramuscularly challenged group of birds.
Seven days after intranasal inoculation, two of the 
three birds examined were found to have a fibrinous 
pericarditis, salpingitis and lesions associated with 
both the thoracic and abdominal air sacs. No gross 
lesions were found in the birds in this group killed at 
10 and 14 days after intranasal infection.
In the orally infected group, slight enlargement of 
the spleen was recorded in four of the six birds 
examined over the period of 10 to 14 days; however, 
no other lesions were found.
P anatipestifer isolation
P  anatipestifer was isolated, in pure culture, from 
the brain and heart muscle of the five birds challenged 
intramuscularly. In the intranasally challenged group, 
the organism was recovered from the brains in two of 
the three birds examined and also from the air sacs of 
one of these birds seven days after infection. 
Attempts to isolate the organism from the brain, 
spleen and air sacs from each of the birds examined in 
the orally challenged group were unsuccessful.
Optimisation o f  dilution o f  tracheal washings 
in the e l is a
The results show (Table 2) that undiluted tracheal 
wash preparation gave the greatest discrimination 
between the positive and negative sample pools after 
these had been corrected for non-specific binding. 
For this reason, it was decided not to dilute the 
tracheal fluids further for use in the assay.
Prediction curve
The limit of detection for the assay was found to be 
0*18 absorbance units. Fig 1 shows the sample 
dilution curves for the tracheal washings from nine 
ducks when assayed by serial titration, in log2 steps, 
by the e l i s a . Using this information, the prediction
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FIG 3: Concentrations of antibodies in sera (a,c) and tracheal w ashes 
(b,d) from ducks following oral or intranasal infection with P anati­
pestifer. Each symbol represents the  serum  and tracheal sample end­
point titre for each bird killed a t the  tim e indicated. The solid line 
represents the  m ean sample log2 end-point titre value
curve was derived (Fig 2) and a graph of the measured 
absorbances obtained for these samples versus log2 
end-point titre for which a linear relationship was 
derived (r = 0-97).
Ig antibodies in sera and tracheal washings
Fig 3 shows that circulating antibodies to P  anati­
pestifer were first detected at seven days in sera 
obtained from two of the three ducks examined in the 
intranasally challenged group. Three days later, high 
levels of antibodies were found in only one of the 
three ducks killed at this time. At 14 days, no circulat­
ing antibodies were detectable in the remaining three 
birds. Antibodies were first detectable at four days, in 
the trachea in two of the three birds examined follow­
ing nasal instillation. At seven days, increased con­
centrations of antibodies were found in the trachea in 
two of the three birds, but these were still extremely 
low (4’83 log2 and 6 ’33 log^. Over the 10 to 14 day 
period, antibodies were detected in the trachea of five 
of the six birds, ranging in end-point titre value from 
1 *42 log2 to 4* 50 log2. Tracheal washings from two of 
three ducks killed at 14 days gave end-point titres of 
1 -42 log2 and 4*5 log2, but no circulating antibodies 
were detected in the serum of the same birds. In the 
orally challenged group, circulating antibodies were 
found in only one bird at seven days as shown in 
Fig 3. At seven to 14 days after infection, end-point 
titre values ranging from 0*17 log2 to 4*5 log2 were 
measured in the tracheal washings obtained from five 
of the remaining nine ducks in this group. A poor 
correlation (r = 0*30) between levels of antibodies in 
the tracheal washings and sera was found.
Passive immunisation
Table 3 shows the levels of P  anatipestifer anti­
bodies detected in the trachea and sera of ducks 
passively immunised with anti-P anatipestifer anti­
serum. Twenty-four hours after immunisation, five 
of the birds examined were shown to have P  anati­
pestifer antibodies present in the trachea as well as the 
sera. The mean e l i s a  log2 end-point titres for the sera 
and tracheal washes obtained from this group of birds 
were 4 ‘26 log2 and 3-45 log2 respectively. Over the 
period of two to five days, the mean serum end-point 
titres had fallen from 2*7 log2 to 1-06 log2. A similar 
decline in the mean tracheal antibody titre was 
recorded over the same period. However, at five days, 
tracheal antibodies were barely detectable in four of 
five birds examined. The fifth bird in this group had 
no tracheal antibodies demonstrable by the e l i s a . No 
antibodies to P  anatipestifer were found in the 
trachea and sera obtained from the unimmunised 
group of ducks.
Discussion
The levels of P  anatipestifer antibodies in sera and 
tracheas were expressed as Iog2 end-point titres deter­
mined by reference to a prediction curve. Generalised 
parallelism between the constructed dose-response 
curves for the nine tracheal samples was not found; 
however, the use of a prediction curve for converting 
the measured absorbance of these samples into an 
end-point titre was justified by demonstrating a high 
measure of correlation (r = 0 * 97) between the two 
parameters.
TABLE 3: Levels of antibodies to P  anatipestifer in tracheal 
washings and sera, expressed as log2 end-point titres, for three 
groups of five birds administered anti-P anatipestifer antiserum 
intraperitoneally
Bird
num ber Sam ple
Days after serum  administration 
1 2  5
1 TW* 3-42t 1-33 0-17
Serum 5-464 2-62 0-92
2 TW ‘ 0-25 1-75 0-25
Serum 3-69 2-92 1-08
3 TW 3-25 0-17 0-92
Serum 2-46 3-00 1-00
4 TW 6-17 0-33 <0-1
Serum 5-54 1-85 1-23
5 TW 4-17 1-75 0-25
Serum 4-15 3-23 1-08
Mean TW 3-45 ± 2-135 1-07 ±0-77 0-40 ±  0-35
Serum 4-26 ± 1-29 2-72 ±  0-54 1-06 ±0-11
* Tracheal washing
+ ,4  Log2 end-point titre values for tracheal w ashings and sera w hen 
assayed undiluted and a t a dilution of 1:100, respectively, in the  
ELISA
§ Standard deviation
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This study has evaluated the clinical, pathological 
and immunological responses in ducks following the 
administration of P  anatipestifer by three different 
routes. Standardisation of the factors which may 
influence the establishment of infection in groups of 
experimental animal is crucial. To this end, ducks 
used in these studies were derived from the same batch 
and reared in special isolation units. Birds were 
screened before use for previous exposure to P  anati­
pestifer infection and shown to be free of humoral 
antibodies to this organism. The results of the 
investigations reported in the present paper have 
shown that the clinical and pathological responses in 
the duck vary considerably depending on the route of 
infection by the organism, despite the high patho­
genicity of the serotype used. Clinical signs of disease, 
incoordination and diarrhoea, were observed in all 
five ducks given P  anatipestifer intramuscularly and 
consequently 100 per cent mortality occurred in this 
group two days later. In contrast, it was noted that 
signs of disease were reduced in ducks infected orally 
or intranasally. These findings agree with those of 
Asplin (1956), who reported high mortality in Khaki 
Campbell ducklings when given P  anatipestifer intra­
muscularly, but none when the birds were challenged 
by the oral and intranasal routes. However, these 
present studies have shown that the establishment of 
infection and subsequent signs of disease in the 
affected birds can occasionally occur after intranasal 
administration. Evidence of an established infection 
in this group was demonstrated by the successful 
isolation of the challenge serotype from the brain in 
two of the three birds examined seven days later. 
Further evidence of infection, indicated by the 
presence of serum antibodies, was recorded in two of 
the six remaining birds in the intranasally challenged 
group; however, no gross lesions were found in these 
birds.
The considerable variation in susceptibility found 
in the intranasally challenged group suggests a greater 
complexity of the pathogen-host relationship in this 
instance. Low concentrations of antibodies (0-5 log2 
to 6*33 log2) were detected in the tracheas in nine of 
12 birds examined in the intranasally challenged 
group. It is realised, however, that these values may 
not represent the actual levels of antibodies present in 
the tracheas. The dilution effect incurred in removing 
antibodies from the trachea or inefficient recovery 
may effect the accuracy of the result.
A total of nine birds examined from both the orally 
and intranasally challenged groups were found to 
have antibodies present in the tracheal washings but 
not in the serum. This suggests that antibodies were 
present in the tracheas as a result of local synthesis. 
However, the assay system used detected antibodies 
principally of the IgG class with possibly some IgM, 
but would not have detected IgA class antibodies in
test samples (Nordic Immunological Laboratories, 
personal communication). Since anti-duck IgA anti­
sera were not available commercially, therefore the 
possible expression of IgA was not investigated. In 
view of these findings, a degree of protection in the 
presence of a local immune response is suggested; 
however, the possible involvement of cell-mediated 
immunity is not known. In the orally challenged 
group, circulating antibodies were detected in only 
one of the 15 birds examined. The pH of the gizzard, 
2*33, and that of the proventriculus, 3-41 (Sturkie 
1954), in the duck may have an influence on the 
survival of P  anatipestifer organisms entering by this 
route. However, the presence of lymphoid tissue in 
the lamina propria of the proventriculus and the gut 
(Payne 1971) may suggest that other immune 
mechanisms are involved. Antibodies were detected in 
the tracheas in five of the nine remaining birds in this 
group, but at levels barely exceeding the limit of 
detection of the assay. The local response detected in 
this group indicates respiratory exposure, possibly 
following excretion of the organisms in the faeces. 
However, even though the method used for the 
administration of the oral dose was found to be very 
effective, this does not negate the possibility that 
some contamination of the respiratory tract may have 
occurred during dosing.
The results of the passive immunisation studies 
indicate that the intraperitoneal administration of P  
anatipestifer antibodies to the duck results in rapid 
transfer of serum antibodies to the surface of the 
tracheal mucosa. This may suggest that the protective 
effect at the mucosal surface is probably enhanced in 
the presence of circulating antibodies. It is suggested, 
therefore, that the intramuscular vaccination of 
ducks against the disease may be of value in reducing 
the severity of respiratory lesions, particularly on 
farms where high respiratory exposure might be 
expected.
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Development o f an ELISA for the Detection of 
Antibodies to Pasteurella anatipestifer
R. M. H atfield, B. A. M orris and R. R. H enry
Division o f  C linical Biochemistry, D epartm ent o f  Biochemistry, 
University o f  Surrey, Guildford, UK
IN T R O D U C T IO N
Pasteurella anatipestifer (PA), species incertae sedis, is responsible for an 
economically im p o rtan t  disease o f  commercially raised ducks (Anas 
platyrhynchos). D ucks o f  all ages are susceptible to infection, bu t the disease 
is usually associated with birds aged between three and  six weeks. 
U nacceptable  losses as a result o f  high m orta lity  and  the necessity for 
increased culling and  condem nation  at slaughter usually follow. T he 
poultry  industry  currently  uses rapid slide agglu tination  (RSA) and  a g a r  gel 
precipitin (AGP) m ethods to detect antibodies to this o rganism ; however, 
these procedures are  insensitive and  only detect agg lu tinating  a n d /o r  
precipitating antibodies. T here  is a need for a rapid, sensitive and  
reproducible m ethod  capable  o f  screening large num bers  o f  sera for anti- 
PA antibodies. This poste r presen ta tion  describes the first developm ent and  
validation o f  an E LISA  for the detection o f  anti-PA an tibod ies  in duck  
sera.
M A T E R IA L S  A N D  M E T H O D S
Antigen
A freeze-thaw ed extract o f  PA type 2 con ta in ing  50 m g p ro te in /100  ml was 
diluted 1:8 in c a rb o n a te -b ic a rb o n a te  buffer (pH 9-6) and  100/d volum es o f  
th is .p repara tion  used to coa t the assay wells o f  the m ic ro ti tra t io n  plate.
Positive and Negative Reference Sera
F o u r  birds were inoculated  with an a lhydrogel-adsorbed  form alised PA 
vaccine given a t 23 and  48 days after hatching. These birds were bled 10
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days following the booster injection and the harvested sera com bined to 
form the positive control pool.
N on-vaccinated birds, reared in special isolation units, were bled at 27 
days o f  age and these samples used to provide the negative contro l pool.
Effect o f Sodium Chloride Concentration in PBS/Tween 80 Wash Buffer on 
Non-specific Binding (NSB)
Positive and negative reference sera were diluted to 1:100 in each o f  a series 
o f  PBS/Tween 80 buffers con ta in ing  N aCl concen tra tions ranging from 
0-15 to 2*0m and  the ELISA perform ed. NSB was evaluated  as the am oun t 
o f  co lour developed in the absence o f  antigen.
ELISA
100/d volumes o f  the test sera diluted to 1:100 in PBS/Tween 80 were 
pipetted into the antigen-coated wells o f  a m icro titra tion  plate and 
incubated for 1 h at 37°C. The plate was then washed and  100 /d o f  a 1:600 
d ilu tion o f  rabbit anti-duck im m unoglobulin  an tiserum  were added. After 
incubation  for 1 h, the plate was again washed and  100 /d o f  a horseradish  
peroxidase-labelled donkey an ti-rabb it  IgG antiserum  diluted to 1:4000 
were added, followed by a further incubation for 1 h. U n b o u n d  conjugate 
was rem oved by washing and the substra te  hydrogen peroxide with o- 
phenylenediam ine, prepared in p h o sp h a te -c itra te  buffer (pH 5*0), added. 
The reaction was stopped after 45 min at 22°C by the add ition  o f  100 /d o f  
2-5 m H 2SOa .
Prediction Curve
Nineteen sera were assayed at a 1:100 dilution in the E L ISA  and  the 
m easured absorbance  obtained  for each o f  these samples p lo tted  against 
the ^crum end-poin t titre. The line o f  best fit was ob tained  using the m ethod 
o f  least squares regression analysis.
Precision
T hree  duck serum QC pools, representing varying levels o f  anti-PA
antibodies, were added random ly  to ten antigen-coated  wells o f  the assay
plate and  the E LISA  perform ed. F rom  the s tand ard  deviation* o f  the
abso rbance  m easurem ents, the within-assay CV was derived for the serum
Q C  pools. T he between-assay CV (n =  60) was derived by assaying the same
Q C  pools in the ELISA  over six consecutive assays.
r *
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Specificity
Antisera were raised against PA types 1 and 2, Salmonella typhimuriunu  
Salm onella ana (urn, Pasteurella m ultocida , Escherichia coli and A cine to- 
hacter calcoaceticm \ and  samples shown by RSA to contain  agglutinating 
antibodies to the hom ologous antigen. These sera were then assayed in the 
ELISA.
Comparison of ELISA, RSA and AG P Tests for Detecting Anti-PA 
Antibodies
D ucks were injected 27 days after hatching with a PA vaccine and  bled at 
intervals thereafter. Serum  samples were stored at — 20°C until required.
R ESU LTS
Preparation of PA Antigen
This organism  was found to grow very readily on blood agar, and  the stock 
antigen  p rep a ra t io n  used for the d u ra t io n  o f  these investigations 
dem onstra ted  no loss o f  im m unoreactiv ity  in the ELISA.
Reduction of NSB in the ELISA
It was found that by increasing the N aCl concentra tion  in the PBS/ 
Tween 80 diluent progressively from 0*15 to 1*0m it reduced the NSB value 
from  0*25 to 0*04 absorbance  units. N aC l was added to the PBS/Tween 80 
wash buffer to give a final concentra tion  o f  1*0m in all further work.
Prediction Curve
Significant correlation  (r =  0*99) was dem onstra ted  between the abso rbance  
m easurem ents ob ta ined  f o r a  1:100 dilution o f  sample in the E LISA  and  its 
end-po in t titre (Fig. 1). This enabled serum an tibody  levels to be expressed 
as a titre value.
Precision
W ithin-assay CVs o f  3*2,4*9 and  6*3% respectively were found for the three 
duck serum  Q C  pools representing high, m id-range and low levels o f  anti- 
PA antibodies. Similarly, between-assay CVs o f  6*8, 8*3 and  8*6% 
respectively were obtained.
Specificity
Samples know n to con ta in  agglu tinating  antibodies to the po ten tia lly  
interfering bacterial antigens gave no significant reactions. T here  were no
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Fig. 1. Correlation between end-point titre and A460 of a 1:100 dilution of 19
duck sera as determined by ELISA.
false positives, the ELISA  detecting antibodies to  PA only  in serum  samples 
from  birds inoculated with tha t organism.
Comparison of ELISA, RSA and A G P
F o u r  days after vaccination, anti-PA  antibodies were ju s t  detectable in two 
o f  the five birds. Three days later, an tibodies were detected by ELISA  in all 
five birds, but no t by RSA o r  AGP. Ten days after vaccination, 
agglu tinating  antibodies were detected in two o f  the experim ental birds by 
RSA. N o t until four days later were precipitating antibodies show n to be 
present in one o f  these birds by AGP.
C O N C L U S IO N S
A reproducib le  and  specific E LISA  has been developed for the detection o f  
a n ti-P. unutipestifer antibodies. High NSBs initially encountered  were 
reduced by the use o f  1*0m N aC l in the sam ple diluent.
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It was established tha t  log2 end-poin t titre exhibited a significant linear 
co rre la tion  with A 450 o f  a 1:100 dilution o f  serum in the ELISA and 
enabled a prediction curve to  be constructed.
T his assay is able to detect an ti -P. anatipestifer antibodies earlier than 
either RSA o r  A G P  and  therefore provides a much earlier warning o f  onset 
o f  infection.
